<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Sci</journal-id><journal-id journal-id-type="iso-abbrev">Brain Sci</journal-id><journal-id journal-id-type="publisher-id">brainsci</journal-id><journal-title-group><journal-title>Brain Sciences</journal-title></journal-title-group><issn pub-type="epub">2076-3425</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7764187</article-id><article-id pub-id-type="pmid">33321899</article-id><article-id pub-id-type="doi">10.3390/brainsci10120964</article-id><article-id pub-id-type="publisher-id">brainsci-10-00964</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Indian Medicinal Herbs and Formulations for Alzheimer&#x02019;s Disease, from Traditional Knowledge to Scientific Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mehla</surname><given-names>Jogender</given-names></name><xref ref-type="aff" rid="af1-brainsci-10-00964">1</xref><xref rid="c1-brainsci-10-00964" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Pooja</given-names></name><xref ref-type="aff" rid="af2-brainsci-10-00964">2</xref><xref rid="c1-brainsci-10-00964" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Pahuja</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="af3-brainsci-10-00964">3</xref></contrib><contrib contrib-type="author"><name><surname>Diwan</surname><given-names>Deepti</given-names></name><xref ref-type="aff" rid="af1-brainsci-10-00964">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7264-0849</contrib-id><name><surname>Diksha</surname><given-names>Diksha</given-names></name><xref ref-type="aff" rid="af2-brainsci-10-00964">2</xref></contrib></contrib-group><aff id="af1-brainsci-10-00964"><label>1</label>Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA; <email>diwand@wustl.edu</email></aff><aff id="af2-brainsci-10-00964"><label>2</label>Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110029, India; <email>ddiksha896@gmail.com</email></aff><aff id="af3-brainsci-10-00964"><label>3</label>Division of Basic Medical Sciences, Indian Council of Medical Research, Ministry of Health and Family Welfare, Government of India, V. Ramalingaswamy Bhawan, New Delhi 110029, India; <email>pmonika@icmr.gov.in</email></aff><author-notes><corresp id="c1-brainsci-10-00964"><label>*</label>Correspondence: <email>jogender.mehla@wustl.edu</email> (J.M.); <email>drgupta.pooja@gmail.com</email> (P.G.)</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>10</volume><issue>12</issue><elocation-id>964</elocation-id><history><date date-type="received"><day>17</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>07</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cognitive impairment, associated with ageing, stress, hypertension and various neurodegenerative disorders including Parkinson&#x02019;s disease and epilepsy, is a major health issue. The present review focuses on Alzheimer&#x02019;s disease (AD), since it is the most important cause of cognitive impairment. It is characterized by progressive memory loss, language deficits, depression, agitation, mood disturbances and psychosis. Although the hallmarks of AD are cholinergic dysfunction, &#x003b2;-amyloid plaques and neurofibrillary tangle formation, it is also associated with derangement of other neurotransmitters, elevated levels of advanced glycation end products, oxidative damage, neuroinflammation, genetic and environmental factors. On one hand, this complex etiopathology makes a response to commonly used drugs such as donepezil, rivastigmine, galantamine and memantine less predictable and often unsatisfactory. On the other hand, it supports the use of herbal medicines due to their nonspecific antioxidant and anti-inflammatory activity and specific cholinesterase inhibitory activity. The popularity of herbal medicines is also increasing due to their perceived effectiveness, safety and affordability. In the present article, the experimental and clinical evidence have been reviewed for various Indian herbal medicines such as <italic>Centella asiatica</italic>, <italic>Bacopa monnieri</italic>, <italic>Curcuma longa</italic>, <italic>Clitoria ternatea</italic>, <italic>Withania somnifera</italic>, <italic>Celastrus paniculatus</italic>, <italic>Evolvulus alsinoides</italic>, <italic>Desmodium gangeticum</italic>, <italic>Eclipta alba</italic>, <italic>Moringa oleifera</italic> and <italic>Convolvulus pluricaulis,</italic> which have shown potential in cognitive impairment. Some commonly available herbal formulations for memory impairment in India have also been reviewed.</p></abstract><kwd-group><kwd>Alzheimer&#x02019;s disease</kwd><kwd>cognitive impairment</kwd><kwd>herbal medicine</kwd><kwd>memory</kwd><kwd>complimentary and alternative medicine</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-brainsci-10-00964"><title>1. Introduction</title><p>Ayurveda mentions three aspects of mental abilities, i.e., Dhi (process of acquisition/learning), Dhuti (process of retention) and Smriti (process of recall) [<xref rid="B1-brainsci-10-00964" ref-type="bibr">1</xref>]. A dysfunction in the process of acquisition/learning, retention or recall is known as dementia. Worldwide, about 40 million elderly are living with dementia [<xref rid="B2-brainsci-10-00964" ref-type="bibr">2</xref>,<xref rid="B3-brainsci-10-00964" ref-type="bibr">3</xref>]. In India, an estimated 3.7 million elderly people have dementia, and the prevalence is expected to increase two-fold by 2030 and three-fold by 2050 [<xref rid="B4-brainsci-10-00964" ref-type="bibr">4</xref>]. Dementia is associated with neurodegenerative disorders such as Alzheimer&#x02019;s disease (AD), Parkinson&#x02019;s disease and epilepsy. This review is focused on the potential of herbal medicine in AD since it is responsible for more than two-thirds of all dementia cases [<xref rid="B5-brainsci-10-00964" ref-type="bibr">5</xref>,<xref rid="B6-brainsci-10-00964" ref-type="bibr">6</xref>].</p><p>Cognitive functions that are mainly affected in AD patients include memory, executive functioning, language, visuospatial functioning and attention. Several hypotheses have been proposed for establishing the cause of AD. Cholinergic hypothesis, which is the oldest theory, describes acetylcholine (ACh) deficiency as the causative factor [<xref rid="B7-brainsci-10-00964" ref-type="bibr">7</xref>]. Currently available therapies for AD management are based on this hypothesis [<xref rid="B8-brainsci-10-00964" ref-type="bibr">8</xref>]. The &#x003b2;-amyloid hypothesis, most cogent hypothesis [<xref rid="B9-brainsci-10-00964" ref-type="bibr">9</xref>,<xref rid="B10-brainsci-10-00964" ref-type="bibr">10</xref>,<xref rid="B11-brainsci-10-00964" ref-type="bibr">11</xref>,<xref rid="B12-brainsci-10-00964" ref-type="bibr">12</xref>] provides the basis for development of new therapeutic strategies for AD treatment [<xref rid="B13-brainsci-10-00964" ref-type="bibr">13</xref>]. The histopathological hallmarks of AD are neuritic plaque and neurofibrillary tangle (NFT) formation in the brain [<xref rid="B14-brainsci-10-00964" ref-type="bibr">14</xref>]. Other associated factors that may also contribute to neurodegeneration in AD are elevated levels of advanced glycation end products, oxidative damage and neuroinflammation (<xref ref-type="fig" rid="brainsci-10-00964-f001">Figure 1</xref>). The involvement of free radicals and inflammation in pathogenesis of AD hint towards the possible role of antioxidant and anti-inflammatory agents as therapeutic tools [<xref rid="B15-brainsci-10-00964" ref-type="bibr">15</xref>]. Studies have also reported that antioxidants protect against A&#x003b2; induced neuronal toxicity [<xref rid="B16-brainsci-10-00964" ref-type="bibr">16</xref>,<xref rid="B17-brainsci-10-00964" ref-type="bibr">17</xref>]. Fuzhisan (FZS), a herbal drug, demonstrated a neuroprotective effect by inhibiting A&#x003b2; (25&#x02013;35)-induced activation of cyclin-dependent kinase 5, calcium influx, calpain activation and tau hyperphosphorylation [<xref rid="B18-brainsci-10-00964" ref-type="bibr">18</xref>]. Inhibitory effect of an aqueous extract of <italic>Ceylon cinnamon (C. zeylanicum)</italic> on tau aggregation and filament formation has also been reported [<xref rid="B19-brainsci-10-00964" ref-type="bibr">19</xref>].</p></sec><sec id="sec2-brainsci-10-00964"><title>2. Limitations of Currently Approved Cognition Enhancers</title><p>Currently approved drugs for AD include cholinesterase inhibitors (donepezil, rivastigmine and galantamine) and NMDA receptor antagonist (memantine). Cholinesterase inhibitors provide only symptomatic relief of behavioral deficits without modifying the complex pathologies in mild to moderate AD patients [<xref rid="B20-brainsci-10-00964" ref-type="bibr">20</xref>]. However, memantine is mainly recommended for moderate to severe AD cases [<xref rid="B20-brainsci-10-00964" ref-type="bibr">20</xref>]. Cholinesterase inhibitors significantly improve the cognition in patients with mild to moderate AD but their efficacy for neuropsychiatric symptoms is still questionable. AD patients receiving cholinesterase inhibitors experience adverse effects like nausea, vomiting, diarrhea, dizziness, etc. [<xref rid="B21-brainsci-10-00964" ref-type="bibr">21</xref>]. The common adverse effects associated with AChE inhibitors are nausea, vomiting, diarrhea, abdominal pain, loss of appetite and weight, though these can be minimized by slow dose escalation and administration with food. Other adverse effects of AChE inhibitors such as extrapyramidal symptoms, sleep disorder and cardiorespiratory adverse effects, are associated with central cholinergic over-activity whereas muscle cramps, weakness and urinary incontinence, are associated with peripheral cholinergic over-activity [<xref rid="B22-brainsci-10-00964" ref-type="bibr">22</xref>]. These adverse effects are often dose limiting and disabling in nature. Further, AChE inhibitors do not address neuronal degeneration and associated changes in the brain.</p><p>Cholinergic dysfunction, amyloid-<italic>&#x003b2;</italic> neurotoxicity, oxidative damage and inflammation have been targeted for treatment of AD but with limited success [<xref rid="B23-brainsci-10-00964" ref-type="bibr">23</xref>,<xref rid="B24-brainsci-10-00964" ref-type="bibr">24</xref>]. Studies indicate that antioxidants (vitamins E and C) and non-steroidal anti-inflammatory drugs slow the progression of AD [<xref rid="B25-brainsci-10-00964" ref-type="bibr">25</xref>,<xref rid="B26-brainsci-10-00964" ref-type="bibr">26</xref>,<xref rid="B27-brainsci-10-00964" ref-type="bibr">27</xref>,<xref rid="B28-brainsci-10-00964" ref-type="bibr">28</xref>,<xref rid="B29-brainsci-10-00964" ref-type="bibr">29</xref>,<xref rid="B30-brainsci-10-00964" ref-type="bibr">30</xref>]. Hormone replacement therapy has also been tried as a therapeutic strategy. Though it performed better than tacrine [<xref rid="B31-brainsci-10-00964" ref-type="bibr">31</xref>], it is no longer recommended, as it may increase the risk of adverse cardiovascular events and breast cancer [<xref rid="B32-brainsci-10-00964" ref-type="bibr">32</xref>].</p><p>Memantine showed promising anti-Alzheimer effects in preclinical experimental models, however, in clinical studies, it has not shown clear therapeutic efficacy in AD [<xref rid="B33-brainsci-10-00964" ref-type="bibr">33</xref>]. It is currently being used in the treatment of moderate to severe AD. The rate of decline in behavioral and functional impairment in patients with moderate to severe AD is reduced by memantine [<xref rid="B34-brainsci-10-00964" ref-type="bibr">34</xref>]. Patients taking memantine experience adverse effects like fatigue, pain, confusion, urinary incontinence, urinary tract infection, peripheral edema, etc. [<xref rid="B35-brainsci-10-00964" ref-type="bibr">35</xref>]. Thus, the search continues for effective and affordable medicines, which when prescribed for long duration, have acceptable adverse effects or interaction with food and drugs and delay the progression or reverse the disease process.</p><p>Herbal medicines, supported by a wealth of traditional knowledge, may serve the purpose as they can target AD pathophysiology at multiple sites, both at cellular and molecular levels. Though the mechanisms of action of herbal medicines are not clear, it has been proposed that they exert their protective effects against cognitive impairment through nonspecific antioxidant and anti-inflammatory activities and through specific action on AChE, &#x003b2;-amyloid fibril formation and tau aggregation (<xref ref-type="fig" rid="brainsci-10-00964-f002">Figure 2</xref>) [<xref rid="B19-brainsci-10-00964" ref-type="bibr">19</xref>,<xref rid="B36-brainsci-10-00964" ref-type="bibr">36</xref>].</p><p>Therefore, the present article reviews selected herbal drugs and formulations commonly studied for the treatment of AD.</p></sec><sec id="sec3-brainsci-10-00964"><title>3. Herbal Medicines for Alzheimer&#x02019;s Disease, Experimental and Clinical Evidence</title><p>Herbal drugs and complementary medicines have been used since ancient times for treatment of neurological disorders. Several herbal medicines worldwide have been used for neurodegenerative disorders. For example, <italic>Salvia lavandulaefolia</italic> (Spanish sage) and <italic>Salvia officinalis</italic> (common sage) are being used for improving memory in Europe since the 16th century [<xref rid="B37-brainsci-10-00964" ref-type="bibr">37</xref>]; and are also supported by clinical trials [<xref rid="B38-brainsci-10-00964" ref-type="bibr">38</xref>,<xref rid="B39-brainsci-10-00964" ref-type="bibr">39</xref>]. <italic>Bacopa monniera</italic> (water hyssop) has been used in the Indian Ayurvedic system to improve memory and intellectual functions as an immemorial custom. <italic>Centella asiatica</italic> (Asiatic pennywort), another Ayurvedic remedy, is given in combination with milk to improve memory [<xref rid="B40-brainsci-10-00964" ref-type="bibr">40</xref>]. <italic>Withania somnifera</italic> root, a rejuvenative tonic, is also used in Ayurveda to enhance memory [<xref rid="B41-brainsci-10-00964" ref-type="bibr">41</xref>,<xref rid="B42-brainsci-10-00964" ref-type="bibr">42</xref>]. Herbal medicines are becoming popular due to their perceived effectiveness, safety and affordability. Indeed, only recently, scientific studies have started providing evidence and support for the use of herbal medicines in memory related disorders.</p><p>Various CNS active Indian herbal medicines like <italic>Withania somnifera</italic>, <italic>Centella asiatica</italic>, <italic>Celastrus paniculatus</italic> and <italic>Bacopa monnieri</italic> have shown cognitive improvement in experimental models of AD when given as prophylactic treatment [<xref rid="B43-brainsci-10-00964" ref-type="bibr">43</xref>,<xref rid="B44-brainsci-10-00964" ref-type="bibr">44</xref>,<xref rid="B45-brainsci-10-00964" ref-type="bibr">45</xref>,<xref rid="B46-brainsci-10-00964" ref-type="bibr">46</xref>,<xref rid="B47-brainsci-10-00964" ref-type="bibr">47</xref>,<xref rid="B48-brainsci-10-00964" ref-type="bibr">48</xref>]. A randomized, double-blind exploratory trial reported comparable efficacy of a <italic>Gingko biloba</italic> extract and donepezil in AD patients with associated neuropsychiatric problems. The combination was reported to be superior to donepezil monotherapy in terms of both safety and efficacy [<xref rid="B49-brainsci-10-00964" ref-type="bibr">49</xref>].</p><sec id="sec3dot1-brainsci-10-00964"><title>3.1. Centella asiatica</title><p>Plant description: <italic>Centella asiatica</italic> (<italic>C. asiatica</italic>), a small, annual herb belonging to the family Apiceae is found throughout India and commonly known as mandukparni or jalbrahmi. It has small fan-shaped green leaves with white or light purple-to-pink or white flowers and it bears small oval fruit [<xref rid="B50-brainsci-10-00964" ref-type="bibr">50</xref>]. The leaves of mandukparni have been used as a memory enhancer in the Ayurvedic system of medicine [<xref rid="B51-brainsci-10-00964" ref-type="bibr">51</xref>]. Its use has also been described in the African system of medicine, and traditional Chinese medicine. It is used to delay ageing, prevent memory related disorders and is given with milk to enhance memory [<xref rid="B40-brainsci-10-00964" ref-type="bibr">40</xref>].</p><p>Main chemical constituents: The main chemical constituents of <italic>C. asiatica</italic> are asiaticosides, asiatic acid, madecassoside and madasiatic acid [<xref rid="B50-brainsci-10-00964" ref-type="bibr">50</xref>]. Other chemical compounds isolated from <italic>C. asiatica</italic> are brahmoside and brahminoside, isothankuniside, thankuniside and centelloside [<xref rid="B50-brainsci-10-00964" ref-type="bibr">50</xref>].</p><p>Pharmacological activities: <italic>C. asiatica</italic> is well known for its broad pharmacological activities such anti-inflammatory, antioxidative stress, antiapoptotic effects, neuroprotective effects, wound healing, antipsoriatic, antiulcer, hepatoprotective, antidepressant activity, nootropic activity, anticonvulsant, sedative, immunostimulant, cardioprotective, antidiabetic, cytotoxic and antitumor, antiviral, antibacterial, insecticidal and antifungal [<xref rid="B50-brainsci-10-00964" ref-type="bibr">50</xref>].</p><p>Preclinical studies: Aqueous extract of <italic>C. asiatica</italic> in 100, 200 and 300 mg/kg doses given orally for 14 days has been reported to dose-dependently improve cognitive functions in normal rats [<xref rid="B52-brainsci-10-00964" ref-type="bibr">52</xref>]. Pretreatment with the extract for 21 days significantly reversed streptozotocin induced cognitive impairment [<xref rid="B51-brainsci-10-00964" ref-type="bibr">51</xref>]. The authors attributed the beneficial effect of <italic>C. asiatica</italic> to antioxidant activity as evidenced by a decrease in malondialdehyde, increase in glutathione, catalase and superoxide dismutase levels. A study by Rao et al. [<xref rid="B53-brainsci-10-00964" ref-type="bibr">53</xref>] demonstrated that 15 days treatment with <italic>C. asiatica</italic> at a dose of 200 mg/kg from day 15 to 30 postpartum stimulated learning and memory in rats, which lasted for at least 6 months postpartum. They also observed an increase in dendritic arborization of hippocampal CA3 neurons, which may be one reason for improvement in brain function. Another study showed improved cognitive outcome in elderly subjects following prescribed dose of 500 mg/b.i.d dried <italic>C. asiatica</italic> for a 6-month period [<xref rid="B54-brainsci-10-00964" ref-type="bibr">54</xref>]. Dhanasekaran et al. [<xref rid="B55-brainsci-10-00964" ref-type="bibr">55</xref>] found that an 8 month treatment with 2.5 mg/kg of aqueous extract of <italic>C. asiatica</italic> significantly decreased amyloid beta 1-40 and 1-42 levels in the hippocampus of PSAPP transgenic mice expressing &#x0201c;Swedish&#x0201d; amyloid precursor protein and M146L presenilin 1 mutations, which result in spontaneous amyloid beta plaque formation. A reduction in Congo red stained fibrillar amyloid plaques was detected on the long-term treatment with 5.0 mg/kg dose.</p><p><italic>C. asiatica</italic> aqueous leaf extract showed improvement in learning and memory in rats, and modulated dopamine, 5-hydroxytryptamine (5-HT) and noradrenaline systems in the rat brain in-vivo [<xref rid="B56-brainsci-10-00964" ref-type="bibr">56</xref>]. The leaf extract also had sedative, antidepressant and cholinomimetic activities [<xref rid="B57-brainsci-10-00964" ref-type="bibr">57</xref>] suggesting its suitability for treatment of AD associated cognitive dysfunction and depression and anxiety. The leaf extract stimulated dendrites of neuronal cells in the rat brain [<xref rid="B51-brainsci-10-00964" ref-type="bibr">51</xref>] and induced neurite elongation in human SH-SY-5Y cells and accelerated axonal regenerate in rats [<xref rid="B58-brainsci-10-00964" ref-type="bibr">58</xref>]. Cyclic AMP response element binding property (CREB) and its phosphorylated form are involved in memory formation [<xref rid="B59-brainsci-10-00964" ref-type="bibr">59</xref>]. Reduced level of phosphorylated CREB has been reported in AD patients and experimental models of AD [<xref rid="B60-brainsci-10-00964" ref-type="bibr">60</xref>]. The aqueous extract of <italic>C. asiatica</italic> leaves enhanced phosphorylation of CREB in both neuroblastoma cells, which express inducible A&#x000df; and in cortical primary cells, which were chronically exposed to external A&#x000df; in-vitro. The extract increased neuronal dendritic arborization and axonal regeneration in rats [<xref rid="B51-brainsci-10-00964" ref-type="bibr">51</xref>,<xref rid="B58-brainsci-10-00964" ref-type="bibr">58</xref>,<xref rid="B61-brainsci-10-00964" ref-type="bibr">61</xref>].</p><p>Triterpenoids are the major active component of ethanolic extract of <italic>C. asiatica</italic>, which consists of many chemical constituents such as asiatic acid, mecadessic acid, asiaticoside, scentellin, asiaticin and centellicin [<xref rid="B62-brainsci-10-00964" ref-type="bibr">62</xref>,<xref rid="B63-brainsci-10-00964" ref-type="bibr">63</xref>,<xref rid="B64-brainsci-10-00964" ref-type="bibr">64</xref>]. Asiatic acid and its derivatives have shown a promising memory improving effect [<xref rid="B65-brainsci-10-00964" ref-type="bibr">65</xref>] by improving ACh synthesis [<xref rid="B66-brainsci-10-00964" ref-type="bibr">66</xref>,<xref rid="B67-brainsci-10-00964" ref-type="bibr">67</xref>]. It has been patented (Hoechst Aktiengesellschaft) for the treatment of dementia and as a cognition enhancer. The exact constituent responsible for cognition enhancing effects of the herb remains to be established. However, studies suggest that perhaps triterpene saponins present in the leaf improve cognitive function by influencing central neurotransmitters.</p><p>Clinical evidence: In a randomized, double-blind placebo-controlled, study, <italic>C. asiatica</italic> extract was administered to healthy volunteers as 250&#x02013;750 mg once daily dose for 2 months. The high dose enhanced working memory and improved self-rated mood [<xref rid="B68-brainsci-10-00964" ref-type="bibr">68</xref>].</p><p>Thus, clinical and experimental studies support memory enhancing potential of <italic>C. asiatica.</italic> However, its use for treatment of AD remains to be evaluated.</p><p>Toxicity: <italic>C. asiatica</italic> extract and asiaticoside were found to be well tolerated in experimental studies. Asiaticoside did not cause any toxicity up to 1 g/kg oral dose [<xref rid="B69-brainsci-10-00964" ref-type="bibr">69</xref>]. In acute toxicity study, <italic>C. asiatica</italic> extract up to 10 g/kg did not shown any sign of toxicity whereas in the subacute toxicity study, no toxicity was observed when the extract was administered at the doses of 10&#x02013;1000 mg/kg. In the chronic toxicity study, doses up to 1200 mg/kg/day for six months did not result in significant toxicity in Wistar rats [<xref rid="B70-brainsci-10-00964" ref-type="bibr">70</xref>]. However, in one study, oral administration of 1000 mg/kg/day dried <italic>C. asiatica</italic> for 30 days caused hepatotoxicity in albino rats [<xref rid="B71-brainsci-10-00964" ref-type="bibr">71</xref>].</p></sec><sec id="sec3dot2-brainsci-10-00964"><title>3.2. Bacopa monnieri</title><p>Plant description: <italic>Bacopa monnieri</italic> (<italic>B. monniera</italic>)<italic>,</italic> belonging to the Scrophulariaceae family is a small, perennial creeping herb with numerous branches, small oblong leaves and light purple or white flowers. In India, it is commonly called Brahmi and is known for its revitalizing, Medhya rasayana and nootropic activities as it strengthens memory and intellect (Medhya). Bacopa has been used for the treatment of various ailments for thousands of years by the practitioners of the traditional system of medicine of India [<xref rid="B72-brainsci-10-00964" ref-type="bibr">72</xref>].</p><p>Main chemical constituents: The main chemical compounds of <italic>B. monniera</italic> are triterpenoid saponins known as bacosides. The alkaloids brahmine, nicotine and herpestine have also been reported in this plant. Novel saponins called bacopasides I&#x02013;XII have also been identified [<xref rid="B72-brainsci-10-00964" ref-type="bibr">72</xref>].</p><p>Pharmacological activities: This medicinal herb possesses various biological activities such as anticonvulsant, antidepressant, anxiolytic, analgesic, anti-inflammatory, antioxidant, antimicrobial, antiulcerogenic, anti-<italic>Helicobacter pylori</italic>, adaptogenic, antineoplastic, bronchodilatory, hepatoprotective and immunostimulatory [<xref rid="B72-brainsci-10-00964" ref-type="bibr">72</xref>].</p><p>Preclinical studies: The extract of <italic>B. monniera</italic> has been reported to contain several beneficial bioactive components such as alkaloids, flavonoids, glycoside, triterpenoids saponins and alcohols. The alcoholic extract of <italic>B. monniera</italic> improved acquisition, consolidation and retention of memory in the foot shock motivated brightness discrimination test, active conditioned avoidance test and Sidman continuous avoidance responses in rats [<xref rid="B73-brainsci-10-00964" ref-type="bibr">73</xref>,<xref rid="B74-brainsci-10-00964" ref-type="bibr">74</xref>]. Bacosides A and B (a mixture of 2 saponins) may be responsible for its facilitatory effect on learning and memory. Besides, bacosides has been proven for its antioxidant and anti-inflammatory effects [<xref rid="B75-brainsci-10-00964" ref-type="bibr">75</xref>] bacosides also attenuated the retrograde amnesia produced by immobilization induced stress, electroconvulsive shock and scopolamine [<xref rid="B76-brainsci-10-00964" ref-type="bibr">76</xref>]. They enhanced protein kinase activity and increased the protein content in the hippocampus, which may also contribute to their memory enhancing effect [<xref rid="B74-brainsci-10-00964" ref-type="bibr">74</xref>,<xref rid="B77-brainsci-10-00964" ref-type="bibr">77</xref>,<xref rid="B78-brainsci-10-00964" ref-type="bibr">78</xref>]. Administration of bacosides (200 mg/kg) for 3 months in middle-aged and aged rats exerted a protective effect against age associated alterations in the neurotransmission system, behavioral paradigms, hippocampal neuronal loss and oxidative stress markers [<xref rid="B79-brainsci-10-00964" ref-type="bibr">79</xref>]. The involvement of the microRNA 124-CREB pathway and serotonergic receptor in the memory enhancing mechanism of standardized extract of <italic>B. monniera</italic> (BESEB CDRI-08) has also been reported [<xref rid="B80-brainsci-10-00964" ref-type="bibr">80</xref>,<xref rid="B81-brainsci-10-00964" ref-type="bibr">81</xref>].</p><p>The effect of alcoholic extract of <italic>Bacopa</italic> has been evaluated at the dose of 20, 40 and 80 mg/kg on cognitive functions and neurodegeneration in the animal model of AD induced by bilateral intracerebroventricular administration of AF64A. They found that <italic>Bacopa</italic> improved the escape latency in the Morris water maze test and prevented the reduction in cholinergic neuron density [<xref rid="B47-brainsci-10-00964" ref-type="bibr">47</xref>,<xref rid="B82-brainsci-10-00964" ref-type="bibr">82</xref>]. Besides, oral administration of 40 mg/kg/day of the <italic>Bacopa</italic> extract for 5 weeks prevented neurotoxicity in rats exposed to aluminum chloride [<xref rid="B83-brainsci-10-00964" ref-type="bibr">83</xref>]. Cognitive deficit induced by intracerebroventricular (ICV) injection of cholchicine and ibotenic acid into the nucleus basalis magnocellularis was attenuated by standardized <italic>Bacopa</italic> extract by reversing the depletion of ACh level, reduction in choline acetyl transferase (ChAT) activity and decrease in muscarinic cholinergic receptor binding in frontal cortex and hippocampus [<xref rid="B84-brainsci-10-00964" ref-type="bibr">84</xref>]. Holcomb et al. [<xref rid="B43-brainsci-10-00964" ref-type="bibr">43</xref>] reported that administration of ethanolic extract of <italic>Bacopa</italic> leaves at doses of 40 and 160 mg/kg for 2 and 8 months reduced A<italic>&#x003b2;</italic> 1&#x02013;40 and 1&#x02013;42 levels in the cortex of PSAPP mice. Bacopa, at the dose of 50 mg/kg, demonstrated the neuroprotective effect in the colchicine model of dementia through its antioxidant effect and restored the activity of Na<sup>+</sup>K<sup>+</sup>ATPase and AChE [<xref rid="B85-brainsci-10-00964" ref-type="bibr">85</xref>]. The neuronal dendritic growth stimulating property of <italic>Bacopa</italic> has also been reported which may be responsible for its memory enhancing property [<xref rid="B86-brainsci-10-00964" ref-type="bibr">86</xref>].</p><p>Clinical evidence: In a double-blind, placebo-controlled trial in 38 healthy volunteers (ages 18&#x02013;60 years), single dose of 300 mg <italic>B. monniera</italic> extract (containing 55% combined bacosides A and B) did not cause any significant change in cognitive function at 2 h [<xref rid="B87-brainsci-10-00964" ref-type="bibr">87</xref>]. However, six week <italic>Bacopa</italic> administration (300 mg for subjects under 90 kg, and 450 mg for subjects over 90 kg, equivalent to 6 g and 9 g dried rhizome, respectively) in a double-blind, randomized, placebo controlled fashion was associated with significant improvement in retention of new information in 40&#x02013;65 year old healthy adults. Though there was no difference in the rate of acquisition of information [<xref rid="B88-brainsci-10-00964" ref-type="bibr">88</xref>].</p><p>Stough et al. [<xref rid="B89-brainsci-10-00964" ref-type="bibr">89</xref>] reported significant improvement in verbal learning, memory consolidation and speed of early information processing following <italic>Bacopa</italic> administration (containing 55% combined bacosides) for 12 weeks at a dose of 300 mg daily in a double-blind placebo-controlled study in healthy volunteers (age 18&#x02013;60 years, <italic>n</italic> = 46). Since the effects were not observed until five weeks of treatment, the slow onset of action may be attributed to <italic>Bacopa</italic>&#x02019;s antioxidant properties and/or its effect on the cholinergic system. In another randomized, double-blind, placebo-controlled trial in 54 elderly participants without clinical signs of dementia (mean age 73.5 years), similar <italic>Bacopa</italic> treatment enhanced an auditory verbal learning test, delayed word recall memory scores and a stroop test relative to the placebo [<xref rid="B14-brainsci-10-00964" ref-type="bibr">14</xref>]. In subjects above 55 years of age with memory impairment, standardized <italic>Bacopa</italic> extract 125 mg was given twice daily for 12 weeks in a double blind, placebo-controlled manner. There was a significant improvement in mental control, logical memory and paired associated learning [<xref rid="B90-brainsci-10-00964" ref-type="bibr">90</xref>]. Furthermore, <italic>Bacopa</italic> extract at the dose of 300 mg/kg, daily for 12 weeks improved memory acquisition and retention in healthy older Australians population [<xref rid="B91-brainsci-10-00964" ref-type="bibr">91</xref>].</p><p>In children (age 6&#x02013;8 years), <italic>Bacopa</italic> syrup (350 mg <italic>Bacopa</italic> powder), when administered three times a day for three months, resulted in significant improvement as compared to the placebo [<xref rid="B92-brainsci-10-00964" ref-type="bibr">92</xref>]. However, this study was not blinded. Negi et al. [<xref rid="B93-brainsci-10-00964" ref-type="bibr">93</xref>] carried out a double-blind, randomized, placebo-controlled trial in 36 children diagnosed with attention deficit/hyperactivity disorder (mean age 8.3&#x02013;9.3 years). Nineteen children received <italic>Bacopa</italic> extract (standardized to contain 20% bacosides) at a dosage of 50 mg twice daily for 12 weeks. As compared to placebo, a significant improvement in cognitive function was observed in <italic>Bacopa</italic>-treated children at 12 weeks as evidenced by improvement in sentence repetition, logical memory and paired associate learning tasks, which was maintained at 16 weeks (after four weeks of placebo administration).</p><p>Toxicity: The LD<sub>50</sub> of orally administered <italic>Bacopa</italic> extracts in rats was 5 g/kg for aqueous extract and 17 g/kg of the alcoholic extract [<xref rid="B77-brainsci-10-00964" ref-type="bibr">77</xref>]. The intraperitoneal LD<sub>50</sub> was 1000 mg/kg for aqueous extract and 15 g/kg for alcoholic extract [<xref rid="B94-brainsci-10-00964" ref-type="bibr">94</xref>]. A double-blind, placebo-controlled trial in healthy male volunteers reported safety and tolerability of bacosides in single (20&#x02013;30 mg) and multiple (100&#x02013;200 mg) daily doses over a four-week period [<xref rid="B77-brainsci-10-00964" ref-type="bibr">77</xref>]. A randomized, double-blind, placebo-controlled trial reported that <italic>Bacopa</italic> treatment (300 mg/kg, daily) for 12 weeks caused increased stool frequency, abdominal cramps and nausea, which may be due to either an upregulation of ACh level or saponin-mediated gastrointestinal tract irritation, or both [<xref rid="B91-brainsci-10-00964" ref-type="bibr">91</xref>].</p></sec><sec id="sec3dot3-brainsci-10-00964"><title>3.3. Curcuma longa</title><p>Plant description: <italic>Curcuma longa</italic> (<italic>C. longa</italic>) Linn is a perennial herb belonging to the family Zingiberaceae. It is grown for commercial use in South and Southeast Asia. Curcumin, also known as turmeric, is obtained from the rhizome of the plant, and is commonly used in India as a food flavoring and coloring agent. Several preparations of the plant have been used for centuries in the Ayurvedic system of medicine [<xref rid="B95-brainsci-10-00964" ref-type="bibr">95</xref>].</p><p>Main chemical constituents: Curcuminoids are main chemical constituents of turmeric, which include mainly curcumin (diferuloyl methane), demethoxycurcumin and bisdemethoxycurcmin. Other chemical compounds reported in this plant are alpha- and beta-tumerone, artumerone, alpha- and gamma-atlantone, curlone, zingiberene and curcumol [<xref rid="B96-brainsci-10-00964" ref-type="bibr">96</xref>].</p><p>Pharmacological activities: Previous studies reported the various pharmacological properties of curcuminoids such as neuroprotective, analgesic, antiproliferative, anti-inflammatory, anticancer, antidiabetic, hypocholesterolemic, antithrombotic, antihepatotoxic, antidiarrheal, carminative, diuretic, antirheumatic, hypotensive, antimicrobial, antiviral, antioxidant, larvicidal, insecticidal, antivenomous and antityrosinase effects [<xref rid="B97-brainsci-10-00964" ref-type="bibr">97</xref>].</p><p>Preclinical studies: It is also one of the most systematically studied plants for various diseases [<xref rid="B98-brainsci-10-00964" ref-type="bibr">98</xref>]. It has been reported in various experimental studies to possess wide variety of biological and pharmacological activities including antioxidant, anti-inflammatory and cholesterol-lowering properties, all three of which are key processes involved in the pathogenesis of AD.</p><p>Water insolubility is a major limitation for curcumin, which has been overcome, to some extent, by synthesis of biodegradable poly (lactic-co-glycolic acid) (PLGA) coated curcumin nanoparticles. These nanoparticles were found to be able to destroy amyloid aggregation and exhibit antioxidative activity without a cytotoxic effect [<xref rid="B99-brainsci-10-00964" ref-type="bibr">99</xref>,<xref rid="B100-brainsci-10-00964" ref-type="bibr">100</xref>]. Nanoliposomes of curcumin have high affinity for A&#x003b2;1-42 fibrils and were found to inhibit the formation of fibrillar and oligomeric A&#x003b2; in-vitro [<xref rid="B101-brainsci-10-00964" ref-type="bibr">101</xref>,<xref rid="B102-brainsci-10-00964" ref-type="bibr">102</xref>]. Apolipoprotein E3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin (ApoE3-C-PBCA) provided photostability, enhanced the cellular uptake of curcumin and increased its efficacy against A&#x003b2; induced cytotoxicity [<xref rid="B103-brainsci-10-00964" ref-type="bibr">103</xref>]. Curcumin also demonstrated a protective effect against A&#x003b2; neurotoxicity by decreasing A&#x003b2; production through downregulation of presenilin 1 (PS1) and GSK-3-&#x003b2; expression and accelerating A&#x003b2; fibril conversion [<xref rid="B104-brainsci-10-00964" ref-type="bibr">104</xref>,<xref rid="B105-brainsci-10-00964" ref-type="bibr">105</xref>].</p><p>Curcumin has been shown to reduce both in-vivo and in-vitro A&#x003b2; plaque deposition [<xref rid="B106-brainsci-10-00964" ref-type="bibr">106</xref>,<xref rid="B107-brainsci-10-00964" ref-type="bibr">107</xref>]. Curcumin treatment for six months significantly decreased the elevated levels of oxidized protein and proinflammatory interleukin-1&#x003b2; in the transgenic APPSw mouse brain (Tg2576) [<xref rid="B106-brainsci-10-00964" ref-type="bibr">106</xref>]. Plaque formation and the concentration of insoluble and soluble A&#x003b2; were also lowered by curcumin in the same study. Pretreatment with curcumin (10, 20 and 50 mg/kg, p.o for 21 days) ameliorated memory impairment in the sporadic AD model in mice [<xref rid="B108-brainsci-10-00964" ref-type="bibr">108</xref>]. Furthermore, curcumin in diet form improved the spatial memory, oxidative stress and synaptophysin loss via reducing A&#x003b2; deposits [<xref rid="B109-brainsci-10-00964" ref-type="bibr">109</xref>]. Significant cognitive improvement was documented at low (160 ppm) and high (1000 ppm) doses of curcumin after administration for the 6-month period in the double transgenic AD model (APP/PS1) [<xref rid="B110-brainsci-10-00964" ref-type="bibr">110</xref>]. In-vivo, curcumin may protect cells from beta amyloid attack and subsequent oxidative stress-induced damage [<xref rid="B111-brainsci-10-00964" ref-type="bibr">111</xref>]. Curcumin can inhibit A&#x003b2; aggregation or promote its disaggregation at low concentrations (IC<sub>50</sub> = 0.81&#x02013;1 &#x003bc;M). Monomeric A&#x003b2; formed fewer aggregates in the presence of curcumin, whereas increasing doses of curcumin promoted disassembly of preformed A&#x003b2; aggregates. Structurally, curcumin is similar to Congo red and can prevent oligomer formation after binding to plaques and recognize secondary structure in fibrillar and oligomeric A&#x003b2;. Low dose curcumin significantly lowered the soluble A&#x003b2; levels, insoluble amyloid and plaque burden by nearly 40% [<xref rid="B106-brainsci-10-00964" ref-type="bibr">106</xref>]. Additionally, curcumin treatment for 7 days caused reduction in plaques burden and reversed structural changes in dystrophic dendrites in APPswe/PS1dE9 mouse model of AD [<xref rid="B112-brainsci-10-00964" ref-type="bibr">112</xref>].</p><p>Impaired insulin or insulin-like growth factor-1 (IGF-1) signaling is associated with AD. It leads to hyperphosphorylation of the tau protein, mitochondrial dysfunction, oxidative stress and necrosis, and contributes to cognitive impairment [<xref rid="B113-brainsci-10-00964" ref-type="bibr">113</xref>,<xref rid="B114-brainsci-10-00964" ref-type="bibr">114</xref>,<xref rid="B115-brainsci-10-00964" ref-type="bibr">115</xref>]. Curcumin significantly improved cognitive function by improving the IGF-1 level in the intracerebroventricular (ICV)-streptozotocin (STZ) model of sporadic AD [<xref rid="B116-brainsci-10-00964" ref-type="bibr">116</xref>]. It also suppressed IL-1 and glial fibrillary acidic protein, reduced oxidative damage and plaque burden and decreased the amount of insoluble amyloid [<xref rid="B26-brainsci-10-00964" ref-type="bibr">26</xref>]. Another experimental study showed that curcumin treatment restored learning and memory functions in the STZ model of AD by reducing the oxidative stress, enhancing ChAT activity and restoring insulin receptor protein [<xref rid="B117-brainsci-10-00964" ref-type="bibr">117</xref>,<xref rid="B118-brainsci-10-00964" ref-type="bibr">118</xref>].</p><p>Curcumin suppressed the microgliosis in neuronal layers, but it failed to reduce within plaques microgliosis and even significantly increased microgliosis immediately adjacent to plaques, raising the possibility that it may stimulate microglial phagocytosis of amyloid. Other possible mechanisms for curcumin induced neuroprotective effects include inhibition of IL-1-induced increase in alpha-1-antichymotrypsin (&#x003b1;<sub>1</sub>ACT) and NF&#x003ba;B-mediated transcription of apolipoprotein E (ApoE). Both &#x003b1;<sub>1</sub>ACT [<xref rid="B119-brainsci-10-00964" ref-type="bibr">119</xref>,<xref rid="B120-brainsci-10-00964" ref-type="bibr">120</xref>] and ApoE [<xref rid="B121-brainsci-10-00964" ref-type="bibr">121</xref>,<xref rid="B122-brainsci-10-00964" ref-type="bibr">122</xref>,<xref rid="B123-brainsci-10-00964" ref-type="bibr">123</xref>,<xref rid="B124-brainsci-10-00964" ref-type="bibr">124</xref>] have been shown to be proamyloidogenic in APP transgenic mice. Curcumin can also reduce two other proamyloidogenic factors, oxidative damage [<xref rid="B125-brainsci-10-00964" ref-type="bibr">125</xref>,<xref rid="B126-brainsci-10-00964" ref-type="bibr">126</xref>] and raised cholesterol levels [<xref rid="B127-brainsci-10-00964" ref-type="bibr">127</xref>]. The neuroprotective effect of curcuminoid mixture and its individual components on inflammatory and apoptotic gene expression in AD using an A&#x003b2; plus ibotenic acid-infused rat model has also been reported [<xref rid="B128-brainsci-10-00964" ref-type="bibr">128</xref>]. Additionally, Ahmed and colleagues also reported that a curcuminoids mixture (bisdemethoxycurcumin, demethoxycurcumin and curcumin) treatment improved memory function in amyloid fragment induced AD-like conditions in rats [<xref rid="B129-brainsci-10-00964" ref-type="bibr">129</xref>]. Nonetheless, chronic treatment with curcumin also prevented the colchicine induced cognitive impairment in rats by reducing the oxidative stress [<xref rid="B130-brainsci-10-00964" ref-type="bibr">130</xref>].</p><p>Chronic stress induces impairment of spatial cognition, neuroendocrine and plasticity abnormalities due to an increase in serum corticosterone levels. Curcumin exerts its neuroprotective effect by normalizing the corticosterone response, resulting in downregulating of calcium/calmodulin kinase II and glutamate receptor (NMDA-2B) levels [<xref rid="B131-brainsci-10-00964" ref-type="bibr">131</xref>]. The protective effect of curcumin on a A&#x003b2;1&#x02013;40 AD model was documented by Wang et al. [<xref rid="B132-brainsci-10-00964" ref-type="bibr">132</xref>] and Yin et al. [<xref rid="B133-brainsci-10-00964" ref-type="bibr">133</xref>], where treatment with 300 mg/kg curcumin reversed spatial learning and memory impairment accompanied by hippocampal regeneration. Evidence also suggests that metals are concentrated in the AD brain and curcumin chelates iron and copper (but not zinc) bound to beta amyloid potentially contributing to amyloid reduction [<xref rid="B134-brainsci-10-00964" ref-type="bibr">134</xref>]. A different approach was followed by McClure et al. [<xref rid="B135-brainsci-10-00964" ref-type="bibr">135</xref>], where aerosol-mediated treatment of young 5XFAD mice with curcumin averted A&#x003b2; buildup and memory deficits in adulthood as compared to the untreated mice.</p><p>Thus, this multitarget compound is a promising therapeutic agent for AD and associated cognitive decline. However, despite intensive curcumin related research in various diseases, there is a lack of clinical data on the efficacy of curcumin in AD.</p><p>Toxicity: In a phase I trial with 25 healthy subjects, curcumin up to 8000 mg/day for 3 months did not show any toxicity [<xref rid="B136-brainsci-10-00964" ref-type="bibr">136</xref>]. In an acute toxicity study, ethanolic extract of rhizome of <italic>C. longa</italic> at the doses of 0.5, 1.0 and 3.0 mg/kg did not cause any sign of toxicity in mice. Moreover, no toxicity was found at 100 mg/kg/day in the 90-day toxicity study in mice [<xref rid="B137-brainsci-10-00964" ref-type="bibr">137</xref>].</p></sec><sec id="sec3dot4-brainsci-10-00964"><title>3.4. Clitoria ternatea</title><p>Plant description: <italic>Clitoria ternatea</italic> (<italic>C. ternatea</italic>) is a perennial tropical climber herb with slender downy stem, found throughout the tropical regions of India, growing wild and in gardens, bearing white or blue flowers. <italic>C. ternatea</italic> belongs to family Fabaceae commonly called &#x0201c;butterfly&#x0201d;. It is a commonly used Ayurvedic medicine. <italic>C. ternatea</italic> is called Aparajit (Hindi), Aparajita (Bengali) and Kakkattan in Indian traditional medicine [<xref rid="B138-brainsci-10-00964" ref-type="bibr">138</xref>]. The extracts of <italic>C. ternatea</italic> have been used in Ayurveda, as an ingredient in &#x0201c;Medhya rasayana&#x0201d;.</p><p>Main chemical constituents: Various phytocomponents such as taraxerol, teraxerone, ternatins, delphinidin-3, delphinidin-3&#x000df;-glucoside, malvidin-3&#x000df;-glucoside, 3 monoglucoside, 3-rutinoside, 3-neohisperidoside, 3-o-rhamnosyl Glycoside, kaempferol-3-o-rhamnosyl, aparajitin, beta-sitosterol, malvidin-3&#x000df;-glucoside, kaemphferol, p-coumaric acid, etc., are isolated from <italic>C. ternatea</italic> [<xref rid="B138-brainsci-10-00964" ref-type="bibr">138</xref>].</p><p>Pharmacological activities: In previous studies, various biological activities including nootropic, anticonvulsant, antidepressant, antianxiety, antistress, antioxidant, anti-inflammatory, antihyperlipidemic, antidiabetic, antiasthmatic, analgesic, immunomodulatory, cytotoxicity, platelet aggregation inhibitory, antimicrobial, gastroprotective and hepatoprotective of <italic>C ternatea</italic> have been documented [<xref rid="B138-brainsci-10-00964" ref-type="bibr">138</xref>].</p><p>Preclinical studies: The nootropic activity of methanolic extract of aerial parts of <italic>C. ternatea</italic> (100 mg/kg, p.o) has been reported by using elevated plus maze and the object recognition test in rats [<xref rid="B139-brainsci-10-00964" ref-type="bibr">139</xref>]. Taranalli and Cheeramkuzhy evaluated the ethanolic extracts of roots and aerial parts of <italic>C. ternatea</italic> at the dose of 300 and 500 mg/kg, p.o in amnesia induced by submaximal electroshock [<xref rid="B140-brainsci-10-00964" ref-type="bibr">140</xref>]. They also estimated the ACh level in the whole brain and different parts of it. The aerial parts extract resulted in improved memory retention and increased brain ACh content, which was more at 300 mg/kg as compared to the 500 mg/kg dose. The root extract exhibited similar but more marked effects, which were almost equal at both doses.</p><p>Rai et al. [<xref rid="B141-brainsci-10-00964" ref-type="bibr">141</xref>] described the learning and memory enhancing effect of the <italic>C. ternatea</italic> root extract during the growth spurt period in rats. They intubated 7-day old neonatal rats and administered 50 and 100 mg/kg of the aqueous root extract of <italic>C. ternatea</italic> for 30 days. The extract improved retention in the passive avoidance task and spatial performance in the T-maze test. The behavioral changes were reported to be long lasting as indicated by a 30 days post-treatment evaluation. A previous study also showed that the aqueous root extract (50 and 100 mg/kg, p.o for 30 days) enhanced dendritic arborization of amygdala neurons in rats [<xref rid="B142-brainsci-10-00964" ref-type="bibr">142</xref>]. This cognition enhancing effect was hypothesized to be due to the presence of growth factors similar to the brain derived neurotrophic factor or nerve growth factor. Increase in hippocampus acetylcholine content [<xref rid="B139-brainsci-10-00964" ref-type="bibr">139</xref>] may be one of the reasons for nootropic activity of <italic>C. ternatea</italic> root. In addition, Rai [<xref rid="B143-brainsci-10-00964" ref-type="bibr">143</xref>] reported that the <italic>C. ternatea</italic> root extract exhibited the neurogenesis-promoting sequel on the anterior subventricular zone of neural stem cells. More recently, Damodaran et al. [<xref rid="B144-brainsci-10-00964" ref-type="bibr">144</xref>] documented the neuroprotective effect of the <italic>C. ternatea</italic> root extract in reversing chronic cerebral hypoperfusion-induced neural damage and memory impairment at doses of 200 and 300 mg/kg. In another study, Mehla and colleagues showed anti-AD effects of <italic>C. ternatea</italic> in ICV-STZ induced AD-like conditions in rats [<xref rid="B145-brainsci-10-00964" ref-type="bibr">145</xref>]. These observations suggest that <italic>C. ternatea</italic> extract exerts its beneficial effect by preventing the progression of cognitive deterioration in AD. However, the potential of <italic>C. ternatea</italic> extract still needs to be systematically evaluated for human use.</p><p>Toxicity: Ethanolic extract of aerials parts and root of <italic>C. ternatea</italic> have been studied at 200&#x02013;3000 mg/kg, p.o in mice. A cathartic effect of root extract was observed. Mice treated with a dose above 2000 mg/kg had ptosis and were lethargic. The extract was not lethal orally but resulted in severe CNS depression and death when used intraperitoneally at dose of 2900 mg/kg and above [<xref rid="B140-brainsci-10-00964" ref-type="bibr">140</xref>]. Taur and Patil [<xref rid="B146-brainsci-10-00964" ref-type="bibr">146</xref>] reported LD<sub>50</sub> of ethanolic extract of <italic>C. ternatea</italic> root to be more than 1300 mg/kg.</p></sec><sec id="sec3dot5-brainsci-10-00964"><title>3.5. Withania somnifera</title><p>Plant description: <italic>Withania somnifera</italic> (<italic>W. somnifera</italic>) is a small woody shrub belonging to the family Solanaceae and is widely grown in India. It is commonly called Indian ginseng or winter cherry or ashwagandha. Its flowers are greenish or yellowish in color and about one centimeter long [<xref rid="B147-brainsci-10-00964" ref-type="bibr">147</xref>,<xref rid="B148-brainsci-10-00964" ref-type="bibr">148</xref>]. Ashwagandha is mentioned in ancient Sanskrit writings from India as a &#x0201c;Medhya rasayan&#x0201d;. It is also known as Indian ginseng and is widely used in Ayurveda. It is an ingredient in many formulations prescribed as a general tonic to increase energy, improve overall health and longevity [<xref rid="B147-brainsci-10-00964" ref-type="bibr">147</xref>,<xref rid="B148-brainsci-10-00964" ref-type="bibr">148</xref>].</p><p>Main chemical constituents: The major phytoconstituents of <italic>W. somnifera</italic> are isopellertierine, anferine, withanolides, withaferins, sitoindoside VII and VIII and withanoloides. Other chemical compounds are withanine, somniferine, somnine, somniferinine, withananine, pseudo-withanine, tropine, pseudo-tropine, 3-a-gloyloxytropane, choline and cuscohygrine [<xref rid="B149-brainsci-10-00964" ref-type="bibr">149</xref>,<xref rid="B150-brainsci-10-00964" ref-type="bibr">150</xref>,<xref rid="B151-brainsci-10-00964" ref-type="bibr">151</xref>,<xref rid="B152-brainsci-10-00964" ref-type="bibr">152</xref>].</p><p>Pharmacological activities: <italic>W. somnifera</italic> exhibits a broad range of biological activities like anti-inflammatory, antioxidant, neuroprotective, antischemic, anti-Parkinson&#x02019;s, antiepileptic, anxiolytic, antidepression, antiarthritic, cardioprotective, antidiabetic, anticancer, antistress, nephroprotective, heptoprotective, antihypoxic, immunomodulatory, hypolipidaemic and antimicrobial [<xref rid="B152-brainsci-10-00964" ref-type="bibr">152</xref>].</p><p>Preclinical studies: Total alkaloid extract (ashwagandholine, AG) of <italic>W. somnifera</italic> root has been studied for its effects on CNS [<xref rid="B153-brainsci-10-00964" ref-type="bibr">153</xref>]. <italic>W. somnifera</italic> attenuated the memory loss induced by STZ through the antioxidant mechanism [<xref rid="B154-brainsci-10-00964" ref-type="bibr">154</xref>]. The root preparation has been shown to have protective effects in neurodegenerative disorders by reducing stress induced degeneration in the brain hippocampus of rats [<xref rid="B155-brainsci-10-00964" ref-type="bibr">155</xref>]. The extract containing sitoindosides VII&#x02013;X and withaferin A (50 mg/kg, p.o for two weeks) reversed ibotenic acid-induced cognitive deficit and reduction in cholinergic markers (e.g., ACh and ChAT) in rats [<xref rid="B156-brainsci-10-00964" ref-type="bibr">156</xref>]. Sitoindosides VII-X and withaferin differentially (40 mg/kg for 7 days) but favorably altered the AChE activity and enhanced M<sub>1</sub>- and M<sub>2</sub>-muscarinic receptor-binding in various brain regions [<xref rid="B157-brainsci-10-00964" ref-type="bibr">157</xref>]. Withaferin A and Withanolide A suggested to have a potent immunomodulatory effect in BV-2 microglial cells by triggering the Nrf2 pathway, leading to production of the neuroprotective protein, such as heme oxygenase-1 [<xref rid="B158-brainsci-10-00964" ref-type="bibr">158</xref>].</p><p>Withanoside IV, another chemical constituent of <italic>Withania</italic>, when administered orally at the dose of 10 micromol/kg prevented cognitive impairment in the experimental model of AD [<xref rid="B44-brainsci-10-00964" ref-type="bibr">44</xref>]. Sominone (1 microM) a metabolite of Withanoside IV, induced axonal and dendritic regeneration and synaptic reconstruction in cultures of rat cortical neurons damaged by the amyloid peptide, A&#x003b2;(25&#x02013;35) [<xref rid="B44-brainsci-10-00964" ref-type="bibr">44</xref>]. Therefore, withanoside IV may act as a prodrug, with sominone as the active component. The enhancement of spatial memory by sominone may be attributed to neuritic outgrowth, which is mediated by the neurotrophic factor receptor, RET [<xref rid="B159-brainsci-10-00964" ref-type="bibr">159</xref>]. Methanolic root extract dose dependently enhanced in-vitro dendrite formation in human neuroblastoma cells [<xref rid="B159-brainsci-10-00964" ref-type="bibr">159</xref>]. A study carried out by Jayaprakasam et al. [<xref rid="B160-brainsci-10-00964" ref-type="bibr">160</xref>] stated that withanamides (A/C) present in <italic>W. somnifera</italic> fruits protect pheochromocytoma-(PC-12) from &#x003b2;-amyloid induced toxicity. In the same study, &#x003b2;-amyloid fibril formation was prevented, possibly due to the presence of a serotonin moiety in both withanamide compounds.</p><p>Treatment with <italic>Withania</italic> root extract (1 g/kg, p.o for 30 days) reversed the AD pathology by upregulating the low-density lipoprotein receptor-related protein, which enhanced the A&#x003b2; clearance and ameliorated the cognitive deficit in middle-aged and old APP/PS1 mice [<xref rid="B161-brainsci-10-00964" ref-type="bibr">161</xref>]. Alcoholic extract of the <italic>Withania</italic> leaf and its component withanone was neuroprotective against scopalmine induced changes in the brain [<xref rid="B162-brainsci-10-00964" ref-type="bibr">162</xref>]. An in-vitro, inhibitory effect on the fibril formation by A&#x003b2; peptide has also been reported [<xref rid="B163-brainsci-10-00964" ref-type="bibr">163</xref>]. The increase in cortical muscarinic ACh receptor capacity might partly explain the cognition-enhancing and memory-improving effects of <italic>Withania</italic>. The root extract and their chemical constituents such as glycowithanolides also possess anxiolytic, antidepressant, anti-inflammatory and antioxidant activities, which may be relevant in AD treatment [<xref rid="B164-brainsci-10-00964" ref-type="bibr">164</xref>,<xref rid="B165-brainsci-10-00964" ref-type="bibr">165</xref>]. Furthermore, withanone, a chemical constituent from root extract of <italic>W. somnifera</italic> showed improvement in cognitive functions by inhibiting amyloid processing and reducing the elevated levels of proinflammatory cytokines and oxidative stress markers [<xref rid="B166-brainsci-10-00964" ref-type="bibr">166</xref>]. <italic>W. somnifera</italic> (20 mg/mL) treatment mitigated the A&#x003b2; toxicity and mediated longevity in the AD model of <italic>Drosophila melanogaster</italic> [<xref rid="B167-brainsci-10-00964" ref-type="bibr">167</xref>].</p><p>Clinical evidence: A prospective, randomized, double-blind, placebo-controlled study reported that treatment with ashwagandha-root extract (300 mg twice daily for eight weeks) improved immediate and general memory functions and enhanced executive function, attention and information processing speed in adults with a mild cognitive impairment [<xref rid="B168-brainsci-10-00964" ref-type="bibr">168</xref>]. In a systematic review, Ng and colleagues mentioned that <italic>W. somnifera</italic> extract ameliorated cognitive impairment and improved executive functions in adults with mild cognitive impairment [<xref rid="B169-brainsci-10-00964" ref-type="bibr">169</xref>]. There is limited data available on the clinical use of <italic>Withania</italic> for cognitive impairment.</p><p>Toxicity: Different preparations and extracts of <italic>W. somnifera</italic> root did not cause any toxicity even on chronic treatment [<xref rid="B170-brainsci-10-00964" ref-type="bibr">170</xref>]. Ashwagandholine 2% suspension in propylene glycol had a LD<sub>50</sub> of 465 mg/kg in rats and 432 mg/kg in mice [<xref rid="B171-brainsci-10-00964" ref-type="bibr">171</xref>]. Whereas intraperitoneal administration of aqueous-methanol root extract caused 50% lethality in mice at a dose of 1076 &#x000b1; 78 mg/kg [<xref rid="B172-brainsci-10-00964" ref-type="bibr">172</xref>]. Equimolar combination of sitoindosides VII and VIII and withaferin-A (SG-2) when administered once intraperitoneal, the LD<sub>50</sub> was 1564 &#x000b1; 92 mg/kg [<xref rid="B172-brainsci-10-00964" ref-type="bibr">172</xref>].</p></sec><sec id="sec3dot6-brainsci-10-00964"><title>3.6. Celastrus paniculatus</title><p>Plant description: <italic>Celastrus paniculatus</italic> (<italic>C. paniculatus</italic>) is a large climber of the family Celastraceae. It grows throughout India, on sub-Himalayan slopes and the hilly regions of Punjab and South India. It is commonly known as jyotismati, which comes from the Sanskrit words &#x0201c;jyoti teja&#x0201d; or fire of mind and &#x0201c;mati&#x0201d;&#x02014;intelligence. Traditionally, the bark and seeds have been used as a brain tonic, to promote intellect and to improve digestion, stimulant and expectorant [<xref rid="B173-brainsci-10-00964" ref-type="bibr">173</xref>]. In Ayurveda, <italic>C. paniculatus</italic> has been used to treat many diseases like depression, leprosy, paralysis, fever and arthritis. The seed oil and fruit are commonly used for their tranquilizer, sedative and wound healing properties [<xref rid="B174-brainsci-10-00964" ref-type="bibr">174</xref>].</p><p>Main chemical constituents: <italic>C. paniculatus</italic> shows the presence of various phytoconstituents such as sesquiterpenoid polyalcohols and esters (malkanguniol, malkangunin, polyalcohol A&#x02013;D and celapnin); alkaloids (paniculatine and celastrine); phenolic triterpenoids (celastrol and paniculatadiol); fatty acids (oleic, linoleic, linolenic, palmitic, stearic and lignoceric acid) and agarofuran derivatives [<xref rid="B175-brainsci-10-00964" ref-type="bibr">175</xref>].</p><p>Pharmacological activities: Various pharmacological activities such as hypolipidemic, neuroprotective, anti-infertility, antiarthritic, wound healing, anti-inflammatory, antioxidant, analgesic, antimalarial, antibacterial and fungicidal action of <italic>C. paniculatus</italic> have been reported [<xref rid="B176-brainsci-10-00964" ref-type="bibr">176</xref>].</p><p>Preclinical studies: Celastrus seed extract and oil have been evaluated in different experimental models of cognitive impairment such as scopolamine and sodium nitrite induced amnesia. The aqueous, methanolic, chloroform and petroleum ether extracts of seeds of <italic>C. paniculatus</italic> were investigated for their effect on cognitive function in rats. The aqueous extract showed significant improvement in cognitive performance at the doses of 200 and 300 mg/kg, p.o for 14 days. In another study, methanolic extract reported to have memory-enhancing activity in rats at doses of 100, 200 and 400 mg/kg [<xref rid="B177-brainsci-10-00964" ref-type="bibr">177</xref>]. The antioxidant activity of <italic>C. paniculatus</italic> may be involved in improving the cognitive function [<xref rid="B45-brainsci-10-00964" ref-type="bibr">45</xref>]. The oil of <italic>C. paniculatus</italic> seeds when given for 14 days to Wistar rats at a dose of 400 mg/kg resulted in enhanced learning and memory in radial arm maze and decreased the AChE enzyme activity in hypothalamus, frontal cortex and hippocampus [<xref rid="B178-brainsci-10-00964" ref-type="bibr">178</xref>]. Karanth et al. [<xref rid="B179-brainsci-10-00964" ref-type="bibr">179</xref>] also demonstrated a similar effect of <italic>C. paniculatus</italic> at the dose of 400 mg/kg for 3 days. In another study, rats treated with 850 mg/kg of <italic>C. paniculatus</italic> oil for 15 days had significantly improved retention in two passive avoidance tasks [<xref rid="B56-brainsci-10-00964" ref-type="bibr">56</xref>]. The seed oil treatment for 14 days at the doses of 50, 200 and 400 mg/kg, p.o reversed scopolamine induced spatial memory impairment in the Morris water maze and increased locomotor activity without affecting AChE activity in rats [<xref rid="B180-brainsci-10-00964" ref-type="bibr">180</xref>]. The aqueous seed extract improved memory performance in elevated plus maze and in sodium nitrite induced amnesia by reducing the AChE activity [<xref rid="B181-brainsci-10-00964" ref-type="bibr">181</xref>]. Furthermore, <italic>C. paniculatus</italic> seed oil treatment showed memory improvement in scopolamine induced amnesia in mice [<xref rid="B182-brainsci-10-00964" ref-type="bibr">182</xref>]. <italic>C. paniculatus</italic> has not undergone clinical trials for safety and efficacy. Animal toxicology data is also lacking to date.</p></sec><sec id="sec3dot7-brainsci-10-00964"><title>3.7. Evolvulus alsinoides</title><p>Plant description: <italic>Evolvulus alsinoides</italic> L. (<italic>E. alsionoides,</italic> dwarf morning glory), belonging to the family Convolvulaceae, is a perennial herb with small woody and branched rootstock. <italic>E. alsionoides</italic> is a weed, found mainly in the swampy regions of tropical and subtropical regions of the world. It has numerous branches (greater than 30 cm) with long hairs. The leaves are small, acute, elliptical with small size and blue-colored flowers [<xref rid="B183-brainsci-10-00964" ref-type="bibr">183</xref>]. It is locally known as Shankhpushpi and is very commonly used in Ayurveda. It is a key ingredient in majority of Medhya Rasayana formulations available in the Indian market. It is traditionally used as a memory enhancer in children and elderly and for neurological disorders like epilepsy [<xref rid="B184-brainsci-10-00964" ref-type="bibr">184</xref>].</p><p>Main chemical constituents: Major chemical constituents are octadecanoic acid, n-hexadecanoic acid, piperine, squalene, ethyl oleate and cholesterol [<xref rid="B185-brainsci-10-00964" ref-type="bibr">185</xref>].</p><p>Pharmacological activities: Studies indicate that <italic>Evolvulus alsionoides</italic> (<italic>E. alsionoides</italic>) possesses in-vitro antioxidant [<xref rid="B186-brainsci-10-00964" ref-type="bibr">186</xref>], immunomodulatory [<xref rid="B187-brainsci-10-00964" ref-type="bibr">187</xref>], adaptogenic, antiamnesic [<xref rid="B188-brainsci-10-00964" ref-type="bibr">188</xref>] and antiulcer [<xref rid="B189-brainsci-10-00964" ref-type="bibr">189</xref>] activities.</p><p>Preclinical studies: Nahata et al. [<xref rid="B190-brainsci-10-00964" ref-type="bibr">190</xref>] reported learning and memory enhancing property of its ethanolic extract and ethyl acetate and aqueous fractions in rats. The ethanolic extract (100 mg/kg, p.o) also protected against scopolamine induced dementia in rats [<xref rid="B188-brainsci-10-00964" ref-type="bibr">188</xref>]. Three days oral treatment with <italic>E. alsionoides</italic> (100 mg/kg) was effective in decreasing scopolamine induced deficit in adult male Swiss mice [<xref rid="B188-brainsci-10-00964" ref-type="bibr">188</xref>]. Pretreatment with hydro-alcoholic extract at the doses of 100, 300 and 500 mg/kg, p.o ameliorated the ICV-STZ induced cognitive impairment by decreasing the oxidative stress and rho kinase (ROCK II) expression in the rat brain [<xref rid="B15-brainsci-10-00964" ref-type="bibr">15</xref>,<xref rid="B145-brainsci-10-00964" ref-type="bibr">145</xref>]. In-vitro, aqueous and hydroalcoholic extracts of <italic>E. alsinoides</italic> showed free radicals scavenging, anti-inflammatory and enzymes (cholinesterase, glycogen synthase kinase-3-&#x003b2;, Rho kinase (ROCKI I), prolyl endopeptidase, catechol-o-methyl transferase and monoglycerol lipase) inhibitory activity, all of which are involved in the pathophysiology of AD [<xref rid="B15-brainsci-10-00964" ref-type="bibr">15</xref>]. Previous studies also indicated the memory enhancing effect of <italic>E. alsionoides</italic> in the experimental model of amnesia [<xref rid="B191-brainsci-10-00964" ref-type="bibr">191</xref>,<xref rid="B192-brainsci-10-00964" ref-type="bibr">192</xref>]. The methanol and water extract of <italic>E. alsinoides</italic> documented to exhibit acetylcholinesterase activity, supporting its potential in reverting neuronal dysfunctions and thus in management of AD [<xref rid="B193-brainsci-10-00964" ref-type="bibr">193</xref>]. <italic>E. alsionoides</italic> has not been studied systematically for clinical efficacy and toxicological effects.</p></sec><sec id="sec3dot8-brainsci-10-00964"><title>3.8. Desmodium gangeticum</title><p>Plant description: <italic>Desmodium gangeticum</italic> (<italic>D. gangeticum</italic>)<italic>,</italic> belonging to the family Fabaceae, commonly known as Salpani in Hindi and is found in abundance throughout India. It is a perennial undershrub, 60&#x02013;130 cm high with somewhat angular branches. Its leaves are simple, ovateoblong or rounded with purplish or white flowers, 4&#x02013;7 cm [<xref rid="B194-brainsci-10-00964" ref-type="bibr">194</xref>]. It has been used in the traditional system of medicine as a bitter tonic, febrifuge, antiemetic, digestive and in various inflammatory conditions due to vata disorder [<xref rid="B195-brainsci-10-00964" ref-type="bibr">195</xref>]. In Satpuda hills of India, powdered root of <italic>D. gangeticum</italic> is applied along with honey to treat a mouth ulcer. In Uttat Pradesh state of India, the leaf paste of <italic>D. gangeticum</italic> and aloe vera are applied to prevent hair fall [<xref rid="B196-brainsci-10-00964" ref-type="bibr">196</xref>].</p><p>Main chemical constituents: <italic>D. gangeticum</italic> shows the presence of alkaloids (tryptamines and phenylethylamines), pterocarpanoids (gangetin and desmodin), phospholipids, sterols, flavone and glycosides [<xref rid="B197-brainsci-10-00964" ref-type="bibr">197</xref>].</p><p>Pharmacological activities: It shows various pharmacological activities including antileishmanial, immunomodulatory, antioxidant, anti-inflammatory, antinociceptive, cardioprotective, antiulcer, antiamnesic and hepatoprotective [<xref rid="B194-brainsci-10-00964" ref-type="bibr">194</xref>].</p><p>Preclinical studies: Aqueous extract of <italic>D. gangeticum</italic> when administered orally at the dose of 50, 100 and 200 mg/kg for 7 days improved memory in mice [<xref rid="B198-brainsci-10-00964" ref-type="bibr">198</xref>,<xref rid="B199-brainsci-10-00964" ref-type="bibr">199</xref>]. Scopolamine and ageing induced amnesias were also prevented in rats by pretreatment with the aqueous extract of <italic>D. gangeticum</italic> [<xref rid="B198-brainsci-10-00964" ref-type="bibr">198</xref>]. Moreover, treatment of mice with the chloroform extract (400 mg/kg) and alkaloidal fraction (50 mg/kg) of <italic>D. gangeticum</italic> for 6 days alleviated the scopolamine-induced amnesia [<xref rid="B200-brainsci-10-00964" ref-type="bibr">200</xref>]. Antioxidant, anti-inflammatory and AChE inhibitory activity of <italic>D. gangeticum</italic> has also been reported [<xref rid="B199-brainsci-10-00964" ref-type="bibr">199</xref>,<xref rid="B201-brainsci-10-00964" ref-type="bibr">201</xref>,<xref rid="B202-brainsci-10-00964" ref-type="bibr">202</xref>]. These pharmacological properties indicate the potential of <italic>D. gangeticum</italic> in the management of AD related cognitive impairment. Yet, not much clinical evidence is available to this effect. Toxicity studies are also required to establish the safety of this potentially useful herb.</p></sec><sec id="sec3dot9-brainsci-10-00964"><title>3.9. Eclipta Species</title><p>Plant description: <italic>Eclipta alba</italic> (L.) Hassk (<italic>E. alba</italic>) is an annual erect or prostrate herb, belonging to the Asteraceae family. There are four major varieties of Eclipta based on the colors of flower like red, yellow, white and blue. The flowers of <italic>E. alba</italic> are white in color and largely harvested due to its therapeutic activity [<xref rid="B203-brainsci-10-00964" ref-type="bibr">203</xref>]. Its stem is reddish-purple in color with up-turned hairs and roots are greyish with cylindrical shape [<xref rid="B204-brainsci-10-00964" ref-type="bibr">204</xref>]. <italic>Eclipta alba</italic> (<italic>E. alba</italic>), commonly known as Bringharaj, is well known in the traditional system of medicine for its beneficial effects on learning and memory [<xref rid="B205-brainsci-10-00964" ref-type="bibr">205</xref>]. Another species of Eclipta, commonly known as false daisy, is <italic>E. prostrate</italic>. It has also been traditionally used for treatment of memory related disorders, hepatic disorders and atherosclerosis [<xref rid="B206-brainsci-10-00964" ref-type="bibr">206</xref>].</p><p>Main chemical constituents: The major chemical constituents present in <italic>E. alba</italic> are coumestans, flavonoids, sterols, alkaloids, triterpenoid saponins and volatile oil.</p><p>Pharmacological activities: It has good antimicrobial properties like antibacterial, antifungal and antimalarial. It also shows antidiabetic, hepatoprotective, hypolipidemic, anticancer, hair growth promoting and memory enhancement and immunomodulatory properties [<xref rid="B207-brainsci-10-00964" ref-type="bibr">207</xref>].</p><p>Preclinical studies: The ethanolic extract of <italic>E. alba</italic> resulted in improvement in learning and memory abilities in passive avoidance and the elevated plus maze test in rats after both acute and chronic administration [<xref rid="B207-brainsci-10-00964" ref-type="bibr">207</xref>]. Saponins, the main chemical constituent of butanol fraction of <italic>E. prostrate</italic>, prevented ethanol induced memory impairment in rats [<xref rid="B208-brainsci-10-00964" ref-type="bibr">208</xref>]. Kim et al. [<xref rid="B209-brainsci-10-00964" ref-type="bibr">209</xref>] also reported that butanol fraction increased ACh content, decreased MAO-B activity and reduced oxidative stress in the rat brain. Lipid lowering and antioxidant activities of <italic>Eclipta</italic> plants have also been reported [<xref rid="B210-brainsci-10-00964" ref-type="bibr">210</xref>]. <italic>E. alba</italic> also possesses antiviral, antinociceptive, anti-inflammatory, bronchodilator, antibacterial, antipyretic, tonic, expectorant and hepatoprotective activity [<xref rid="B211-brainsci-10-00964" ref-type="bibr">211</xref>,<xref rid="B212-brainsci-10-00964" ref-type="bibr">212</xref>]. Previous study also reported the improvement in learning and memory functions of rats [<xref rid="B213-brainsci-10-00964" ref-type="bibr">213</xref>]. Based on the animal data available, the herb needs to be evaluated clinically.</p><p>Toxicity: An aqueous extract of <italic>E. alba</italic> did not cause any toxicity at a dose of 2.0 g/kg orally and 200 mg/kg by intravenous and intraperitoneal routes. The LD<sub>50</sub> in mice were 7.841 g/kg, 302.8 and 328.3 mg/kg for oral and intravenous and intraperitoneal routes respectively [<xref rid="B137-brainsci-10-00964" ref-type="bibr">137</xref>]. The alcoholic extract did not show any toxicity in rats and mice and the minimum lethal dose was found to be greater than 2.0 g/kg when given orally and intraperitonially in mice [<xref rid="B214-brainsci-10-00964" ref-type="bibr">214</xref>].</p></sec><sec id="sec3dot10-brainsci-10-00964"><title>3.10. Moringa oleifera</title><p>Plant description: <italic>Moringa oleifera</italic> (<italic>M. oleifera</italic>) belonging to the family Moringaceae is the commonly distributed species of this family. This plant is native to India and the height of trees can reach up to 10 m. It has fragile branches and bipinnate or tripinnate leaves. It has yellowish white flowers 0.5&#x02013;1 cm long and around 2 cm broad [<xref rid="B215-brainsci-10-00964" ref-type="bibr">215</xref>]. It is commonly known as a drumstick. <italic>M. oleifera</italic> has shown antimicrobial activity and traditionally been used to clarify water due to its coagulant property. Oil of <italic>M. oleifera</italic> has high stability and contains a large amount oleic acid, hence used as an edible oil, biodiesel and lubrication of machinery [<xref rid="B216-brainsci-10-00964" ref-type="bibr">216</xref>].</p><p>Main chemical constituents: The major chemical constituents in <italic>M. oleifera</italic> are vitamins (vitamin A and C), polyphenols (flavonoids, chlorogenic acid and phenolic acids), alkaloids, glucosinolates, isothiocyanates, tannins and saponins [<xref rid="B217-brainsci-10-00964" ref-type="bibr">217</xref>].</p><p>Pharmacological activities: Various pharmacological activities like nootropic, anti-inflammatory, hypocholesterolemic, hypotensive and antioxidant effects of its leaves have been reported [<xref rid="B218-brainsci-10-00964" ref-type="bibr">218</xref>,<xref rid="B219-brainsci-10-00964" ref-type="bibr">219</xref>,<xref rid="B220-brainsci-10-00964" ref-type="bibr">220</xref>,<xref rid="B221-brainsci-10-00964" ref-type="bibr">221</xref>,<xref rid="B222-brainsci-10-00964" ref-type="bibr">222</xref>]. Additionally, it has also shown hypolipidemic, antiobesity, antidiabetic, anti-inflammatory, immunomodulatory and anticancer effects. <italic>M. oleifera</italic> is a good source of vitamin, hence prevents night-blindness and delays cataract development [<xref rid="B217-brainsci-10-00964" ref-type="bibr">217</xref>].</p><p>Preclinical studies: Pretreatment with <italic>M. oleifera</italic> at an oral dose of 250 mg/kg prevented hypoxia induced memory impairment in rats by maintaining the monoamines levels in the brain [<xref rid="B223-brainsci-10-00964" ref-type="bibr">223</xref>]. The ethanolic leaf extract at a dose of 250 mg/kg, p.o for 14 days provided protection against cognitive impairment induced by ICV&#x02013;colchicine. It restored colchicine induced changes in the brain norepinephrine, serotonin and dopamine levels [<xref rid="B224-brainsci-10-00964" ref-type="bibr">224</xref>]. Improvement in learning and memory has been suggested to be due to its antioxidant effect. Other studies also demonstrated the protective effect of <italic>M. oleifera</italic> against memory impairment in experimental models of dementia [<xref rid="B225-brainsci-10-00964" ref-type="bibr">225</xref>,<xref rid="B226-brainsci-10-00964" ref-type="bibr">226</xref>]. Intriguingly, <italic>M. oleifera</italic> was shown to mitigate hyperphosphorylation and A&#x003b2; pathology also in hyperhomocysteinemia-induced AD in rats [<xref rid="B227-brainsci-10-00964" ref-type="bibr">227</xref>]. The mechanism of action, composition of the herb and difference between different extracts need to be established before it can be taken to clinical trials.</p><p>Toxicity: The aqueous leaf extract was found safe in rats after oral administration of 2000 mg/kg [<xref rid="B228-brainsci-10-00964" ref-type="bibr">228</xref>]. The acute toxicity of aqueous and ethanolic extract of <italic>M. oleifera</italic> root was evaluated in mice with the LD<sub>50</sub> of 15.9 g/kg and 17.8 g/kg, respectively [<xref rid="B229-brainsci-10-00964" ref-type="bibr">229</xref>].</p></sec><sec id="sec3dot11-brainsci-10-00964"><title>3.11. Convolvulus pluricaulis</title><p>Plant description: <italic>Convolvulus pluricaulis</italic> (<italic>C. pluricaulis</italic>) Choisy is a perennial, wild, prostrate herb, which belongs to the Convulvulaceae family and is mainly found in Northern India. It has long branches of about 30 cm and blue flowers. Its leaves are elliptical in shape and located alternately with flowers and branches [<xref rid="B230-brainsci-10-00964" ref-type="bibr">230</xref>]. It is commonly known as shankhpushpi and is used as a nervine tonic in the Ayurvedic system of medicine, to improve memory and intellect [<xref rid="B230-brainsci-10-00964" ref-type="bibr">230</xref>]. It is classified as Medhya rasayana (promotes intellectual capacity) and Majjadhatu rasayana (rejuvenates the nervous tissue). The leaves of <italic>C. pluricaulis</italic> have been used for depression and other mental disturbances [<xref rid="B231-brainsci-10-00964" ref-type="bibr">231</xref>].</p><p>Main chemical constituents: The major chemical components are alkaloids (shankhpushpine and convolamine), volatile oils, favanoid-kampferol, phytosterol, amino acids, fatty acids, scopoletin and beta-sitosterol (Sethiya NK) [<xref rid="B232-brainsci-10-00964" ref-type="bibr">232</xref>].</p><p>Pharmacological activities: Various neuropharmacological actions such nootropic, antistress, antidepressant, anxyiolytic, anticonvulsant and sedative activities of this plant are well reported [<xref rid="B233-brainsci-10-00964" ref-type="bibr">233</xref>,<xref rid="B234-brainsci-10-00964" ref-type="bibr">234</xref>,<xref rid="B235-brainsci-10-00964" ref-type="bibr">235</xref>,<xref rid="B236-brainsci-10-00964" ref-type="bibr">236</xref>]. Furthermore, it also possesses antiamnesic, antiulcer, anticatatonic, antibacterial, immunomodulatory and cardiovascular activity [<xref rid="B232-brainsci-10-00964" ref-type="bibr">232</xref>].</p><p>Preclinical studies: The ethanolic extract of <italic>C. pluricaulis</italic> and its ethyl acetate and aqueous fraction at the dose of 100 and 200 mg/kg, p.o showed memory enhancing properties in Cook and Weidley&#x02019;s Pole Climbing Apparatus, passive avoidance paradigms and active avoidance tests [<xref rid="B237-brainsci-10-00964" ref-type="bibr">237</xref>]. Convolvine, a chemical constituent of <italic>C. pluricaulis</italic> potentiated the effect of arecoline (memory enhancer) and improved cognitive dysfunction in AD [<xref rid="B238-brainsci-10-00964" ref-type="bibr">238</xref>,<xref rid="B239-brainsci-10-00964" ref-type="bibr">239</xref>]. Sharma et al. [<xref rid="B240-brainsci-10-00964" ref-type="bibr">240</xref>] also reported that the ethanolic extract at 100 and 200 mg/kg oral dose significantly improved memory in young and aged mice but the retention was better in young mice. <italic>C. pluricaulis</italic> also possesses antioxidant and hypolipidemic effects, which may be partially responsible for improvement in cognitive function [<xref rid="B190-brainsci-10-00964" ref-type="bibr">190</xref>,<xref rid="B241-brainsci-10-00964" ref-type="bibr">241</xref>]. <italic>C. pluricaulis</italic> administration for 3 months at the dose of 150 mg/kg prevented aluminum chloride induced neurotoxicity by decreasing AChE activity, reducing oxidative stress and preserving the activity of ChAT and Nerve Growth Factor-Tyrosine kinase A receptor (NGF-TrkA) [<xref rid="B242-brainsci-10-00964" ref-type="bibr">242</xref>]. Alcoholic extract of <italic>C. pluricaulis</italic> Choisy (leaves) showed A&#x003b2; production inhibition in-vitro [<xref rid="B243-brainsci-10-00964" ref-type="bibr">243</xref>]. Additionally, isolated bioactive coumarins from <italic>C. pluricaulis</italic> ameliorated scopolamine induced amnesia in mice [<xref rid="B244-brainsci-10-00964" ref-type="bibr">244</xref>]. Despite detailed experimental studies, the herb has not been evaluated clinically.</p><p>Toxicity: <italic>C. pluricaulis</italic> has not been studied for toxicity. <italic>C. microphyllus,</italic> another plant of the same family had the LD<sub>50</sub> of 1250 mg/kg after oral administration of the whole plant extract [<xref rid="B245-brainsci-10-00964" ref-type="bibr">245</xref>].</p></sec></sec><sec id="sec4-brainsci-10-00964"><title>4. Other Plants with Potential Memory Enhancing Activity</title><p>Several other plants may improve cognitive functions and be useful in AD. However, very limited, if any, literature is present to review the plants individually. These less explored plants include <italic>Acorus calamus</italic> (vach), <italic>Prunus amygdalus</italic> (badam), <italic>Orchis mascula</italic> (salap), <italic>Syzygium aromaticum</italic> (lavang), <italic>Mukta pishti</italic> (pearl), <italic>Tinospora cordifolia</italic> (guduchi), <italic>Picrorrhiza kurroa</italic> (kutki), <italic>Zingiber officinale</italic> (sonth), <italic>Boerhaavia diffusa</italic> (punarnava)<italic>, Commiphora wightii (guggal</italic>)<italic>, Piper longum</italic> (pippali)<italic>, Carum copticum</italic> (ajwain)<italic>, Cyperus rotundus</italic> (coco-grass), <italic>Santalum album</italic> (Indian sandalwood)<italic>, Elettaria cardamomum</italic> (cardamom)<italic>, Foeniculum vulgare</italic> (fennel)<italic>, Rosa damascene</italic> (damask rose) and <italic>Cinnamomum cassia</italic> (cassia).</p></sec><sec sec-type="methods" id="sec5-brainsci-10-00964"><title>5. Methodology</title><p>Search criteria: Database searches were conducted on PUBMED, and GOOGLE SCHOLAR using keywords: dementia, herbal products/drugs/medicine, Alzheimer&#x02019;s disease and complementary and alternative medicines. The searches were limited to those plant/plant products, which are mentioned in Indian Ayurvedic literature for their potential use in some form of dementia and literature available online in the English language.</p><p>Inclusion criteria: The following studies were included in the present review article: (1) preclinical studies (in-vitro and in-vivo studies); (2) clinical studies and (3) herbal medicine identified with their regional or Hindi name.</p><p>Exclusion criteria: The following criteria was used in the present review to exclude the studies: (a) herbal drugs of non-Indian origin; (b) articles available in the language other than English and (c) full text not available.</p></sec><sec id="sec6-brainsci-10-00964"><title>6. Indian Herbal Formulations Studied in Alzheimer&#x02019;s Disease</title><sec id="sec6dot1-brainsci-10-00964"><title>6.1. Mentat</title><p>Compound formulations are commonly used in Ayurveda, based on the concept that such combinations provide synergistic therapeutic effect with minimal adverse effects. BR-16A (Mentat) is a polyherbal formulation used as Medhya Rasayana in Ayurveda and is used to improve memory and cognitive deficits associated with chronic illness and aging [<xref rid="B156-brainsci-10-00964" ref-type="bibr">156</xref>]. The ingredients in BR-16A are Brahmi (<italic>Bacopa monnieri</italic>), Mandookaparni (<italic>Centella asiatica</italic>), Ashwagandha (<italic>Withania somnifera</italic>), Shankapushpi (<italic>Evolvulus alsinoides</italic>), Jatamansi (<italic>Nardostachys jatamansi</italic>), Vach (<italic>Acorus calamus</italic>), Tagar (<italic>Valeriana wallachii</italic>), Badam (<italic>Prunus amygdalus</italic>), Salap (<italic>Orchis mascula</italic>), Lavang (<italic>Syzgium aromaticum</italic>), Pearl (<italic>Mukta pishti</italic>), Malkangni (<italic>Celastrus paniculatus</italic>) and Sonth (<italic>Zingiber officinale</italic>).</p><p>Mentat has been shown to augment acquisition and retention of learning in rats and prevented cognitive deficits induced by variety of insults including prenatal undernutrition, postnatal environmental impoverishment, sodium nitrite hypoxia, aluminum, increasing age and electroconvulsive shock induced antero-grade and retro-grade amnesia [<xref rid="B246-brainsci-10-00964" ref-type="bibr">246</xref>,<xref rid="B247-brainsci-10-00964" ref-type="bibr">247</xref>,<xref rid="B248-brainsci-10-00964" ref-type="bibr">248</xref>]. Administration for 20 days at a dose of 100 mg/kg/day significantly prolonged the shortened step-through latency induced by aluminum administration and also significantly improved retention of learning in aged rats [<xref rid="B248-brainsci-10-00964" ref-type="bibr">248</xref>]. Ramteke et al. [<xref rid="B249-brainsci-10-00964" ref-type="bibr">249</xref>] reported that administration of BR-16A facilitated learning and memory in rats on the Hebb Williams complex maze as compared to control. BR-16A also showed dose dependent improvement in learning and memory in scopolamine induced amnesia in rats [<xref rid="B250-brainsci-10-00964" ref-type="bibr">250</xref>]. Mentat when administered for 2 weeks reversed the cognitive deficit and cholinergic dysfunction induced by colchicine and ibotenic acid model of AD [<xref rid="B251-brainsci-10-00964" ref-type="bibr">251</xref>].</p><p>Clinical evidence: It improved memory quotient of normal subjects in different age groups [<xref rid="B252-brainsci-10-00964" ref-type="bibr">252</xref>], increased memory span and attenuated fluctuations of attention in normal adults and improved learning ability in children with behavioral problems or minimal brain damage [<xref rid="B253-brainsci-10-00964" ref-type="bibr">253</xref>].</p><p>Toxicity: In an acute toxicity study, Mentat did not show any sign of toxicity up to the dose of 1.5 g/kg. The LD<sub>50</sub> was found to be 1.75 g/kg after intraperitoneal injection [<xref rid="B254-brainsci-10-00964" ref-type="bibr">254</xref>] and 2400 mg/kg after oral administration [<xref rid="B250-brainsci-10-00964" ref-type="bibr">250</xref>].</p></sec><sec id="sec6dot2-brainsci-10-00964"><title>6.2. Trasina</title><p>Trasina is a polyherbal formulation of some Indian medicinal plants, which are classified as Medhya rasayana in Ayurveda. It consists of <italic>Withania somnifera</italic> (80 mg), <italic>Ocimum sanctum</italic> (190 mg), <italic>Eclipta alba</italic> (10 mg), <italic>Tinospora cordifolia</italic> (10 mg), <italic>Picrorrhiza kurroa</italic> (10 mg) and shilajit (20 mg). It has shown significant nootropic effect at a dose of 200 and 500 mg/kg, p.o when administered for 21 days in colchicine and ibotenic acid induced cognitive impairment. Trasina, dose dependently, improved both memory and cholinergic markers like acetylcholine concentration, choline acetyl transferase activity and muscarinic cholinergic receptor binding in the frontal cortex and hippocampus of rat brain after 14 and 21 days of treatment. Thus, its nootropic effect may be attributed to the correction of cholinergic dysfunction [<xref rid="B255-brainsci-10-00964" ref-type="bibr">255</xref>].</p></sec><sec id="sec6dot3-brainsci-10-00964"><title>6.3. Memorin</title><p>Memorin consists of <italic>Mandookparni</italic> (60 mg), Shankhpushpi (60 mg), Jatamansi (30 mg), Yashtimadhu (60 mg) and Smruti sagar (60 mg). The effect of memorin was evaluated by Andrade, 1998 in an age related memory disorder and reported beneficial effects in elderly persons who experienced age related memory decline [<xref rid="B256-brainsci-10-00964" ref-type="bibr">256</xref>]. Additionally, memorin (200 mg/day/kg) was found to attenuate retrograde and anterograde amnesia in rats when tested using passive avoidance learning paradigms in the shuttle box and T-maze test [<xref rid="B257-brainsci-10-00964" ref-type="bibr">257</xref>].</p></sec><sec id="sec6dot4-brainsci-10-00964"><title>6.4. Bramhi Ghrita</title><p>It is a polyherbal Ayurvedic formulation that contains <italic>Bacopa monneri</italic> (40% <italic>w</italic>/<italic>w</italic>), <italic>Evolvulus alsinoids</italic> (20% <italic>w</italic>/<italic>w</italic>), <italic>Acorus calamus</italic> (20% <italic>w</italic>/<italic>w</italic>), <italic>Saussurea lappa</italic> (20% <italic>w</italic>/<italic>w</italic>) and cow&#x02019;s ghee (750 mL). Traditionally, it is used as a memory enhancer [<xref rid="B258-brainsci-10-00964" ref-type="bibr">258</xref>]. Achliya et al. [<xref rid="B259-brainsci-10-00964" ref-type="bibr">259</xref>] evaluated the learning and memory enhancing effect of this formulation at 30, 50 and 100 mg/kg oral doses. The results of this study showed that <italic>Bramhi Ghrita</italic> at the doses of 50 and 100 mg/kg, p.o decreased the transfer latency in elevated plus maze and escape latency in Morris water maze test. Additionally, it enhanced the learning and memory of rats indicating the nootropic activity [<xref rid="B260-brainsci-10-00964" ref-type="bibr">260</xref>].</p></sec><sec id="sec6dot5-brainsci-10-00964"><title>6.5. Abana</title><p>Abana, another polyherbal Ayurvedic formulation, is available in tablet form consisting of <italic>Terminalia arjuna</italic> (30 mg), <italic>Withania somnifera</italic> (20 mg), <italic>Nepeta hindostana</italic> (20), Dashamoola (20 mg), <italic>Tinospora cordifolia</italic> (10 mg), <italic>Phyllanthus emblica</italic> (10 mg), <italic>Terminalia chebula</italic> (10 mg), <italic>Eclipta alba</italic> (10 mg), <italic>Glycyrrhiza glabra</italic> (10 mg), <italic>Asparagus racemosus</italic> (10 mg), <italic>Boerhaavia diffusa</italic> (10 mg), Shilajeet (20 mg), <italic>Centella asiatica</italic> (10 mg), <italic>Convolvulus pluricaulis</italic> (10 mg), <italic>Ocimum sanctum</italic> (10 mg), <italic>Nardostachys jatamansi</italic> (10 mg), <italic>Piper longum</italic> (10 mg), <italic>Carum copticum</italic> (10 mg), <italic>Zingiber officinale</italic> (10 mg), Shankh bhasma (10 mg), Makardhwaj (10 mg), <italic>Cyperus rotundus</italic> (5 mg), <italic>Acorus calamus</italic> (5 mg), <italic>Embelia ribes</italic> (5 mg), <italic>Syzygium aromaticum</italic> (5 mg), <italic>Celastrus paniculatus</italic> (5 mg), <italic>Santalum album</italic> (5 mg), <italic>Elettaria cardamomum</italic> (5 mg), <italic>Foeniculum vulgare</italic> (5 mg), <italic>Rosa damascena</italic> (5 mg), <italic>Cinnamomum cassia</italic> (5 mg), Jaharmohra (10 mg), Abhrak bhasma (5 mg), Akik pishti (5 mg), Yeshab pishti (5 mg), Yakut pishti (5 mg), Praval pishti (5 mg) and <italic>Crocus sativus</italic> (2 mg).</p><p>Abana was administered for 15 days at the doses of 50, 100 and 200 mg/kg orally to young and aged mice and retention memory was tested using elevated plus the maze and passive avoidance test. It was also tested in scopolamine and diazepam induced amnesia at same doses. Abana reduced the brain AChE activity in a dose dependent manner. The results of these studies indicate that Abana improves memory, which may be due to reduction in brain AChE activity. Acute oral administration of Abana in mice did not cause any toxicity up to the dose of 2000 mg/kg [<xref rid="B261-brainsci-10-00964" ref-type="bibr">261</xref>].</p></sec></sec><sec id="sec7-brainsci-10-00964"><title>7. Herbal Drugs: Regulatory Status</title><p>The regulatory guidelines for herbal medicines differ from country to country. USFDA classifies herbal medicines into dietary supplements and botanical drugs. Safety and efficacy studies are not needed for marketing of dietary supplements, but they should be so labeled. For botanicals, description of the product and documentation of prior human experience of the product is required. The requirements may vary from non-clinical studies to clinical trials, batch effect analysis [<xref rid="B262-brainsci-10-00964" ref-type="bibr">262</xref>]. In European Union, Committee on Herbal Medicinal Products (HMPC) issues scientific opinions on herbal substances and preparations [<xref rid="B263-brainsci-10-00964" ref-type="bibr">263</xref>]. The regulatory pathways depend on prior human exposure and range from traditional use registration; well established use marketing authorization and to stand alone or mixed application.</p><p>In India, herbal medicines are governed by Drugs and Cosmetics Act 1940, and Rules 1946. The development pathway is similar to other synthetic drugs, if they have to be incorporated into the modern system of medicine as per new drugs and clinical trials rule, 2019 [<xref rid="B264-brainsci-10-00964" ref-type="bibr">264</xref>]. Licensing, composition, formulation and manufacturing of products, labeling, packing and quality is done as per Schedule T [<xref rid="B265-brainsci-10-00964" ref-type="bibr">265</xref>]. Safety and efficacy studies are undertaken in accordance with AYUSH GCP guidelines [<xref rid="B266-brainsci-10-00964" ref-type="bibr">266</xref>].</p></sec><sec id="sec8-brainsci-10-00964"><title>8. Issues and Challenges with Herbal Drugs</title><p>Quality control of herbal drug: Extraction technique and processing step may cause variation in the concentration of active constituents, which necessitates quality control of herbal medicines. The macroscopic and microscopic property of herbal medicines should be examined for quality control. Determination of ash value, heavy metals, pesticide residues and microbial contamination should be carried out.</p><p>Herb-drug interaction: Coadministration of herbal drugs with prescribed drugs may result in serious adverse effects. Herbal drugs contain numerous unidentified constituents, which make it difficult to assess the nature of interactions. Additionally, it is generally believed that herbal medicines are safe since they belong to a natural origin but recently many of the herbs were found to exhibit adverse drug reactions [<xref rid="B267-brainsci-10-00964" ref-type="bibr">267</xref>]. Some reports also showed that adverse events are caused due to the herb&#x02013;drug interaction [<xref rid="B267-brainsci-10-00964" ref-type="bibr">267</xref>,<xref rid="B268-brainsci-10-00964" ref-type="bibr">268</xref>,<xref rid="B269-brainsci-10-00964" ref-type="bibr">269</xref>]. Heterogeneity in doses and frequency of use also obstruct precise assessment of drug interactions. CYP450 is involved in the metabolism of drugs used for management of AD [<xref rid="B270-brainsci-10-00964" ref-type="bibr">270</xref>,<xref rid="B271-brainsci-10-00964" ref-type="bibr">271</xref>]. Hence CYP450 inhibition by herbal drugs should be assessed for predicting potential herb&#x02013;drug interactions. <italic>Ginkgo biloba</italic> when given with donepezil cause an increased effect in AD due to additive cholinergic activity. However, when it was given with phenytoin, it causes breakthrough seizures due to the induction of CYP2C19. Curcumin increase the oral bioavailability of celiprolol due to inhibition of intestinal CYP450 enzymes and p-glycoprotein [<xref rid="B272-brainsci-10-00964" ref-type="bibr">272</xref>]. Moreover, coadministration of curcumin and donepezil (reversible cholinesterase inhibitor) had a synergistic effect on cognition and oxidative stress [<xref rid="B273-brainsci-10-00964" ref-type="bibr">273</xref>] and good BBB permeability [<xref rid="B274-brainsci-10-00964" ref-type="bibr">274</xref>]. More experimental and clinical studies need to be performed to evaluate the herb&#x02013;drug interaction. Such interactions may be prevented with disclosure of concomitant use by the patients and awareness of physicians. In the elderly population, the absorption, metabolism and elimination of drugs are already impaired. Concomitantly use of herbal medicines may worsen the impairment. Therefore, herbal drugs should be used cautiously in elderly patients.</p><p>Adulteration: Herbal drugs are many times substituted or adulterated with other inferior products with morphological resemblance of authentic herb. This type of adulteration is more common for herbs with volatile components. The adulterants may not have a therapeutic benefit or may even cause adverse effects. Therefore, quality assurance of herbal medicines should be mandatory.</p><p>Labeling of herbal medicines: Proper labeling can reduce the risk of inappropriate use and adverse effects. The label should contain the name and amount of herbal drug and active ingredients, direction for intake, its intended use, storage conditions, shelf life, adverse effects and warnings, if any.</p><p>Pharmacovigilance for herbal medicines: Modern times rely more on the systematically studied modern medicines as they must adhere to stringent national and international regulations also. On the other hand, traditional systems of medicine suffer from a lack of or inadequate regulatory guidelines. In addition, herbal medicines are widely perceived to be safe due to their natural origins. However, as reviewed above, several herbal medicines exhibit adverse effects on their own or due to adverse herb&#x02013;drug interactions with concomitant medicines. Apart from these inherent risks of herbal medicines, several adverse effects associated with them may be due to improper labeling, unknown composition, a lack of standardization, inferior quality, contamination, adulteration, improper use and even quackery.</p><p>Patients with Alzheimer&#x02019;s disease constitute a special subgroup due to their vulnerability and their inability to communicate adverse events, in later stages of the disease. This population needs special attention with respect to the monitoring of adverse effects and drug&#x02013;drug interactions. Hence, there is a need to integrate pharmacovigilance of herbal medicines with that of the modern medicine, under the national pharmacovigilance programs.</p></sec><sec sec-type="conclusions" id="sec9-brainsci-10-00964"><title>9. Conclusions and Future Prospectus</title><p>The alternative systems of medicine have been used since ancient times and different extracts of medicinal plants and herbal formulations have demonstrated potential for use in AD. Medicinal plants provide a fertile ground for new drug discovery because of the presence of various chemical constituents and their ability to act on different biological targets. However, much work remains to be done to translate this potential into actual medicine. Standardization of plant extracts is an urgent need in herbal drug research. Phytoconstituents responsible for pharmacological activities should be isolated, identified and systematically tested. Multicenter clinical trials should be performed to validate the efficacy of these herbal medicines alone or in the form of formulations for the treatment of AD. The present article reviewed the reported efficacy of herbal medicines against AD in experimental and clinical studies.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-brainsci-10-00964"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dua</surname><given-names>J.S.</given-names></name><name><surname>Prasad</surname><given-names>D.N.</given-names></name><name><surname>Tripathi</surname><given-names>A.C.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name></person-group><article-title>Role of traditional medicine in neuropsychopharmacology</article-title><source>Asian J. Pharm. Clin. Res.</source><year>2009</year><volume>2</volume><fpage>72</fpage><lpage>76</lpage></element-citation></ref><ref id="B2-brainsci-10-00964"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P.-P.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Meng</surname><given-names>X.-Y.</given-names></name><name><surname>Kang</surname><given-names>J.-S.</given-names></name></person-group><article-title>History and progress of hypotheses and clinical trials for Alzheimer&#x02019;s disease</article-title><source>Signal Transduct. Target.</source><year>2019</year><volume>4</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.1038/s41392-019-0063-8</pub-id></element-citation></ref><ref id="B3-brainsci-10-00964"><label>3.</label><element-citation publication-type="journal"><article-title>2020 Alzheimer&#x02019;s disease facts and figures</article-title><source>Alzheimer&#x02019;s Dement.</source><year>2020</year><volume>16</volume><fpage>391</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1002/alz.12068</pub-id></element-citation></ref><ref id="B4-brainsci-10-00964"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Shaji</surname><given-names>K.S.</given-names></name><name><surname>Jotheeswaran</surname><given-names>A.T.</given-names></name><name><surname>Girish</surname><given-names>N.</given-names></name><name><surname>Bharath</surname><given-names>S.</given-names></name><name><surname>Dias</surname><given-names>A.</given-names></name><name><surname>Pattabiraman</surname><given-names>M.</given-names></name><name><surname>Varghese</surname><given-names>M.</given-names></name></person-group><source>Alzheimer&#x02019;s and Related Disorders Society of India</source><comment>The Dementia India Report 2010, Prevalence, Impact, Costs and Services for Dementia</comment><publisher-name>ARDSI</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>2010</year><fpage>10</fpage><lpage>55</lpage></element-citation></ref><ref id="B5-brainsci-10-00964"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Sidhu</surname><given-names>J.</given-names></name><name><surname>Goyal</surname><given-names>A.</given-names></name><name><surname>Goyal</surname><given-names>A.</given-names></name><name><surname>Tsao</surname><given-names>J.W.</given-names></name></person-group><article-title>Alzheimer Disease</article-title><source>StatPearls [Internet]</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2020</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK499922/">https://www.ncbi.nlm.nih.gov/books/NBK499922/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-11-25">(accessed on 25 November 2020)</date-in-citation></element-citation></ref><ref id="B6-brainsci-10-00964"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussbaum</surname><given-names>R.L.</given-names></name><name><surname>Ellis</surname><given-names>C.E.</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease and Parkinson&#x02019;s disease</article-title><source>N. Engl. J. Med.</source><year>2003</year><volume>348</volume><fpage>1356</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1056/NEJM2003ra020003</pub-id><pub-id pub-id-type="pmid">12672864</pub-id></element-citation></ref><ref id="B7-brainsci-10-00964"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>P.</given-names></name></person-group><article-title>Selective Loss of Central Cholinergic Neurons in Alzheimer&#x02019;s Disease</article-title><source>Lancet</source><year>1976</year><volume>308</volume><fpage>1403</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(76)91936-X</pub-id></element-citation></ref><ref id="B8-brainsci-10-00964"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>B.</given-names></name></person-group><article-title>A review on cholinesterase inhibitors for Alzheimer&#x02019;s disease</article-title><source>Arch. Pharmacal Res.</source><year>2013</year><volume>36</volume><fpage>375</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1007/s12272-013-0036-3</pub-id></element-citation></ref><ref id="B9-brainsci-10-00964"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyreuther</surname><given-names>K.</given-names></name><name><surname>Masters</surname><given-names>C.L.</given-names></name></person-group><article-title>Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer&#x02019;s disease, precursor-product relationships in the derangement of neuronal function</article-title><source>Brain Pathol.</source><year>1991</year><volume>1</volume><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3639.1991.tb00667.x</pub-id><pub-id pub-id-type="pmid">1669714</pub-id></element-citation></ref><ref id="B10-brainsci-10-00964"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J.</given-names></name><name><surname>Allsop</surname><given-names>D.</given-names></name></person-group><article-title>Amyloid deposition as the central event in the aetiology of Alzheimer&#x02019;s disease</article-title><source>Trends Pharmacol Sci.</source><year>1991</year><volume>12</volume><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/0165-6147(91)90609-V</pub-id><pub-id pub-id-type="pmid">1763432</pub-id></element-citation></ref><ref id="B11-brainsci-10-00964"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J.A.</given-names></name><name><surname>Higgins</surname><given-names>G.</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease, the amyloid cascade hypothesis</article-title><source>Science</source><year>1992</year><volume>256</volume><fpage>184</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1126/science.1566067</pub-id><pub-id pub-id-type="pmid">1566067</pub-id></element-citation></ref><ref id="B12-brainsci-10-00964"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname><given-names>D.J.</given-names></name></person-group><article-title>The molecular pathology of Alzheimer&#x02019;s disease</article-title><source>Neuron</source><year>1991</year><volume>6</volume><fpage>487</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(91)90052-2</pub-id><pub-id pub-id-type="pmid">1673054</pub-id></element-citation></ref><ref id="B13-brainsci-10-00964"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname><given-names>D.J.</given-names></name><name><surname>Hardy</surname><given-names>J.</given-names></name></person-group><article-title>The amyloid hypothesis of Alzheimer&#x02019;s disease at 25 years</article-title><source>EMBO Mol. Med.</source><year>2016</year><volume>8</volume><fpage>595</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.15252/emmm.201606210</pub-id><pub-id pub-id-type="pmid">27025652</pub-id></element-citation></ref><ref id="B14-brainsci-10-00964"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabrese</surname><given-names>C.</given-names></name><name><surname>Gregory</surname><given-names>W.L.</given-names></name><name><surname>Leo</surname><given-names>M.</given-names></name><name><surname>Kraemer</surname><given-names>D.</given-names></name><name><surname>Bone</surname><given-names>K.</given-names></name><name><surname>Oken</surname><given-names>B.</given-names></name></person-group><article-title>Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial</article-title><source>J. Altern. Complement. Med.</source><year>2008</year><volume>14</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1089/acm.2008.0018</pub-id><pub-id pub-id-type="pmid">18611150</pub-id></element-citation></ref><ref id="B15-brainsci-10-00964"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehla</surname><given-names>J.</given-names></name><name><surname>Pahuja</surname><given-names>M.</given-names></name><name><surname>Dethe</surname><given-names>S.M.</given-names></name><name><surname>Agarwal</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>Y.</given-names></name></person-group><article-title>Amelioration of intracerebroventricular streptozotocin induced cognitive impairment by Evolvulus alsinoides in rats: In vitro and in vivo evidence</article-title><source>Neurochem. Int.</source><year>2012</year><volume>61</volume><fpage>1052</fpage><lpage>1064</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2012.07.022</pub-id><pub-id pub-id-type="pmid">22892278</pub-id></element-citation></ref><ref id="B16-brainsci-10-00964"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>A.J.</given-names></name><name><surname>Malfroy</surname><given-names>B.</given-names></name><name><surname>Baudry</surname><given-names>M.</given-names></name></person-group><article-title>beta-Amyloid toxicity in organotypic hippocampal cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>2312</fpage><lpage>2316</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.6.2312</pub-id><pub-id pub-id-type="pmid">8637869</pub-id></element-citation></ref><ref id="B17-brainsci-10-00964"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappolla</surname><given-names>M.A.</given-names></name><name><surname>Sos</surname><given-names>M.</given-names></name><name><surname>Omar</surname><given-names>R.A.</given-names></name><name><surname>Bick</surname><given-names>R.J.</given-names></name><name><surname>Hickson-Bick</surname><given-names>D.L.M.</given-names></name><name><surname>Reiter</surname><given-names>R.J.</given-names></name><name><surname>Efthimiopoulos</surname><given-names>S.</given-names></name><name><surname>Robakis</surname><given-names>N.K.</given-names></name></person-group><article-title>Melatonin Prevents Death of Neuroblastoma Cells Exposed to the Alzheimer Amyloid Peptide</article-title><source>J. Neurosci.</source><year>1997</year><volume>17</volume><fpage>1683</fpage><lpage>1690</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-05-01683.1997</pub-id><pub-id pub-id-type="pmid">9030627</pub-id></element-citation></ref><ref id="B18-brainsci-10-00964"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name></person-group><article-title>Fuzhisan, a Chinese Herbal Medicine, Inhibits Beta-Amyloid-Induced Neurotoxicity and Tau Phosphorylation Through Calpain/Cdk5 Pathway in Cultured Cortical Neurons</article-title><source>Neurochem. Res.</source><year>2011</year><volume>36</volume><fpage>801</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1007/s11064-011-0405-6</pub-id><pub-id pub-id-type="pmid">21243427</pub-id></element-citation></ref><ref id="B19-brainsci-10-00964"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>D.W.</given-names></name><name><surname>George</surname><given-names>R.C.</given-names></name><name><surname>Scaramozzino</surname><given-names>F.</given-names></name><name><surname>LaPointe</surname><given-names>N.E.</given-names></name><name><surname>Anderson</surname><given-names>R.A.</given-names></name><name><surname>Donald</surname><given-names>J.G.</given-names></name><name><surname>John</surname><given-names>L.</given-names></name></person-group><article-title>Cinnamon extract inhibits tau aggregation associated with Alzheimer&#x02019;s disease in vitro</article-title><source>J. Alzheimers Dis.</source><year>2009</year><volume>17</volume><fpage>585</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.3233/JAD-2009-1083</pub-id><pub-id pub-id-type="pmid">19433898</pub-id></element-citation></ref><ref id="B20-brainsci-10-00964"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>K.-X.</given-names></name><name><surname>Tan</surname><given-names>M.-S.</given-names></name><name><surname>Tan</surname><given-names>C.-C.</given-names></name><name><surname>Cao</surname><given-names>X.-P.</given-names></name><name><surname>Hou</surname><given-names>X.-H.</given-names></name><name><surname>Guo</surname><given-names>Q.-H.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Mok</surname><given-names>V.</given-names></name><name><surname>Yu</surname><given-names>J.-T.</given-names></name></person-group><article-title>Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer&#x02019;s disease: A network meta-analysis of 41 randomized controlled trials</article-title><source>Alzheimer&#x02019;s Res.</source><year>2018</year><volume>10</volume><fpage>126</fpage><pub-id pub-id-type="doi">10.1186/s13195-018-0457-9</pub-id></element-citation></ref><ref id="B21-brainsci-10-00964"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>H.</given-names></name><name><surname>Ohnishi</surname><given-names>T.</given-names></name><name><surname>Nakagawa</surname><given-names>R.</given-names></name><name><surname>Yoshizawa</surname><given-names>K.</given-names></name></person-group><article-title>The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer&#x02019;s disease: A Bayesian network meta-analysis</article-title><source>Int. J. Geriatr. Psychiatry</source><year>2016</year><volume>31</volume><fpage>892</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1002/gps.4405</pub-id><pub-id pub-id-type="pmid">26680338</pub-id></element-citation></ref><ref id="B22-brainsci-10-00964"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inglis</surname><given-names>F.</given-names></name></person-group><article-title>The tolerability and safety of cholinesterase inhibitors in the treatment of dementia</article-title><source>Int. J. Clin. Pract. Suppl.</source><year>2002</year><volume>127</volume><fpage>45</fpage><lpage>63</lpage></element-citation></ref><ref id="B23-brainsci-10-00964"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>J.</given-names></name><name><surname>Kaye</surname><given-names>J.</given-names></name><name><surname>Montine</surname><given-names>T.</given-names></name><name><surname>Stackman</surname><given-names>R.</given-names></name></person-group><article-title>Phytochemicals in Alzheimer disease, the development of clinical trials</article-title><source>Pharm. Biol.</source><year>2004</year><volume>42</volume><fpage>64</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.3109/138802090893531</pub-id></element-citation></ref><ref id="B24-brainsci-10-00964"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name></person-group><article-title>An overview on therapeutics attenuating amyloid &#x003b2; level in Alzheimer&#x02019;s disease: Targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels</article-title><source>Am. J. Transl. Res.</source><year>2016</year><volume>8</volume><fpage>246</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">27158324</pub-id></element-citation></ref><ref id="B25-brainsci-10-00964"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagi</surname><given-names>Z.</given-names></name><name><surname>Csek&#x00151;</surname><given-names>C.</given-names></name><name><surname>Toth</surname><given-names>E.</given-names></name><name><surname>Koller</surname><given-names>A.</given-names></name></person-group><article-title>Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment</article-title><source>Am. J. Physiol. Circ. Physiol.</source><year>2003</year><volume>285</volume><fpage>H2277</fpage><lpage>H2283</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00448.2003</pub-id></element-citation></ref><ref id="B26-brainsci-10-00964"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>G.M.</given-names></name><name><surname>Morihara</surname><given-names>T.</given-names></name><name><surname>Lim</surname><given-names>G.P.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Begum</surname><given-names>A.</given-names></name><name><surname>Frautschy</surname><given-names>S.A.</given-names></name></person-group><article-title>NSAID and antioxidant prevention of Alzheimer&#x02019;s disease, lessons from in vitro and animal models</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2004</year><volume>1035</volume><fpage>68</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1196/annals.1332.005</pub-id><pub-id pub-id-type="pmid">15681801</pub-id></element-citation></ref><ref id="B27-brainsci-10-00964"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhart</surname><given-names>M.J.</given-names></name><name><surname>Geerlings</surname><given-names>M.I.</given-names></name><name><surname>Ruitenberg</surname><given-names>A.</given-names></name><name><surname>van Swieten</surname><given-names>J.C.</given-names></name><name><surname>Hofman</surname><given-names>A.</given-names></name><name><surname>Witteman</surname><given-names>J.C.M.</given-names></name><name><surname>Breteler</surname><given-names>M.M.B.</given-names></name></person-group><article-title>Dietary intake of antioxidants and risk of Alzheimer disease</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>3223</fpage><lpage>3229</lpage><pub-id pub-id-type="doi">10.1001/jama.287.24.3223</pub-id><pub-id pub-id-type="pmid">12076218</pub-id></element-citation></ref><ref id="B28-brainsci-10-00964"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>E.</given-names></name><name><surname>Rotilio</surname><given-names>D.</given-names></name><name><surname>Di Matteo</surname><given-names>V.</given-names></name><name><surname>Di Giulio</surname><given-names>C.</given-names></name><name><surname>Cacchio</surname><given-names>M.</given-names></name><name><surname>Algeri</surname><given-names>S.</given-names></name></person-group><article-title>A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes</article-title><source>Neurobiol. Aging</source><year>2002</year><volume>23</volume><fpage>719</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/S0197-4580(02)00078-7</pub-id><pub-id pub-id-type="pmid">12392777</pub-id></element-citation></ref><ref id="B29-brainsci-10-00964"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>A.H.</given-names></name><name><surname>O&#x02019;Banion</surname><given-names>M.K.</given-names></name></person-group><article-title>Neuroinflammation and anti-inflammatory therapy for Alzheimer&#x02019;s disease</article-title><source>Adv. Drug Deliv. Rev.</source><year>2002</year><volume>54</volume><fpage>1627</fpage><lpage>1656</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(02)00162-X</pub-id><pub-id pub-id-type="pmid">12453679</pub-id></element-citation></ref><ref id="B30-brainsci-10-00964"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlik</surname><given-names>V.N.</given-names></name><name><surname>Doody</surname><given-names>R.S.</given-names></name><name><surname>Rountree</surname><given-names>S.D.</given-names></name><name><surname>Darby</surname><given-names>E.J.</given-names></name></person-group><article-title>Vitamin E use is associated with improved survival in an Alzheimer&#x02019;s disease cohort</article-title><source>Dement. Geriatr. Cogn. Disord.</source><year>2009</year><volume>28</volume><fpage>536</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1159/000255105</pub-id><pub-id pub-id-type="pmid">20016184</pub-id></element-citation></ref><ref id="B31-brainsci-10-00964"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>B.-K.</given-names></name><name><surname>Kim</surname><given-names>D.K.</given-names></name><name><surname>Kang</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>J.-W.</given-names></name><name><surname>Shin</surname><given-names>M.-H.</given-names></name><name><surname>Na</surname><given-names>D.L.</given-names></name></person-group><article-title>Hormone replacement therapy in postmenopausal women with Alzheimer&#x02019;s disease: A randomized, prospective study</article-title><source>Fertil. Steril.</source><year>2003</year><volume>79</volume><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/S0015-0282(02)04666-6</pub-id><pub-id pub-id-type="pmid">12568834</pub-id></element-citation></ref><ref id="B32-brainsci-10-00964"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>J.L.</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease</article-title><source>N. Engl. J. Med.</source><year>2004</year><volume>351</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1056/NEJMra040223</pub-id><pub-id pub-id-type="pmid">15229308</pub-id></element-citation></ref><ref id="B33-brainsci-10-00964"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folch</surname><given-names>J.</given-names></name><name><surname>Busquets</surname><given-names>O.</given-names></name><name><surname>Ettcheto</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez-L&#x000f3;pez</surname><given-names>E.</given-names></name><name><surname>Castro-Torres</surname><given-names>R.D.</given-names></name><name><surname>Verdaguer</surname><given-names>E.</given-names></name><name><surname>Garcia</surname><given-names>M.L.</given-names></name><name><surname>Olloquequi</surname><given-names>J.</given-names></name><name><surname>Casades&#x000fa;s</surname><given-names>G.</given-names></name><name><surname>Beas-Zarate</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Memantine for the Treatment of Dementia: A Review on its Current and Future Applications</article-title><source>J. Alzheimers Dis.</source><year>2018</year><volume>62</volume><fpage>1223</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.3233/JAD-170672</pub-id><pub-id pub-id-type="pmid">29254093</pub-id></element-citation></ref><ref id="B34-brainsci-10-00964"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullock</surname><given-names>R.</given-names></name></person-group><article-title>Efficacy and Safety of Memantine in Moderate-to-Severe Alzheimer Disease: The Evidence to Date</article-title><source>Alzheimer Dis. Assoc. Disord.</source><year>2006</year><volume>20</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1097/01.wad.0000201847.29836.a5</pub-id><pub-id pub-id-type="pmid">16493232</pub-id></element-citation></ref><ref id="B35-brainsci-10-00964"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossberg</surname><given-names>G.T.</given-names></name><name><surname>Thomas</surname><given-names>S.J.</given-names></name></person-group><article-title>Memantine: A review of studies into its safety and efficacy in treating Alzheimer&#x02019;s disease and other dementias</article-title><source>Clin. Interv. Aging</source><year>2009</year><volume>4</volume><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.2147/CIA.S6666</pub-id><pub-id pub-id-type="pmid">19851512</pub-id></element-citation></ref><ref id="B36-brainsci-10-00964"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youdim</surname><given-names>K.A.</given-names></name><name><surname>Josepha</surname><given-names>J.</given-names></name></person-group><article-title>A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: A multiplicity of effects</article-title><source>Free Radic. Biol. Med.</source><year>2001</year><volume>30</volume><fpage>583</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(00)00510-4</pub-id><pub-id pub-id-type="pmid">11295356</pub-id></element-citation></ref><ref id="B37-brainsci-10-00964"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>N.</given-names></name><name><surname>Court</surname><given-names>G.</given-names></name><name><surname>Bidet</surname><given-names>N.</given-names></name><name><surname>Court</surname><given-names>J.</given-names></name><name><surname>Perry</surname><given-names>E.</given-names></name></person-group><article-title>European Herbs with Cholinergic Activities: Potential in Dementia Therapy</article-title><source>Int. J. Geriatr. Psychiatry</source><year>1996</year><volume>11</volume><fpage>1063</fpage><lpage>1069</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1166(199612)11:12&#x0003c;1063::AID-GPS532&#x0003e;3.0.CO;2-1</pub-id></element-citation></ref><ref id="B38-brainsci-10-00964"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>N.S.</given-names></name><name><surname>Bollen</surname><given-names>C.</given-names></name><name><surname>Perry</surname><given-names>E.K.</given-names></name><name><surname>Ballard</surname><given-names>C.</given-names></name></person-group><article-title>Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial</article-title><source>Pharm. Biochem. Behav.</source><year>2003</year><volume>75</volume><fpage>651</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(03)00108-4</pub-id></element-citation></ref><ref id="B39-brainsci-10-00964"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhondzadeh</surname><given-names>S.</given-names></name><name><surname>Noroozian</surname><given-names>M.</given-names></name><name><surname>Mohammadi</surname><given-names>M.</given-names></name><name><surname>Ohadinia</surname><given-names>S.</given-names></name><name><surname>Jamshidi</surname><given-names>A.H.</given-names></name><name><surname>Khani</surname><given-names>M.</given-names></name></person-group><article-title>Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer&#x02019;s disease, a double blind, randomized and placebo-controlled trial</article-title><source>J. Clin. Pharm. Ther.</source><year>2003</year><volume>28</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2710.2003.00463.x</pub-id><pub-id pub-id-type="pmid">12605619</pub-id></element-citation></ref><ref id="B40-brainsci-10-00964"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manyam</surname><given-names>B.V.</given-names></name></person-group><article-title>Dementia in Ayurveda</article-title><source>J. Altern. Complement. Med.</source><year>1999</year><volume>5</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1089/acm.1999.5.81</pub-id><pub-id pub-id-type="pmid">10100034</pub-id></element-citation></ref><ref id="B41-brainsci-10-00964"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuboyama</surname><given-names>T.</given-names></name><name><surname>Tohda</surname><given-names>C.</given-names></name><name><surname>Komatsu</surname><given-names>K.</given-names></name></person-group><article-title>Neuritic regeneration and synaptic reconstruction induced by withanolide A</article-title><source>Br. J. Pharm.</source><year>2005</year><volume>144</volume><fpage>961</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0706122</pub-id></element-citation></ref><ref id="B42-brainsci-10-00964"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abourjaily</surname><given-names>P.</given-names></name></person-group><article-title>American Herbal Pharmacopoeia and Therapeutic Compendium (A botanical supplement monograph series)</article-title><source>Nutr. Clin. Care</source><year>2001</year><volume>4</volume><fpage>221</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1046/j.1523-5408.2001.00146.x</pub-id></element-citation></ref><ref id="B43-brainsci-10-00964"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holcomb</surname><given-names>L.A.</given-names></name><name><surname>Dhanasekaran</surname><given-names>M.</given-names></name><name><surname>Hitt</surname><given-names>A.R.</given-names></name><name><surname>Young</surname><given-names>K.A.</given-names></name><name><surname>Riggs</surname><given-names>M.</given-names></name><name><surname>Manyam</surname><given-names>B.V.</given-names></name></person-group><article-title>Bacopa monniera extract reduces amyloid levels in PSAPP mice</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2006</year><volume>9</volume><fpage>243</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.3233/JAD-2006-9303</pub-id></element-citation></ref><ref id="B44-brainsci-10-00964"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuboyama</surname><given-names>T.</given-names></name><name><surname>Tohda</surname><given-names>C.</given-names></name><name><surname>Komatsu</surname><given-names>K.</given-names></name></person-group><article-title>Withanoside IV and its active metabolite, sominone, attenuate Ab (25&#x02013;35)-induced neurodegeneration</article-title><source>Eur. J. Neurosci.</source><year>2006</year><volume>23</volume><fpage>1417</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04664.x</pub-id><pub-id pub-id-type="pmid">16553605</pub-id></element-citation></ref><ref id="B45-brainsci-10-00964"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>Y.</given-names></name></person-group><article-title>Antioxidant property of Celastrus paniculatus Willd: A possible mechanism in enhancing cognition</article-title><source>Phytomedicine</source><year>2002</year><volume>9</volume><fpage>302</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1078/0944-7113-00136</pub-id><pub-id pub-id-type="pmid">12120811</pub-id></element-citation></ref><ref id="B46-brainsci-10-00964"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinomol</surname><given-names>G.K.</given-names></name><name><surname>Bharath</surname><given-names>M.M.</given-names></name></person-group><article-title>Exploring the Role of &#x0201c;Brahmi&#x0201d; (<italic>Bacopa monnieri</italic> and <italic>Centella asiatica</italic>) in Brain Function and Therapy</article-title><source>Recent Pat. Endocr. Metab. Immune Drug Discov.</source><year>2011</year><volume>5</volume><fpage>33</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.2174/187221411794351833</pub-id><pub-id pub-id-type="pmid">22074576</pub-id></element-citation></ref><ref id="B47-brainsci-10-00964"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uabundit</surname><given-names>N.</given-names></name><name><surname>Wattanathorn</surname><given-names>J.</given-names></name><name><surname>Mucimapura</surname><given-names>S.</given-names></name><name><surname>Ingkaninan</surname><given-names>K.</given-names></name></person-group><article-title>Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer&#x02019;s disease model</article-title><source>J. Ethnopharmacol.</source><year>2010</year><volume>127</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.09.056</pub-id><pub-id pub-id-type="pmid">19808086</pub-id></element-citation></ref><ref id="B48-brainsci-10-00964"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.H.V.</given-names></name><name><surname>Gupta</surname><given-names>Y.</given-names></name></person-group><article-title>Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer&#x02019;s disease in rats</article-title><source>Clin. Exp. Pharm. Physiol.</source><year>2003</year><volume>30</volume><fpage>336</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1681.2003.03842.x</pub-id></element-citation></ref><ref id="B49-brainsci-10-00964"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yancheva</surname><given-names>S.</given-names></name><name><surname>Ihl</surname><given-names>R.</given-names></name><name><surname>Nikolova</surname><given-names>G.</given-names></name><name><surname>Panayotov</surname><given-names>P.</given-names></name><name><surname>Schlaefke</surname><given-names>S.</given-names></name><name><surname>Hoerr</surname><given-names>R.</given-names></name></person-group><article-title>GINDON Study Group. Ginkgo biloba extract EGb 761<sup>&#x000ae;</sup>, donepezil or both combined in the treatment of Alzheimer&#x02019;s disease with neuropsychiatric features: A randomised, double-blind, exploratory trial</article-title><source>Aging Ment. Health</source><year>2009</year><volume>13</volume><fpage>183</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1080/13607860902749057</pub-id><pub-id pub-id-type="pmid">19347685</pub-id></element-citation></ref><ref id="B50-brainsci-10-00964"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gohil</surname><given-names>K.J.</given-names></name><name><surname>Patel</surname><given-names>J.A.</given-names></name><name><surname>Gajjar</surname><given-names>A.K.</given-names></name></person-group><article-title>Pharmacological review on Centella asiatica: A potential herbal cure-all</article-title><source>Indian J. Pharm. Sci.</source><year>2010</year><volume>72</volume><fpage>546</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.4103/0250-474X.78519</pub-id><pub-id pub-id-type="pmid">21694984</pub-id></element-citation></ref><ref id="B51-brainsci-10-00964"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>K.G.M.</given-names></name><name><surname>Rao</surname><given-names>S.M.</given-names></name><name><surname>Rao</surname><given-names>S.G.</given-names></name></person-group><article-title><italic>Centella asiatica</italic> (L.) Leaf Extract Treatment during the Growth Spurt Period Enhances Hippocampal CA3 Neuronal Dendritic Arborization in Rats</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2006</year><volume>3</volume><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1093/ecam/nel024</pub-id></element-citation></ref><ref id="B52-brainsci-10-00964"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.V.</given-names></name><name><surname>Gupta</surname><given-names>Y.</given-names></name></person-group><article-title>Effect of different extracts of Centella asiatica on cognition and markers of oxidative stress in rats</article-title><source>J. Ethnopharmacol.</source><year>2002</year><volume>79</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(01)00394-4</pub-id><pub-id pub-id-type="pmid">11801389</pub-id></element-citation></ref><ref id="B53-brainsci-10-00964"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>S.B.</given-names></name><name><surname>Chetana</surname><given-names>M.</given-names></name><name><surname>Devi</surname><given-names>P.U.</given-names></name></person-group><article-title>Centella asiatica treatment during postnatal period enhances learning and memory in mice</article-title><source>Physiol. Behav.</source><year>2005</year><volume>86</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2005.07.019</pub-id><?supplied-pmid 16214185?><pub-id pub-id-type="pmid">16214185</pub-id></element-citation></ref><ref id="B54-brainsci-10-00964"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Patwardhan</surname><given-names>K.</given-names></name><name><surname>Gehlot</surname><given-names>S.</given-names></name><name><surname>Gambhir</surname><given-names>I.S.</given-names></name></person-group><article-title>Effect of Centella asiatica on mild cognitive impairment (MCI) and other common age-related clinical problems</article-title><source>Dig. J. Nanomat. Biostruct.</source><year>2008</year><volume>3</volume><fpage>215</fpage><lpage>220</lpage></element-citation></ref><ref id="B55-brainsci-10-00964"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanasekaran</surname><given-names>M.</given-names></name><name><surname>Holcomb</surname><given-names>L.A.</given-names></name><name><surname>Hitt</surname><given-names>A.R.</given-names></name><name><surname>Tharakan</surname><given-names>B.</given-names></name><name><surname>Porter</surname><given-names>J.W.</given-names></name><name><surname>Young</surname><given-names>K.A.</given-names></name><name><surname>Manyam</surname><given-names>B.V.</given-names></name></person-group><article-title>Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer&#x02019;s disease animal model</article-title><source>Phytother. Res.</source><year>2009</year><volume>23</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1002/ptr.2405</pub-id><?supplied-pmid 19048607?><pub-id pub-id-type="pmid">19048607</pub-id></element-citation></ref><ref id="B56-brainsci-10-00964"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalini</surname><given-names>K.</given-names></name><name><surname>Karanth</surname><given-names>K.S.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><name><surname>Aroor</surname><given-names>A.R.</given-names></name></person-group><article-title>Effects of Celastrus paniculatus on passive avoidance performance and biogenic amine turnover in albino rats</article-title><source>J. Ethnopharmacol.</source><year>1995</year><volume>47</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(95)01264-E</pub-id><pub-id pub-id-type="pmid">7500635</pub-id></element-citation></ref><ref id="B57-brainsci-10-00964"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakina</surname><given-names>M.R.</given-names></name><name><surname>Dandiya</surname><given-names>P.C.</given-names></name></person-group><article-title>A psycho-neuropharmacological profile of Centella asiatica extract</article-title><source>Fitoterapia</source><year>1990</year><volume>61</volume><fpage>291</fpage><lpage>296</lpage></element-citation></ref><ref id="B58-brainsci-10-00964"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soumyanath</surname><given-names>A.</given-names></name><name><surname>Zhong</surname><given-names>Y.P.</given-names></name><name><surname>Gold</surname><given-names>S.A.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Koop</surname><given-names>D.R.</given-names></name><name><surname>Bourdette</surname><given-names>D.</given-names></name><name><surname>Gold</surname><given-names>B.G.</given-names></name></person-group><article-title>Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in vitro</article-title><source>J. Pharm. Pharmacol.</source><year>2005</year><volume>57</volume><fpage>1221</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1211/jpp.57.9.0018</pub-id><pub-id pub-id-type="pmid">16105244</pub-id></element-citation></ref><ref id="B59-brainsci-10-00964"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandel</surname><given-names>E.R.</given-names></name></person-group><article-title>The Molecular Biology of Memory Storage: A Dialogue between Genes and Synapses</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>1030</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1126/science.1067020</pub-id><pub-id pub-id-type="pmid">11691980</pub-id></element-citation></ref><ref id="B60-brainsci-10-00964"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto-Sasaki</surname><given-names>M.</given-names></name><name><surname>Ozawa</surname><given-names>H.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name><name><surname>R&#x000f6;sler</surname><given-names>M.</given-names></name><name><surname>Riederer</surname><given-names>P.</given-names></name></person-group><article-title>Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type</article-title><source>Brain Res.</source><year>1999</year><volume>824</volume><fpage>300</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(99)01220-2</pub-id><pub-id pub-id-type="pmid">10196463</pub-id></element-citation></ref><ref id="B61-brainsci-10-00964"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Khan</surname><given-names>I.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name></person-group><article-title>Gotu Kola (Centella Asiatica) Extract Enhances Phosphorylation of Cyclic AMP Response Element Binding Protein in Neuroblastoma Cells Expressing Amyloid Beta Peptide</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2008</year><volume>13</volume><fpage>341</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.3233/JAD-2008-13311</pub-id><pub-id pub-id-type="pmid">18431001</pub-id></element-citation></ref><ref id="B62-brainsci-10-00964"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausen</surname><given-names>B.M.</given-names></name></person-group><article-title><italic>Centella asiatica</italic> (Indian pennywort), an effective therapeutic but a weak sensitizer</article-title><source>Contact Dermat.</source><year>1993</year><volume>29</volume><fpage>175</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0536.1993.tb03532.x</pub-id></element-citation></ref><ref id="B63-brainsci-10-00964"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>J.T.</given-names></name><name><surname>Dubery</surname><given-names>I.A.</given-names></name></person-group><article-title>Pentacyclic Triterpenoids from the Medicinal Herb, <italic>Centella asiatica</italic> (L.) Urban</article-title><source>Molecules</source><year>2009</year><volume>14</volume><fpage>3922</fpage><lpage>3941</lpage><pub-id pub-id-type="doi">10.3390/molecules14103922</pub-id><?supplied-pmid 19924039?><pub-id pub-id-type="pmid">19924039</pub-id></element-citation></ref><ref id="B64-brainsci-10-00964"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>B.S.</given-names></name><name><surname>Aslam</surname><given-names>H.</given-names></name><name><surname>Ali</surname><given-names>S.T.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Begum</surname><given-names>S.</given-names></name></person-group><article-title>Chemical constituents of <italic>Centella asiatica</italic></article-title><source>J. Asian Nat. Prod. Res.</source><year>2007</year><volume>9</volume><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1080/10286020600782454</pub-id><?supplied-pmid 17613628?><pub-id pub-id-type="pmid">17613628</pub-id></element-citation></ref><ref id="B65-brainsci-10-00964"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M.K.</given-names></name><name><surname>Kim</surname><given-names>S.R.</given-names></name><name><surname>Sung</surname><given-names>S.H.</given-names></name><name><surname>Lim</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Choi</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>H.K.</given-names></name><name><surname>Je</surname><given-names>S.</given-names></name><name><surname>Ki</surname><given-names>Y.C.</given-names></name></person-group><article-title>Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity</article-title><source>Res. Commun. Mol. Pathol. Pharmacol.</source><year>2000</year><volume>108</volume><fpage>75</fpage><lpage>86</lpage><?supplied-pmid 11758977?><pub-id pub-id-type="pmid">11758977</pub-id></element-citation></ref><ref id="B66-brainsci-10-00964"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.R.</given-names></name><name><surname>Koo</surname><given-names>K.A.</given-names></name><name><surname>Lee</surname><given-names>M.K.</given-names></name><name><surname>Park</surname><given-names>H.-G.</given-names></name><name><surname>Jew</surname><given-names>S.-S.</given-names></name><name><surname>Cha</surname><given-names>K.-H.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name></person-group><article-title>Asiatic acid derivatives enhance cognitive performance partly by improving acetylcholine synthesis</article-title><source>J. Pharm. Pharm.</source><year>2004</year><volume>56</volume><fpage>1275</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1211/0022357044391</pub-id></element-citation></ref><ref id="B67-brainsci-10-00964"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orhan</surname><given-names>I.E.</given-names></name></person-group><article-title><italic>Centella asiatica</italic> (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2012</year><volume>2012</volume><fpage>946259</fpage><pub-id pub-id-type="doi">10.1155/2012/946259</pub-id></element-citation></ref><ref id="B68-brainsci-10-00964"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wattanathorn</surname><given-names>J.</given-names></name><name><surname>Mator</surname><given-names>L.</given-names></name><name><surname>Muchimapura</surname><given-names>S.</given-names></name><name><surname>Tongun</surname><given-names>T.</given-names></name><name><surname>Pasuriwong</surname><given-names>O.</given-names></name><name><surname>Piyawatkul</surname><given-names>N.</given-names></name><name><surname>Yimtae</surname><given-names>K.</given-names></name><name><surname>Sripanidkulchai</surname><given-names>B.</given-names></name><name><surname>Singkhoraard</surname><given-names>J.</given-names></name></person-group><article-title>Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of <italic>Centella asiatica</italic></article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>116</volume><fpage>325</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.11.038</pub-id><?supplied-pmid 18191355?><pub-id pub-id-type="pmid">18191355</pub-id></element-citation></ref><ref id="B69-brainsci-10-00964"><label>69.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Karting</surname><given-names>T.</given-names></name></person-group><source>Herbs, Spices and Medicinal Plants</source><person-group person-group-type="editor"><name><surname>Cracker</surname><given-names>L.E.</given-names></name><name><surname>Simon</surname><given-names>J.E.</given-names></name></person-group><publisher-name>Oryx Press</publisher-name><publisher-loc>Phoenix, AZ, USA</publisher-loc><year>1998</year><volume>Volume 3</volume><fpage>145</fpage><lpage>173</lpage></element-citation></ref><ref id="B70-brainsci-10-00964"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chivapat</surname><given-names>S.</given-names></name><name><surname>Chavalittumrong</surname><given-names>P.</given-names></name><name><surname>Attawish</surname><given-names>A.</given-names></name><name><surname>Boonruad</surname><given-names>T.</given-names></name><name><surname>Bansiddhi</surname><given-names>J.</given-names></name><name><surname>Phadungpat</surname><given-names>S.</given-names></name><name><surname>Punyamong</surname><given-names>S.</given-names></name><name><surname>Mingmuang</surname><given-names>J.</given-names></name></person-group><article-title>Toxicity study of <italic>Centella asiatica</italic> (L) urban</article-title><source>J. Thai Trad Alt Med.</source><year>2004</year><volume>2</volume><fpage>3</fpage><lpage>17</lpage></element-citation></ref><ref id="B71-brainsci-10-00964"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oruganti</surname><given-names>M.</given-names></name><name><surname>Kumar Roy</surname><given-names>B.</given-names></name><name><surname>Kumar Singh</surname><given-names>K.</given-names></name><name><surname>Prasad</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name></person-group><article-title>Safety assessment of <italic>Centella asiatica</italic> in albino rats</article-title><source>Phcog. J.</source><year>2010</year><volume>2</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0975-3575(10)80043-4</pub-id></element-citation></ref><ref id="B72-brainsci-10-00964"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguiar</surname><given-names>S.</given-names></name><name><surname>Borowski</surname><given-names>T.</given-names></name></person-group><article-title>Neuropharmacological Review of the Nootropic Herb Bacopa monnieri</article-title><source>Rejuvenation Res.</source><year>2013</year><volume>16</volume><fpage>313</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1089/rej.2013.1431</pub-id><pub-id pub-id-type="pmid">23772955</pub-id></element-citation></ref><ref id="B73-brainsci-10-00964"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhari</surname><given-names>K.S.</given-names></name><name><surname>Tiwari</surname><given-names>N.R.</given-names></name><name><surname>Tiwari</surname><given-names>R.R.</given-names></name><name><surname>Sharma</surname><given-names>R.S.</given-names></name></person-group><article-title>Neurocognitive effect of nootropic drug Brahmi (<italic>Bacopa monnieri</italic>) in Alzheimer&#x02019;s disease</article-title><source>Ann. Neurosci.</source><year>2017</year><volume>24</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1159/000475900</pub-id><pub-id pub-id-type="pmid">28588366</pub-id></element-citation></ref><ref id="B74-brainsci-10-00964"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maheshwari</surname><given-names>K.K.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name></person-group><article-title>Effect of bacosides, alcoholic extract of <italic>Bacopa monniera</italic> Linn. (brahmi), on experimental amnesia in mice</article-title><source>Indian J. Exp. Boil.</source><year>2005</year><volume>43</volume><fpage>640</fpage><lpage>645</lpage></element-citation></ref><ref id="B75-brainsci-10-00964"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Murthy</surname><given-names>V.</given-names></name><name><surname>Ramassamy</surname><given-names>C.</given-names></name></person-group><article-title>Modulation of Hydrogen Peroxide and Acrolein-Induced Oxidative Stress, Mitochondrial Dysfunctions and Redox Regulated Pathways by the Bacopa Monniera Extract: Potential Implication in Alzheimer&#x02019;s Disease</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2010</year><volume>21</volume><fpage>229</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-091729</pub-id><?supplied-pmid 20421692?><pub-id pub-id-type="pmid">20421692</pub-id></element-citation></ref><ref id="B76-brainsci-10-00964"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>A.</given-names></name><name><surname>Parle</surname><given-names>M.</given-names></name></person-group><article-title>Brahmi rasayana Improves Learning and Memory in Mice</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2006</year><volume>3</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1093/ecam/nek014</pub-id><?supplied-pmid 16550227?><pub-id pub-id-type="pmid">16550227</pub-id></element-citation></ref><ref id="B77-brainsci-10-00964"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>H.K.</given-names></name><name><surname>Dhawan</surname><given-names>B.N.</given-names></name></person-group><article-title>Neuropsychopharmacological effects of the Ayurvedic nootropic <italic>Bacopa monniera</italic> Linn. (Brahmi)</article-title><source>Indian J. Pharmacol.</source><year>1997</year><volume>29</volume><fpage>S359</fpage><lpage>S365</lpage></element-citation></ref><ref id="B78-brainsci-10-00964"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinath</surname><given-names>S.</given-names></name></person-group><article-title>Memory enhancing medicinal herbs</article-title><source>J. Pharm. Sci. Res.</source><year>2014</year><volume>6</volume><fpage>331</fpage></element-citation></ref><ref id="B79-brainsci-10-00964"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastogi</surname><given-names>M.</given-names></name><name><surname>Ojha</surname><given-names>R.P.</given-names></name><name><surname>Prabu</surname><given-names>P.C.</given-names></name><name><surname>Devi</surname><given-names>B.P.</given-names></name><name><surname>Agrawal</surname><given-names>A.</given-names></name><name><surname>Dubey</surname><given-names>G.P.</given-names></name></person-group><article-title>Prevention of age-associated neurodegeneration and promotion of healthy brain ageing in female Wistar rats by long term use of bacosides</article-title><source>Biogerontology</source><year>2012</year><volume>13</volume><fpage>183</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1007/s10522-011-9367-y</pub-id><?supplied-pmid 22143822?><pub-id pub-id-type="pmid">22143822</pub-id></element-citation></ref><ref id="B80-brainsci-10-00964"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preethi</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>H.K.</given-names></name><name><surname>Charles</surname><given-names>P.D.</given-names></name><name><surname>Rajan</surname><given-names>K.E.</given-names></name></person-group><article-title>Participation of microRNA 124-CREB pathway: A parallel memory enhancing mechanism of standardised extract of <italic>Bacopa monniera</italic> (BESEB CDRI-08)</article-title><source>Neurochem. Res.</source><year>2012</year><volume>37</volume><fpage>2167</fpage><lpage>2177</lpage><pub-id pub-id-type="doi">10.1007/s11064-012-0840-z</pub-id><pub-id pub-id-type="pmid">22837048</pub-id></element-citation></ref><ref id="B81-brainsci-10-00964"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname><given-names>K.E.</given-names></name><name><surname>Singh</surname><given-names>H.K.</given-names></name><name><surname>Parkavi</surname><given-names>A.</given-names></name><name><surname>Charles</surname><given-names>P.D.</given-names></name></person-group><article-title>Attenuation of 1-(m-Chlorophenyl)-Biguanide Induced Hippocampus-Dependent Memory Impairment by a Standardised Extract of <italic>Bacopa monniera</italic> (BESEB CDRI-08)</article-title><source>Neurochem. Res.</source><year>2011</year><volume>36</volume><fpage>2136</fpage><lpage>2144</lpage><pub-id pub-id-type="doi">10.1007/s11064-011-0538-7</pub-id><pub-id pub-id-type="pmid">21735137</pub-id></element-citation></ref><ref id="B82-brainsci-10-00964"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>S.P.</given-names></name><name><surname>Singh</surname><given-names>H.K.</given-names></name><name><surname>Prasad</surname><given-names>S.B.</given-names></name></person-group><article-title>Alterations in Hippocampal Oxidative Stress, Expression of AMPA Receptor GluR2 Subunit and Associated Spatial Memory Loss by Bacopa monnieri Extract (CDRI-08) in Streptozotocin-Induced Diabetes Mellitus Type 2 Mice</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0131862</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0131862</pub-id><pub-id pub-id-type="pmid">26161865</pub-id></element-citation></ref><ref id="B83-brainsci-10-00964"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyoti</surname><given-names>A.</given-names></name><name><surname>Sethi</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>D.</given-names></name></person-group><article-title><italic>Bacopa monniera</italic> prevents from aluminium neuro- toxicity in the cerebral cortex of rat brain</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>111</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.10.037</pub-id><pub-id pub-id-type="pmid">17189676</pub-id></element-citation></ref><ref id="B84-brainsci-10-00964"><label>84.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Ghosal</surname><given-names>S.</given-names></name></person-group><article-title>Effect of Bacopa monniera on animal models of Alzheimer&#x02019;s disease and perturbed central cholinergic markers of cognition in rats</article-title><source>Molecular Aspects of Asian Medicines</source><person-group person-group-type="editor"><name><surname>Siva Sankar</surname><given-names>D.V.</given-names></name></person-group><publisher-name>PJD Publications</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2000</year></element-citation></ref><ref id="B85-brainsci-10-00964"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>D.</given-names></name><name><surname>Sandhir</surname><given-names>R.</given-names></name></person-group><article-title>Neuroprotective Effects of Bacopa monnieri in Experimental Model of Dementia</article-title><source>Neurochem. Res.</source><year>2012</year><volume>37</volume><fpage>1928</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.1007/s11064-012-0811-4</pub-id><?supplied-pmid 22700087?><pub-id pub-id-type="pmid">22700087</pub-id></element-citation></ref><ref id="B86-brainsci-10-00964"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vollala</surname><given-names>V.R.</given-names></name><name><surname>Upadhya</surname><given-names>S.</given-names></name><name><surname>Nayak</surname><given-names>S.</given-names></name></person-group><article-title>Enhanced dendritic arborization of hippocampal CA3 neurons by <italic>Bacopa monniera</italic> extract treatment in adult rats</article-title><source>Romanian J. Morphol. Embryol.</source><year>2011</year><volume>52</volume><fpage>879</fpage><lpage>886</lpage></element-citation></ref><ref id="B87-brainsci-10-00964"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>P.J.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name><name><surname>Lloyd</surname><given-names>J.</given-names></name><name><surname>Hutchison</surname><given-names>C.W.</given-names></name><name><surname>Downey</surname><given-names>L.</given-names></name><name><surname>Stough</surname><given-names>C.</given-names></name></person-group><article-title>The acute effects of an extract of <italic>Bacopa monniera</italic> (Brahmi) on cognitive function in healthy normal subjects</article-title><source>Hum. Psychopharmacol. Clin. Exp.</source><year>2001</year><volume>16</volume><fpage>345</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1002/hup.306</pub-id><?supplied-pmid 12404571?><pub-id pub-id-type="pmid">12404571</pub-id></element-citation></ref><ref id="B88-brainsci-10-00964"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roodenrys</surname><given-names>S.</given-names></name><name><surname>Booth</surname><given-names>D.</given-names></name><name><surname>Bulzomi</surname><given-names>S.</given-names></name><name><surname>Phipps</surname><given-names>A.</given-names></name><name><surname>Micallef</surname><given-names>C.</given-names></name><name><surname>Smoker</surname><given-names>J.</given-names></name></person-group><article-title>Chronic Effects of Brahmi (<italic>Bacopa monnieri</italic>) on Human Memory</article-title><source>Neuropsychopharmacol.</source><year>2002</year><volume>27</volume><fpage>279</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(01)00419-5</pub-id></element-citation></ref><ref id="B89-brainsci-10-00964"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stough</surname><given-names>C.</given-names></name><name><surname>Lloyd</surname><given-names>J.</given-names></name><name><surname>Clarke</surname><given-names>J.</given-names></name><name><surname>Downey</surname><given-names>L.A.</given-names></name><name><surname>Hutchison</surname><given-names>C.W.</given-names></name><name><surname>Rodgers</surname><given-names>T.</given-names></name><name><surname>Nathan</surname><given-names>P.J.</given-names></name></person-group><article-title>The chronic effects of an extract of <italic>Bacopa monniera</italic> (Brahmi) on cognitive function in healthy human subjects</article-title><source>Psychopharmacol</source><year>2001</year><volume>156</volume><fpage>481</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1007/s00213-015-3965-3</pub-id></element-citation></ref><ref id="B90-brainsci-10-00964"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghav</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>H.</given-names></name><name><surname>Dalal</surname><given-names>P.K.</given-names></name><name><surname>Srivastawa</surname><given-names>J.S.</given-names></name><name><surname>Asthana</surname><given-names>O.P.</given-names></name></person-group><article-title>Randomized controlled trial of standardized <italic>Bacopa monniera</italic> extract in age associated memory impairment</article-title><source>Indian J. Psychiatry.</source><year>2006</year><volume>48</volume><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">20703343</pub-id></element-citation></ref><ref id="B91-brainsci-10-00964"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>A.</given-names></name><name><surname>Stevens</surname><given-names>J.</given-names></name></person-group><article-title>Does Bacopa monnieri Improve Memory Performance in Older Persons? Results of a Randomized, Placebo-Controlled, Double-Blind Trial</article-title><source>J. Altern. Complement. Med.</source><year>2010</year><volume>16</volume><fpage>753</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1089/acm.2009.0342</pub-id><pub-id pub-id-type="pmid">20590480</pub-id></element-citation></ref><ref id="B92-brainsci-10-00964"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Chaturvedi</surname><given-names>C.</given-names></name><name><surname>Tewari</surname><given-names>P.V.</given-names></name></person-group><article-title>Efficacy of Bacopa monnieri in revitalizing intellectual functions in children</article-title><source>J. Res. Educ. Indian Med.</source><year>1987</year><volume>1</volume><fpage>12</fpage></element-citation></ref><ref id="B93-brainsci-10-00964"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Negi</surname><given-names>K.S.</given-names></name><name><surname>Singh</surname><given-names>Y.D.</given-names></name><name><surname>Kushwaha</surname><given-names>K.P.</given-names></name><name><surname>Rastogi</surname><given-names>C.K.</given-names></name><name><surname>Rathi</surname><given-names>A.K.</given-names></name><name><surname>Srivastava</surname><given-names>J.S.</given-names></name></person-group><article-title>Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder</article-title><source>Indian J. Psychiatry.</source><year>2000</year><volume>42</volume><fpage>42</fpage><lpage>50</lpage></element-citation></ref><ref id="B94-brainsci-10-00964"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martis</surname><given-names>G.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><name><surname>Karanth</surname><given-names>K.S.</given-names></name></person-group><article-title>Neuropharmacological activity of Herpestis monniera</article-title><source>Fitoterapia</source><year>1992</year><volume>63</volume><fpage>399</fpage><lpage>404</lpage></element-citation></ref><ref id="B95-brainsci-10-00964"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Majeed</surname><given-names>M.</given-names></name><name><surname>Badmaev</surname><given-names>V.</given-names></name><name><surname>Murrray</surname><given-names>F.</given-names></name></person-group><source>Turmeric and the Healing Curcuminoids</source><publisher-name>Keats Publishing, Inc.</publisher-name><publisher-loc>New Canaan, CT, USA</publisher-loc><year>1996</year></element-citation></ref><ref id="B96-brainsci-10-00964"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrone</surname><given-names>D.</given-names></name><name><surname>Ardito</surname><given-names>F.</given-names></name><name><surname>Giannatempo</surname><given-names>G.</given-names></name><name><surname>Dioguardi</surname><given-names>M.</given-names></name><name><surname>Troiano</surname><given-names>G.</given-names></name><name><surname>Russo</surname><given-names>L.L.</given-names></name><name><surname>De Lillo</surname><given-names>A.</given-names></name><name><surname>Laino</surname><given-names>L.</given-names></name><name><surname>Muzio</surname><given-names>L.L.</given-names></name></person-group><article-title>Biological and therapeutic activities, and anticancer properties of curcumin</article-title><source>Exp. Med.</source><year>2015</year><volume>10</volume><fpage>1615</fpage><lpage>1623</lpage><pub-id pub-id-type="doi">10.3892/etm.2015.2749</pub-id><?supplied-pmid 26640527?><pub-id pub-id-type="pmid">26640527</pub-id></element-citation></ref><ref id="B97-brainsci-10-00964"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name><surname>El Rayess</surname><given-names>Y.</given-names></name><name><surname>Rizk</surname><given-names>A.A.</given-names></name><name><surname>Sadaka</surname><given-names>C.</given-names></name><name><surname>Zgheib</surname><given-names>R.</given-names></name><name><surname>Zam</surname><given-names>W.</given-names></name><name><surname>Sestito</surname><given-names>S.</given-names></name><name><surname>Rapposelli</surname><given-names>S.</given-names></name><name><surname>Neffe-Skoci&#x00144;ska</surname><given-names>K.</given-names></name><name><surname>Zieli&#x00144;ska</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications</article-title><source>Front. Pharm.</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.3389/fphar.2020.01021</pub-id></element-citation></ref><ref id="B98-brainsci-10-00964"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Sil</surname><given-names>P.C.</given-names></name></person-group><article-title>The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update</article-title><source>Food Chem. Toxicol.</source><year>2015</year><volume>83</volume><fpage>111</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2015.05.022</pub-id><?supplied-pmid 26066364?><pub-id pub-id-type="pmid">26066364</pub-id></element-citation></ref><ref id="B99-brainsci-10-00964"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>A.</given-names></name><name><surname>Fukuda</surname><given-names>T.</given-names></name><name><surname>Nagaoka</surname><given-names>Y.</given-names></name><name><surname>Hasumura</surname><given-names>T.</given-names></name><name><surname>Morimoto</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Maekawa</surname><given-names>T.</given-names></name><name><surname>Venugopal</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>D.S.</given-names></name></person-group><article-title>Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer&#x02019;s disease</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e32616</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0032616</pub-id><?supplied-pmid 22403681?><pub-id pub-id-type="pmid">22403681</pub-id></element-citation></ref><ref id="B100-brainsci-10-00964"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>S.K.</given-names></name><name><surname>Agarwal</surname><given-names>S.</given-names></name><name><surname>Seth</surname><given-names>B.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Nair</surname><given-names>S.</given-names></name><name><surname>Bhatnagar</surname><given-names>P.</given-names></name><name><surname>Karmakar</surname><given-names>M.</given-names></name><name><surname>Kumari</surname><given-names>M.</given-names></name><name><surname>Chauhan</surname><given-names>L.K.S.</given-names></name><name><surname>Patel</surname><given-names>D.K.</given-names></name><etal/></person-group><article-title>Correction to Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer&#x02019;s Disease Model via Canonical Wnt/&#x003b2;-Catenin Pathway</article-title><source>ACS Nano</source><year>2013</year><volume>8</volume><fpage>76</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1021/nn405077y</pub-id><pub-id pub-id-type="pmid">24467380</pub-id></element-citation></ref><ref id="B101-brainsci-10-00964"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourtas</surname><given-names>S.</given-names></name><name><surname>Canovi</surname><given-names>M.</given-names></name><name><surname>Zona</surname><given-names>C.</given-names></name><name><surname>Aurilia</surname><given-names>D.</given-names></name><name><surname>Niarakis</surname><given-names>A.</given-names></name><name><surname>La Ferla</surname><given-names>B.</given-names></name><name><surname>Salmona</surname><given-names>M.</given-names></name><name><surname>Nicotra</surname><given-names>F.</given-names></name><name><surname>Gobbi</surname><given-names>M.</given-names></name><name><surname>Antimisiaris</surname><given-names>S.G.</given-names></name></person-group><article-title>Curcumin-decorated nanoliposomes with very high affinity for amyloid-&#x003b2;1-42 peptide</article-title><source>Biomaterials</source><year>2011</year><volume>32</volume><fpage>1635</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.10.027</pub-id><pub-id pub-id-type="pmid">21131044</pub-id></element-citation></ref><ref id="B102-brainsci-10-00964"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>M.</given-names></name><name><surname>Moore</surname><given-names>S.</given-names></name><name><surname>Mourtas</surname><given-names>S.</given-names></name><name><surname>Niarakis</surname><given-names>A.</given-names></name><name><surname>Re</surname><given-names>F.</given-names></name><name><surname>Zona</surname><given-names>C.</given-names></name><name><surname>La Ferla</surname><given-names>B.</given-names></name><name><surname>Nicotra</surname><given-names>F.</given-names></name><name><surname>Masserini</surname><given-names>M.</given-names></name><name><surname>Antimisiaris</surname><given-names>S.G.</given-names></name><etal/></person-group><article-title>Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer&#x02019;s A&#x003b2; peptide</article-title><source>Nanomedicine</source><year>2011</year><volume>7</volume><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/j.nano.2011.06.015</pub-id><pub-id pub-id-type="pmid">21722618</pub-id></element-citation></ref><ref id="B103-brainsci-10-00964"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulik</surname><given-names>R.S.</given-names></name><name><surname>M&#x000f6;nkk&#x000f6;nen</surname><given-names>J.</given-names></name><name><surname>Juvonen</surname><given-names>R.O.</given-names></name><name><surname>Mahadik</surname><given-names>K.R.</given-names></name><name><surname>Paradkar</surname><given-names>A.</given-names></name></person-group><article-title>ApoE3 Mediated Poly(butyl) Cyanoacrylate Nanoparticles Containing Curcumin: Study of Enhanced Activity of Curcumin against Beta Amyloid Induced Cytotoxicity Using In Vitro Cell Culture Model</article-title><source>Mol. Pharm.</source><year>2010</year><volume>7</volume><fpage>815</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1021/mp900306x</pub-id><pub-id pub-id-type="pmid">20230014</pub-id></element-citation></ref><ref id="B104-brainsci-10-00964"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caesar</surname><given-names>I.</given-names></name><name><surname>Jonson</surname><given-names>M.</given-names></name><name><surname>Nilsson</surname><given-names>K.P.R.</given-names></name><name><surname>Thor</surname><given-names>S.</given-names></name><name><surname>Hammarstr&#x000f6;m</surname><given-names>P.</given-names></name></person-group><article-title>Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e31424</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031424</pub-id><pub-id pub-id-type="pmid">22348084</pub-id></element-citation></ref><ref id="B105-brainsci-10-00964"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Z.</given-names></name><name><surname>Hongmei</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name></person-group><article-title>Curcumin mediates presenilin-1 activity to reduce &#x003b2;-amyloid production in a model of Alzheimer&#x02019;s disease</article-title><source>Pharm. Rep.</source><year>2011</year><volume>63</volume><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1016/S1734-1140(11)70629-6</pub-id></element-citation></ref><ref id="B106-brainsci-10-00964"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>G.P.</given-names></name><name><surname>Chu</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Beech</surname><given-names>W.</given-names></name><name><surname>Frautschy</surname><given-names>S.A.</given-names></name><name><surname>Cole</surname><given-names>G.M.</given-names></name></person-group><article-title>The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse</article-title><source>J. Neurosci.</source><year>2001</year><volume>21</volume><fpage>8370</fpage><lpage>8377</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-21-08370.2001</pub-id><?supplied-pmid 11606625?><pub-id pub-id-type="pmid">11606625</pub-id></element-citation></ref><ref id="B107-brainsci-10-00964"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Lim</surname><given-names>G.P.</given-names></name><name><surname>Begum</surname><given-names>A.N.</given-names></name><name><surname>Ubeda</surname><given-names>O.J.</given-names></name><name><surname>Simmons</surname><given-names>M.R.</given-names></name><name><surname>Ambegaokar</surname><given-names>S.S.</given-names></name><name><surname>Chen</surname><given-names>P.P.</given-names></name><name><surname>Kayed</surname><given-names>R.</given-names></name><name><surname>Glabe</surname><given-names>C.G.</given-names></name><name><surname>Frautschy</surname><given-names>S.A.</given-names></name><etal/></person-group><article-title>Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>5892</fpage><lpage>5901</lpage><pub-id pub-id-type="doi">10.1074/jbc.M404751200</pub-id><?supplied-pmid 15590663?><pub-id pub-id-type="pmid">15590663</pub-id></element-citation></ref><ref id="B108-brainsci-10-00964"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awasthi</surname><given-names>H.</given-names></name><name><surname>Tota</surname><given-names>S.</given-names></name><name><surname>Hanif</surname><given-names>K.</given-names></name><name><surname>Nath</surname><given-names>C.</given-names></name><name><surname>Shukla</surname><given-names>R.</given-names></name></person-group><article-title>Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow</article-title><source>Life Sci.</source><year>2010</year><volume>86</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2009.11.007</pub-id><?supplied-pmid 19925811?><pub-id pub-id-type="pmid">19925811</pub-id></element-citation></ref><ref id="B109-brainsci-10-00964"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frautschy</surname><given-names>S.A.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>P.</given-names></name><name><surname>Miller</surname><given-names>S.A.</given-names></name><name><surname>Chu</surname><given-names>T.</given-names></name><name><surname>Harris-White</surname><given-names>M.E.</given-names></name><name><surname>Cole</surname><given-names>G.M.</given-names></name></person-group><article-title>Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology</article-title><source>Neurobiol. Aging</source><year>2002</year><volume>22</volume><fpage>993</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1016/S0197-4580(01)00300-1</pub-id></element-citation></ref><ref id="B110-brainsci-10-00964"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Teng</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice</article-title><source>Eur. J. Pharm.</source><year>2014</year><volume>740</volume><fpage>312</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2014.06.051</pub-id></element-citation></ref><ref id="B111-brainsci-10-00964"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.S.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name></person-group><article-title>Curcuminoids from <italic>Curcuma longa</italic> L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult</article-title><source>Neurosci. Lett.</source><year>2001</year><volume>303</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S0304-3940(01)01677-9</pub-id><pub-id pub-id-type="pmid">11297823</pub-id></element-citation></ref><ref id="B112-brainsci-10-00964"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramassamy</surname><given-names>C.</given-names></name></person-group><article-title>Faculty Opinions recommendation of Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model</article-title><source>Fac. Opin. Post-Publ. Peer Rev. Biomed. Lit.</source><year>2008</year><volume>102</volume><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.3410/f.1124469.581659</pub-id></element-citation></ref><ref id="B113-brainsci-10-00964"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De la Monte</surname><given-names>S.M.</given-names></name><name><surname>Wands</surname><given-names>J.R.</given-names></name></person-group><article-title>Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system, relevance to Alzheimer&#x02019;s disease</article-title><source>J. Alzheimers Dis.</source><year>2005</year><volume>7</volume><fpage>45</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.3233/JAD-2005-7106</pub-id><pub-id pub-id-type="pmid">15750214</pub-id></element-citation></ref><ref id="B114-brainsci-10-00964"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname><given-names>M.</given-names></name><name><surname>Brazil</surname><given-names>D.P.</given-names></name><name><surname>Burks</surname><given-names>D.J.</given-names></name><name><surname>Kushner</surname><given-names>J.A.</given-names></name><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Flint</surname><given-names>C.L.</given-names></name><name><surname>Farhang-Fallah</surname><given-names>J.</given-names></name><name><surname>Dikkes</surname><given-names>P.</given-names></name><name><surname>Warot</surname><given-names>X.M.</given-names></name><name><surname>Rio</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation</article-title><source>J. Neurosci.</source><year>2003</year><volume>23</volume><fpage>7084</fpage><lpage>7092</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-18-07084.2003</pub-id><pub-id pub-id-type="pmid">12904469</pub-id></element-citation></ref><ref id="B115-brainsci-10-00964"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname><given-names>M.</given-names></name><name><surname>Gautam</surname><given-names>D.</given-names></name><name><surname>Surjo</surname><given-names>D.</given-names></name><name><surname>Ueki</surname><given-names>K.</given-names></name><name><surname>Baudler</surname><given-names>S.</given-names></name><name><surname>Schubert</surname><given-names>D.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name><name><surname>Alber</surname><given-names>J.</given-names></name><name><surname>Galldiks</surname><given-names>N.</given-names></name><name><surname>K&#x000fc;stermann</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Role for neuronal insulin resistance in neurodegenerative diseases</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>3100</fpage><lpage>3105</lpage><pub-id pub-id-type="doi">10.1073/pnas.0308724101</pub-id><pub-id pub-id-type="pmid">14981233</pub-id></element-citation></ref><ref id="B116-brainsci-10-00964"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isik</surname><given-names>A.T.</given-names></name><name><surname>Celik</surname><given-names>T.</given-names></name><name><surname>Ulusoy</surname><given-names>G.K.</given-names></name><name><surname>Ongoru</surname><given-names>O.</given-names></name><name><surname>Elibol</surname><given-names>B.</given-names></name><name><surname>Doruk</surname><given-names>H.</given-names></name><name><surname>Bozoglu</surname><given-names>E.</given-names></name><name><surname>Kayir</surname><given-names>H.</given-names></name><name><surname>Mas</surname><given-names>M.R.</given-names></name><name><surname>Akman</surname><given-names>S.</given-names></name></person-group><article-title>Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model</article-title><source>AGE</source><year>2008</year><volume>31</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1007/s11357-008-9078-8</pub-id><?supplied-pmid 19234767?><pub-id pub-id-type="pmid">19234767</pub-id></element-citation></ref><ref id="B117-brainsci-10-00964"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>R.</given-names></name><name><surname>Mishra</surname><given-names>B.</given-names></name><name><surname>Tyagi</surname><given-names>E.</given-names></name><name><surname>Nath</surname><given-names>C.</given-names></name><name><surname>Shukla</surname><given-names>R.</given-names></name></person-group><article-title>Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat</article-title><source>Pharm. Res.</source><year>2010</year><volume>61</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2009.12.008</pub-id><?supplied-pmid 20026275?><pub-id pub-id-type="pmid">20026275</pub-id></element-citation></ref><ref id="B118-brainsci-10-00964"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishrat</surname><given-names>T.</given-names></name><name><surname>Hoda</surname><given-names>M.N.</given-names></name><name><surname>Khan</surname><given-names>M.B.</given-names></name><name><surname>Yousuf</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>M.M.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Islam</surname><given-names>F.</given-names></name></person-group><article-title>Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer&#x02019;s type (SDAT)</article-title><source>Eur. Neuropsychopharmacol.</source><year>2009</year><volume>19</volume><fpage>636</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2009.02.002</pub-id><?supplied-pmid 19329286?><pub-id pub-id-type="pmid">19329286</pub-id></element-citation></ref><ref id="B119-brainsci-10-00964"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksenova</surname><given-names>M.V.</given-names></name><name><surname>Aksenov</surname><given-names>M.Y.</given-names></name><name><surname>Butterfield</surname><given-names>D.A.</given-names></name><name><surname>Carney</surname><given-names>J.M.</given-names></name></person-group><article-title>alpha-1-antichymotrypsin interaction with a beta (1-40) inhibits fibril formation but does not affect the peptide toxicity</article-title><source>Neurosci. Lett.</source><year>1996</year><volume>211</volume><fpage>45</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(96)12717-8</pub-id><pub-id pub-id-type="pmid">8809844</pub-id></element-citation></ref><ref id="B120-brainsci-10-00964"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoji</surname><given-names>M.</given-names></name><name><surname>Hirai</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Harigaya</surname><given-names>Y.</given-names></name><name><surname>Ishiguro</surname><given-names>K.</given-names></name><name><surname>Matsubara</surname><given-names>E.</given-names></name></person-group><article-title>Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain</article-title><source>Am. J. Pathol.</source><year>1991</year><volume>138</volume><fpage>247</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">1702930</pub-id></element-citation></ref><ref id="B121-brainsci-10-00964"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beffert</surname><given-names>U.</given-names></name><name><surname>Cohn</surname><given-names>J.S.</given-names></name><name><surname>Petit-Turcotte</surname><given-names>C.</given-names></name><name><surname>Tremblay</surname><given-names>M.</given-names></name><name><surname>Aumont</surname><given-names>N.</given-names></name><name><surname>Ramassamy</surname><given-names>C.</given-names></name><name><surname>Davignon</surname><given-names>J.</given-names></name><name><surname>Poirier</surname><given-names>J.</given-names></name></person-group><article-title>Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer&#x02019;s disease subjects are disease-related and apolipoprotein E genotype dependent</article-title><source>Brain Res.</source><year>1999</year><volume>843</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(99)01894-6</pub-id><pub-id pub-id-type="pmid">10528114</pub-id></element-citation></ref><ref id="B122-brainsci-10-00964"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisgraber</surname><given-names>K.H.</given-names></name><name><surname>Mahley</surname><given-names>R.W.</given-names></name></person-group><article-title>Human apolipoprotein E, the Alzheimer&#x02019;s disease connection</article-title><source>FASEB J.</source><year>1996</year><volume>10</volume><fpage>1485</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1096/fasebj.10.13.8940294</pub-id><pub-id pub-id-type="pmid">8940294</pub-id></element-citation></ref><ref id="B123-brainsci-10-00964"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisniewski</surname><given-names>T.</given-names></name><name><surname>Castano</surname><given-names>E.M.</given-names></name><name><surname>Golabek</surname><given-names>A.</given-names></name><name><surname>Vogel</surname><given-names>T.</given-names></name><name><surname>Frangione</surname><given-names>B.</given-names></name></person-group><article-title>Acceleration of Alzheimer&#x02019;s fibril formation by apolipoprotein E in vitro</article-title><source>Am. J. Pathol.</source><year>1994</year><volume>145</volume><fpage>1030</fpage><lpage>1035</lpage><pub-id pub-id-type="pmid">7977635</pub-id></element-citation></ref><ref id="B124-brainsci-10-00964"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisniewski</surname><given-names>T.</given-names></name><name><surname>Frangione</surname><given-names>B.</given-names></name></person-group><article-title>Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid</article-title><source>Neurosci. Lett.</source><year>1992</year><volume>135</volume><fpage>235</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(92)90444-C</pub-id><pub-id pub-id-type="pmid">1625800</pub-id></element-citation></ref><ref id="B125-brainsci-10-00964"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedlich</surname><given-names>A.L.</given-names></name><name><surname>Butcher</surname><given-names>L.L.</given-names></name></person-group><article-title>Involvement of free oxygen radicals in beta-amyloidosis, an hypothesis</article-title><source>Neurobiol. Aging</source><year>1994</year><volume>15</volume><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/0197-4580(94)90076-0</pub-id><pub-id pub-id-type="pmid">7969721</pub-id></element-citation></ref><ref id="B126-brainsci-10-00964"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensley</surname><given-names>K.</given-names></name><name><surname>Carney</surname><given-names>J.M.</given-names></name><name><surname>Mattson</surname><given-names>M.P.</given-names></name><name><surname>Aksenova</surname><given-names>M.</given-names></name><name><surname>Harris</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>J.F.</given-names></name><name><surname>Floyd</surname><given-names>R.A.</given-names></name><name><surname>Butterfield</surname><given-names>D.A.</given-names></name></person-group><article-title>A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>3270</fpage><lpage>3274</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.8.3270</pub-id><?supplied-pmid 8159737?><pub-id pub-id-type="pmid">8159737</pub-id></element-citation></ref><ref id="B127-brainsci-10-00964"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soudamini</surname><given-names>K.K.</given-names></name><name><surname>Unnikrishnan</surname><given-names>M.C.</given-names></name><name><surname>Soni</surname><given-names>K.B.</given-names></name><name><surname>Kuttan</surname><given-names>R.</given-names></name></person-group><article-title>Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin</article-title><source>Indian J. Physiol. Pharmacol.</source><year>1992</year><volume>36</volume><fpage>239</fpage><lpage>243</lpage><?supplied-pmid 1291474?><pub-id pub-id-type="pmid">1291474</pub-id></element-citation></ref><ref id="B128-brainsci-10-00964"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>T.</given-names></name><name><surname>Gilani</surname><given-names>A.H.</given-names></name></person-group><article-title>A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an A&#x003b2; plus ibotenic acid-infused rat model of Alzheimer&#x02019;s disease</article-title><source>Brain Res.</source><year>2011</year><volume>1400</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2011.05.022</pub-id><?supplied-pmid 21640982?><pub-id pub-id-type="pmid">21640982</pub-id></element-citation></ref><ref id="B129-brainsci-10-00964"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>T.</given-names></name><name><surname>Enam</surname><given-names>S.A.</given-names></name><name><surname>Gilani</surname><given-names>A.H.</given-names></name></person-group><article-title>Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer&#x02019;s disease</article-title><source>Neuroscience</source><year>2010</year><volume>169</volume><fpage>1296</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.05.078</pub-id><?supplied-pmid 20538041?><pub-id pub-id-type="pmid">20538041</pub-id></element-citation></ref><ref id="B130-brainsci-10-00964"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Naidu</surname><given-names>P.</given-names></name><name><surname>Seghal</surname><given-names>N.</given-names></name><name><surname>Padi</surname><given-names>S.</given-names></name></person-group><article-title>Effect of Curcumin on Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress in Rats</article-title><source>J. Med. Food</source><year>2007</year><volume>10</volume><fpage>486</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1089/jmf.2006.076</pub-id><?supplied-pmid 17887943?><pub-id pub-id-type="pmid">17887943</pub-id></element-citation></ref><ref id="B131-brainsci-10-00964"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Shyamala</surname><given-names>S.G.</given-names></name><name><surname>Barish</surname><given-names>P.A.</given-names></name><name><surname>Vernon</surname><given-names>M.M.</given-names></name><name><surname>Pan</surname><given-names>J.</given-names></name><name><surname>Ogle</surname><given-names>W.O.</given-names></name></person-group><article-title>Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress</article-title><source>Neuropharmacol</source><year>2009</year><volume>57</volume><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.06.010</pub-id><?supplied-pmid 19540859?><pub-id pub-id-type="pmid">19540859</pub-id></element-citation></ref><ref id="B132-brainsci-10-00964"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>B.</given-names></name><name><surname>Zeng</surname><given-names>Z.</given-names></name><name><surname>Qiao</surname><given-names>N.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Lou</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Amelioration of &#x003b2;-amyloid-induced cognitive dysfunction and hippocampal axon degeneration by curcumin is associated with suppression of CRMP-2 hyperphosphorylation</article-title><source>Neurosci. Lett.</source><year>2013</year><volume>557</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2013.10.024</pub-id><pub-id pub-id-type="pmid">24157857</pub-id></element-citation></ref><ref id="B133-brainsci-10-00964"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>H.L.</given-names></name><name><surname>Wang</surname><given-names>Y.L.</given-names></name><name><surname>Lin</surname><given-names>J.F.</given-names></name><name><surname>Han</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>X.X.</given-names></name><name><surname>Wang</surname><given-names>Y.T.</given-names></name><name><surname>Geng</surname><given-names>S.</given-names></name></person-group><article-title>Effects of curcumin on hippocampal expression of NgR and axonal regeneration in Abeta-induced cognitive disorder rats</article-title><source>Genet. Mol. Res.</source><year>2014</year><volume>13</volume><fpage>2039</fpage><lpage>2047</lpage><pub-id pub-id-type="doi">10.4238/2014.March.24.8</pub-id><pub-id pub-id-type="pmid">24737429</pub-id></element-citation></ref><ref id="B134-brainsci-10-00964"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baum</surname><given-names>L.</given-names></name><name><surname>Alex</surname><given-names>N.G.</given-names></name></person-group><article-title>Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer&#x02019;s disease animal models</article-title><source>J. Alzheimers Dis.</source><year>2004</year><volume>6</volume><fpage>367</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.3233/JAD-2004-6403</pub-id><pub-id pub-id-type="pmid">15345806</pub-id></element-citation></ref><ref id="B135-brainsci-10-00964"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClure</surname><given-names>R.</given-names></name><name><surname>Ong</surname><given-names>H.</given-names></name><name><surname>Janve</surname><given-names>V.</given-names></name><name><surname>Barton</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Dawes</surname><given-names>M.</given-names></name><name><surname>Jerome</surname><given-names>W.G.</given-names></name><name><surname>Anderson</surname><given-names>A.</given-names></name><name><surname>Massion</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Aerosol Delivery of Curcumin Reduced Amyloid-&#x003b2; Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer&#x02019;s Disease</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2016</year><volume>55</volume><fpage>797</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.3233/JAD-160289</pub-id></element-citation></ref><ref id="B136-brainsci-10-00964"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chainani-Wu</surname><given-names>N.</given-names></name></person-group><article-title>Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric (<italic>Curcuma longa</italic>)</article-title><source>J. Altern. Complement. Med.</source><year>2003</year><volume>9</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1089/107555303321223035</pub-id><pub-id pub-id-type="pmid">12676044</pub-id></element-citation></ref><ref id="B137-brainsci-10-00964"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qadri</surname><given-names>N.M.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Qureshi</surname><given-names>S.</given-names></name><name><surname>Badar</surname><given-names>Y.</given-names></name></person-group><article-title>Acute toxicological evaluation of the aqueous extract of <italic>Eclipta alba</italic> Hassk</article-title><source>Pak. J. Sci. Ind. Res.</source><year>2001</year><volume>44</volume><fpage>38</fpage><lpage>41</lpage></element-citation></ref><ref id="B138-brainsci-10-00964"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>P.K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Kumar</surname><given-names>N.S.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>The Ayurvedic medicine Clitoria ternatea&#x02014;From traditional use to scientific assessment</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>120</volume><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.09.009</pub-id><?supplied-pmid 18926895?><pub-id pub-id-type="pmid">18926895</pub-id></element-citation></ref><ref id="B139-brainsci-10-00964"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>K.</given-names></name><name><surname>Murthy</surname><given-names>K.</given-names></name><name><surname>Karanth</surname><given-names>K.</given-names></name><name><surname>Nalini</surname><given-names>K.</given-names></name><name><surname>Rao</surname><given-names>M.</given-names></name><name><surname>Srinivasan</surname><given-names>K.</given-names></name></person-group><article-title>Clitoria ternatea root extract enhances acetylcholine content in rat hippocampus</article-title><source>Fitoterapia</source><year>2002</year><volume>73</volume><fpage>685</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/S0367-326X(02)00249-6</pub-id><pub-id pub-id-type="pmid">12490229</pub-id></element-citation></ref><ref id="B140-brainsci-10-00964"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taranalli</surname><given-names>A.D.</given-names></name><name><surname>Cheeramkhuzhy</surname><given-names>T.C.</given-names></name></person-group><article-title>Influence of Clitoria ternatea extracts on memory and central cholinergic activity in rats</article-title><source>Pharm Biol.</source><year>2000</year><volume>38</volume><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1076/1388-0209(200001)3811-BFT051</pub-id><pub-id pub-id-type="pmid">21214440</pub-id></element-citation></ref><ref id="B141-brainsci-10-00964"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>K.S.</given-names></name><name><surname>Murthy</surname><given-names>K.D.</given-names></name><name><surname>Karanth</surname><given-names>K.S.</given-names></name><name><surname>Rao</surname><given-names>M.S.</given-names></name></person-group><article-title><italic>Clitoria ternatea</italic> (Linn) root extract treatment during growth spurt period enhances learning and memory in rats</article-title><source>Indian J. Physiol. Pharmacol.</source><year>2001</year><volume>45</volume><fpage>305</fpage><lpage>313</lpage><?supplied-pmid 11881569?><pub-id pub-id-type="pmid">11881569</pub-id></element-citation></ref><ref id="B142-brainsci-10-00964"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>K.S.</given-names></name><name><surname>Murthy</surname><given-names>K.D.</given-names></name><name><surname>Rao</surname><given-names>M.S.</given-names></name><name><surname>Karanth</surname><given-names>K.S.</given-names></name></person-group><article-title>Altered dendritic arborization of amygdale neurons in young adult rats orally intubated with <italic>Clitoria ternatea</italic> aqueous root extract</article-title><source>Phytother. Res.</source><year>2005</year><volume>19</volume><fpage>592</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1002/ptr.1657</pub-id><pub-id pub-id-type="pmid">16161034</pub-id></element-citation></ref><ref id="B143-brainsci-10-00964"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>K.S.</given-names></name></person-group><article-title>Neurogenic potential of Clitoria ternatea aqueous root extract-a basis for enhancing learning and memory</article-title><source>World Acad. Sci. Eng. Technol.</source><year>2010</year><volume>46</volume><fpage>237</fpage><lpage>242</lpage></element-citation></ref><ref id="B144-brainsci-10-00964"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damodaran</surname><given-names>T.</given-names></name><name><surname>Cheah</surname><given-names>P.S.</given-names></name><name><surname>Murugaiyah</surname><given-names>V.</given-names></name><name><surname>Hassan</surname><given-names>Z.</given-names></name></person-group><article-title>The nootropic and anticholinesterase activities of <italic>Clitoria ternatea</italic> Linn. root extract: Potential treatment for cognitive decline</article-title><source>Neurochem. Int.</source><year>2020</year><volume>139</volume><fpage>104785</fpage><pub-id pub-id-type="doi">10.1016/j.neuint.2020.104785</pub-id><pub-id pub-id-type="pmid">32650028</pub-id></element-citation></ref><ref id="B145-brainsci-10-00964"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehla</surname><given-names>J.</given-names></name><name><surname>Pahuja</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>Y.K.</given-names></name></person-group><article-title>Streptozotocin-induced sporadic Alzheimer&#x02019;s disease: Selection of appropriate dose</article-title><source>J Alzheimers Dis.</source><year>2012</year><volume>33</volume><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3233/JAD-2012-120958</pub-id></element-citation></ref><ref id="B146-brainsci-10-00964"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taur</surname><given-names>D.J.</given-names></name><name><surname>Patil</surname><given-names>R.Y.</given-names></name></person-group><article-title>Evaluation of antiasthmatic activity of Clitoria ternatea L. roots</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>136</volume><fpage>374</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.04.064</pub-id><?supplied-pmid 21575696?><pub-id pub-id-type="pmid">21575696</pub-id></element-citation></ref><ref id="B147-brainsci-10-00964"><label>147.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bone</surname><given-names>K.</given-names></name></person-group><source>Clinical Applications of Ayurvedic and Chinese Herbs. Monographs for the Western Herbal Practitioner</source><publisher-name>Phytotherapy Press</publisher-name><publisher-loc>Queensland, Australia</publisher-loc><year>1996</year><fpage>137</fpage><lpage>141</lpage></element-citation></ref><ref id="B148-brainsci-10-00964"><label>148.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>A.</given-names></name><name><surname>Pakrashi</surname><given-names>S.C.</given-names></name></person-group><source>The Treatise on Indian Medicinal Plants. Council for Scientific and Industrial Research</source><publisher-name>Publications &#x00026; Information Directorate</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>1995</year><volume>Volume 4</volume><fpage>208</fpage><lpage>212</lpage></element-citation></ref><ref id="B149-brainsci-10-00964"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dar</surname><given-names>N.J.</given-names></name><name><surname>Hamid</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacologic overview of <italic>Withania somnifera</italic>, the Indian Ginseng</article-title><source>Cell. Mol. Life Sci.</source><year>2015</year><volume>72</volume><fpage>4445</fpage><lpage>4460</lpage><pub-id pub-id-type="doi">10.1007/s00018-015-2012-1</pub-id><?supplied-pmid 26306935?><pub-id pub-id-type="pmid">26306935</pub-id></element-citation></ref><ref id="B150-brainsci-10-00964"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirjalili</surname><given-names>M.H.</given-names></name><name><surname>Moyano</surname><given-names>E.</given-names></name><name><surname>Bonfill</surname><given-names>M.</given-names></name><name><surname>Cusido</surname><given-names>R.M.</given-names></name><name><surname>Palaz&#x000f3;n</surname><given-names>J.</given-names></name></person-group><article-title>Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine</article-title><source>Molecules</source><year>2009</year><volume>14</volume><fpage>2373</fpage><lpage>2393</lpage><pub-id pub-id-type="doi">10.3390/molecules14072373</pub-id><?supplied-pmid 19633611?><pub-id pub-id-type="pmid">19633611</pub-id></element-citation></ref><ref id="B151-brainsci-10-00964"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>L.C.</given-names></name><name><surname>Singh</surname><given-names>B.B.</given-names></name><name><surname>Dagenais</surname><given-names>S.</given-names></name></person-group><article-title>Scientific basis for the therapeutic use of <italic>Withania somnifera</italic> (ashwagandha): A review</article-title><source>Altern. Med. Rev.</source><year>2000</year><volume>5</volume><fpage>334</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">10956379</pub-id></element-citation></ref><ref id="B152-brainsci-10-00964"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Dey</surname><given-names>A.</given-names></name><name><surname>Hadimani</surname><given-names>M.B.</given-names></name><name><surname>Marcovi&#x00107;</surname><given-names>T.</given-names></name><name><surname>Emerald</surname><given-names>M.</given-names></name></person-group><article-title>Chemistry and pharmacology of <italic>Withania somnifera</italic>: An update</article-title><source>Tang (Humanit. Med.)</source><year>2015</year><volume>5</volume><fpage>e1</fpage><pub-id pub-id-type="doi">10.5667/tang.2014.0030</pub-id></element-citation></ref><ref id="B153-brainsci-10-00964"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>C.L.</given-names></name><name><surname>Mehta</surname><given-names>V.L.</given-names></name><name><surname>Das</surname><given-names>P.K.</given-names></name><name><surname>Dhalla</surname><given-names>N.S.</given-names></name></person-group><article-title>Studies on Withania-ashwagandha, Kaul. V. The effect of total alkaloids (ashwagandholine) on the central nervous system</article-title><source>Indian J. Physiol. Pharmacol.</source><year>1965</year><volume>9</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">4957631</pub-id></element-citation></ref><ref id="B154-brainsci-10-00964"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parihar</surname><given-names>M.</given-names></name><name><surname>Chaudhary</surname><given-names>M.</given-names></name><name><surname>Shetty</surname><given-names>R.</given-names></name><name><surname>Hemnani</surname><given-names>T.</given-names></name></person-group><article-title>Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: Prevention by extracts of Withania somnifera and Aloe vera</article-title><source>J. Clin. Neurosci.</source><year>2004</year><volume>11</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.jocn.2003.09.008</pub-id><pub-id pub-id-type="pmid">15080956</pub-id></element-citation></ref><ref id="B155-brainsci-10-00964"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S.</given-names></name><name><surname>Shukla</surname><given-names>S.D.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Bhatnagar</surname><given-names>M.</given-names></name></person-group><article-title>Neuroprotective effects of Withania somnifera Dunn. In hippocampal sub-regions of female albino rat</article-title><source>Phytother. Res.</source><year>2001</year><volume>15</volume><fpage>544</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1002/ptr.802</pub-id><pub-id pub-id-type="pmid">11536389</pub-id></element-citation></ref><ref id="B156-brainsci-10-00964"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Ghosal</surname><given-names>S.</given-names></name></person-group><article-title>Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer&#x02019;s disease and perturbed central cholinergic markers of cognition in rats</article-title><source>Phytother. Res.</source><year>1995</year><volume>9</volume><fpage>110</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650090206</pub-id></element-citation></ref><ref id="B157-brainsci-10-00964"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schliebs</surname><given-names>R.</given-names></name><name><surname>Liebmann</surname><given-names>A.</given-names></name><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Ghosal</surname><given-names>S.</given-names></name><name><surname>Bigl</surname><given-names>V.</given-names></name></person-group><article-title>Systemic administration of defined extracts from Withania somnifera (Indian ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain</article-title><source>Neurochem. Int.</source><year>1997</year><volume>30</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/S0197-0186(96)00025-3</pub-id><pub-id pub-id-type="pmid">9017665</pub-id></element-citation></ref><ref id="B158-brainsci-10-00964"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>G.Y.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Hannink</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>Z.</given-names></name><name><surname>Fritsche</surname><given-names>K.L.</given-names></name><name><surname>Lubahn</surname><given-names>D.B.</given-names></name><name><surname>Simonyi</surname><given-names>A.</given-names></name></person-group><article-title>Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells</article-title><source>Neuromolecular. Med.</source><year>2016</year><volume>18</volume><fpage>241</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1007/s12017-016-8411-0</pub-id><?supplied-pmid 27209361?><pub-id pub-id-type="pmid">27209361</pub-id></element-citation></ref><ref id="B159-brainsci-10-00964"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tohda</surname><given-names>C.</given-names></name><name><surname>Joyashiki</surname><given-names>E.</given-names></name></person-group><article-title>Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET</article-title><source>Br. J. Pharm.</source><year>2009</year><volume>157</volume><fpage>1427</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00313.x</pub-id></element-citation></ref><ref id="B160-brainsci-10-00964"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaprakasam</surname><given-names>B.</given-names></name><name><surname>Padmanabhan</surname><given-names>K.</given-names></name><name><surname>Nair</surname><given-names>M.G.</given-names></name></person-group><article-title>Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer&#x02019;s disease</article-title><source>Phytother Res.</source><year>2010</year><volume>24</volume><fpage>859</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1002/ptr.3033</pub-id><?supplied-pmid 19957250?><pub-id pub-id-type="pmid">19957250</pub-id></element-citation></ref><ref id="B161-brainsci-10-00964"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehgal</surname><given-names>N.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Valli</surname><given-names>R.K.</given-names></name><name><surname>Joshi</surname><given-names>S.D.</given-names></name><name><surname>Mills</surname><given-names>J.T.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name><name><surname>Khanna</surname><given-names>P.</given-names></name><name><surname>Jain</surname><given-names>S.C.</given-names></name><name><surname>Thakur</surname><given-names>S.S.</given-names></name><name><surname>Ravindranath</surname><given-names>V.</given-names></name></person-group><article-title>Withania somnifera reverses Alzheimer&#x02019;s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>3510</fpage><lpage>3515</lpage><pub-id pub-id-type="doi">10.1073/pnas.1112209109</pub-id><?supplied-pmid 22308347?><pub-id pub-id-type="pmid">22308347</pub-id></element-citation></ref><ref id="B162-brainsci-10-00964"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konar</surname><given-names>A.</given-names></name><name><surname>Shah</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Saxena</surname><given-names>N.</given-names></name><name><surname>Kaul</surname><given-names>S.C.</given-names></name><name><surname>Wadhwa</surname><given-names>R.</given-names></name><name><surname>Thakur</surname><given-names>M.K.</given-names></name></person-group><article-title>Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e27265</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0027265</pub-id><?supplied-pmid 22096544?><pub-id pub-id-type="pmid">22096544</pub-id></element-citation></ref><ref id="B163-brainsci-10-00964"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Harris</surname><given-names>R.J.</given-names></name><name><surname>Seal</surname><given-names>C.J.</given-names></name><name><surname>Okello</surname><given-names>E.J.</given-names></name></person-group><article-title>An Aqueous Extract of Withania somnifera Root Inhibits Amyloid &#x003b2; Fibril Formation In Vitro</article-title><source>Phytother. Res.</source><year>2011</year><volume>26</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1002/ptr.3512</pub-id><?supplied-pmid 21567509?><pub-id pub-id-type="pmid">21567509</pub-id></element-citation></ref><ref id="B164-brainsci-10-00964"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhuley</surname><given-names>J.N.</given-names></name></person-group><article-title>Effect of ashwagandha on lipid peroxidation in stress-induced animals</article-title><source>J. Ethnopharmacol.</source><year>1998</year><volume>60</volume><fpage>173</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(97)00151-7</pub-id><pub-id pub-id-type="pmid">9582008</pub-id></element-citation></ref><ref id="B165-brainsci-10-00964"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>S.</given-names></name><name><surname>Kar</surname><given-names>A.</given-names></name></person-group><article-title>Evidence for free radical scavenging activity of Ashwagandha root powder in mice</article-title><source>Indian J. Physiol. Pharmacol.</source><year>1997</year><volume>41</volume><fpage>424</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">10235668</pub-id></element-citation></ref><ref id="B166-brainsci-10-00964"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>A.</given-names></name><name><surname>Bani</surname><given-names>S.</given-names></name><name><surname>Dutt</surname><given-names>P.</given-names></name><name><surname>Satti</surname><given-names>N.K.</given-names></name><name><surname>Suri</surname><given-names>K.A.</given-names></name><name><surname>Qazi</surname><given-names>G.N.</given-names></name></person-group><article-title>Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction</article-title><source>Cytokine</source><year>2018</year><volume>102</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2017.10.019</pub-id><pub-id pub-id-type="pmid">29108796</pub-id></element-citation></ref><ref id="B167-brainsci-10-00964"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname><given-names>M.A.</given-names></name><name><surname>Rosli</surname><given-names>I.M.</given-names></name><name><surname>Jaafar</surname><given-names>S.S.M.</given-names></name><name><surname>Ooi</surname><given-names>H.</given-names></name><name><surname>Leong</surname><given-names>P.</given-names></name><name><surname>Shamsuddin</surname><given-names>S.</given-names></name><name><surname>Najimudin</surname><given-names>N.</given-names></name><name><surname>Azzam</surname><given-names>G.</given-names></name></person-group><article-title>Withania somnifera showed neuroprotective effect and increase longevity in Drosophila Alzheimer&#x02019;s disease model</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.04.27.063107</pub-id></element-citation></ref><ref id="B168-brainsci-10-00964"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhary</surname><given-names>D.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name><name><surname>Bose</surname><given-names>S.</given-names></name></person-group><article-title>Efficacy and Safety of Ashwagandha (<italic>Withania somnifera</italic> (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions</article-title><source>J. Diet. Suppl.</source><year>2017</year><volume>14</volume><fpage>599</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1080/19390211.2017.1284970</pub-id><?supplied-pmid 28471731?><pub-id pub-id-type="pmid">28471731</pub-id></element-citation></ref><ref id="B169-brainsci-10-00964"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>Q.X.</given-names></name><name><surname>Loke</surname><given-names>W.</given-names></name><name><surname>Foo</surname><given-names>N.X.</given-names></name><name><surname>Tan</surname><given-names>W.J.</given-names></name><name><surname>Chan</surname><given-names>H.W.</given-names></name><name><surname>Lim</surname><given-names>D.Y.</given-names></name><name><surname>Yeo</surname><given-names>W.S.</given-names></name></person-group><article-title>A systematic review of the clinical use of <italic>Withania somnifera</italic> (Ashwagandha) to ameliorate cognitive dysfunction</article-title><source>Phytother. Res.</source><year>2019</year><volume>34</volume><fpage>583</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1002/ptr.6552</pub-id><?supplied-pmid 31742775?><pub-id pub-id-type="pmid">31742775</pub-id></element-citation></ref><ref id="B170-brainsci-10-00964"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arseculeratne</surname><given-names>S.N.</given-names></name><name><surname>Gunatilaka</surname><given-names>A.</given-names></name><name><surname>Panabokke</surname><given-names>R.G.</given-names></name></person-group><article-title>Studies on medicinal plants of sri lanka. part 14: Toxicity of some traditional medicinal herbs</article-title><source>J. Ethnopharmacol.</source><year>1985</year><volume>13</volume><fpage>323</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(85)90078-9</pub-id><pub-id pub-id-type="pmid">4058035</pub-id></element-citation></ref><ref id="B171-brainsci-10-00964"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>C.L.</given-names></name><name><surname>Mehta</surname><given-names>V.L.</given-names></name><name><surname>Prasad</surname><given-names>K.</given-names></name><name><surname>Das</surname><given-names>P.K.</given-names></name></person-group><article-title>Studies on Withania ashwagandha, Kaul. IV. The effect of total alkaloids on the smooth muscles</article-title><source>Indian J. Physiol. Pharmacol.</source><year>1965</year><volume>9</volume><fpage>9</fpage><lpage>15</lpage><?supplied-pmid 5864885?><pub-id pub-id-type="pmid">5864885</pub-id></element-citation></ref><ref id="B172-brainsci-10-00964"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grandhi</surname><given-names>A.</given-names></name><name><surname>Mujumdar</surname><given-names>A.</given-names></name><name><surname>Patwardhan</surname><given-names>B.</given-names></name></person-group><article-title>A comparative pharmacological investigation of Ashwagandha and Ginseng</article-title><source>J. Ethnopharmacol.</source><year>1994</year><volume>44</volume><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(94)01119-2</pub-id><pub-id pub-id-type="pmid">7898119</pub-id></element-citation></ref><ref id="B173-brainsci-10-00964"><label>173.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Warrier</surname><given-names>P.K.</given-names></name><name><surname>Ramankutty</surname><given-names>C.</given-names></name><name><surname>Nambiar</surname><given-names>V.P.K.</given-names></name></person-group><source>Indian Medicinal Plants, A Compendium of 500 Species</source><publisher-name>Orient Longman Ltd.</publisher-name><publisher-loc>Madras, India</publisher-loc><year>1997</year><volume>Volume 2</volume><fpage>47</fpage></element-citation></ref><ref id="B174-brainsci-10-00964"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debnath</surname><given-names>M.</given-names></name><name><surname>Biswas</surname><given-names>M.</given-names></name><name><surname>Shukla</surname><given-names>V.K.</given-names></name><name><surname>Nishteswar</surname><given-names>K.</given-names></name></person-group><article-title>Phytochemical and analytical evaluation of Jyotishmati (<italic>Celastrus paniculatus</italic> Willd.) leaf extracts</article-title><source>Ayu</source><year>2014</year><volume>35</volume><fpage>54</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.4103/0974-8520.141929</pub-id><pub-id pub-id-type="pmid">25364201</pub-id></element-citation></ref><ref id="B175-brainsci-10-00964"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>J.</given-names></name><name><surname>Karan</surname><given-names>M.</given-names></name><name><surname>Dogra</surname><given-names>R.</given-names></name></person-group><article-title>Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: Possible antioxidant mechanism</article-title><source>Pharm. Biol.</source><year>2017</year><volume>55</volume><fpage>980</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1080/13880209.2017.1285945</pub-id><pub-id pub-id-type="pmid">28164735</pub-id></element-citation></ref><ref id="B176-brainsci-10-00964"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaiah</surname><given-names>C.V.</given-names></name><name><surname>Kumar</surname><given-names>G.S.</given-names></name><name><surname>Rajendra</surname><given-names>W.</given-names></name></person-group><article-title>Traditional, Ethnomedical, and Pharmacological uses of Celastrus paniculatus</article-title><source>Asian J. Pharm.</source><year>2018</year><volume>12</volume><fpage>S1119</fpage><lpage>S1126</lpage></element-citation></ref><ref id="B177-brainsci-10-00964"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakka</surname><given-names>A.L.</given-names></name></person-group><article-title>A study on nootropic activity of Celastrus paniculata willd whole plant methanolic extract in rats</article-title><source>Asian J. Pharmaceut. Clin. Res.</source><year>2016</year><volume>9</volume><fpage>336</fpage><lpage>341</lpage></element-citation></ref><ref id="B178-brainsci-10-00964"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lekha</surname><given-names>G.</given-names></name><name><surname>Bhagya</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Rao</surname><given-names>N.</given-names></name><name><surname>Irudaya</surname><given-names>A.</given-names></name><name><surname>Karthik</surname><given-names>M.</given-names></name></person-group><article-title>Cognitive enhancement and Neuroprotective effect of <italic>Celastrus paniculatus</italic> Willd. seed oil (Jyothismati oil) on male Wistar rats</article-title><source>J. Pharma. Sci. Tech.</source><year>2010</year><volume>2</volume><fpage>130</fpage><lpage>138</lpage></element-citation></ref><ref id="B179-brainsci-10-00964"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karanth</surname><given-names>K.S.</given-names></name><name><surname>Haridas</surname><given-names>K.K.</given-names></name><name><surname>Gunasundari</surname><given-names>S.</given-names></name><name><surname>Guruswami</surname><given-names>M.N.</given-names></name></person-group><article-title>Effect of Celastrus paniculatus on learning process</article-title><source>Arogya</source><year>1980</year><volume>6</volume><fpage>137</fpage><lpage>139</lpage></element-citation></ref><ref id="B180-brainsci-10-00964"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gattu</surname><given-names>M.</given-names></name><name><surname>Boss</surname><given-names>K.L.</given-names></name><name><surname>Terry</surname><given-names>A.V.</given-names></name><name><surname>Buccafusco</surname><given-names>J.J.</given-names></name></person-group><article-title>Reversal of Scopolamine-Induced Deficits in Navigational Memory Performance by the Seed Oil of Celastrus paniculatus</article-title><source>Pharm. Biochem. Behav.</source><year>1997</year><volume>57</volume><fpage>793</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(96)00391-7</pub-id></element-citation></ref><ref id="B181-brainsci-10-00964"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhanumathy</surname><given-names>M.</given-names></name><name><surname>Harish</surname><given-names>M.</given-names></name><name><surname>Shivaprasad</surname><given-names>H.</given-names></name><name><surname>Sushma</surname><given-names>G.</given-names></name></person-group><article-title>Nootropic activity of Celastrus paniculatus seed</article-title><source>Pharm. Biol.</source><year>2010</year><volume>48</volume><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.3109/13880200903127391</pub-id><?supplied-pmid 20645820?><pub-id pub-id-type="pmid">20645820</pub-id></element-citation></ref><ref id="B182-brainsci-10-00964"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadhav</surname><given-names>K.S.</given-names></name><name><surname>Marathe</surname><given-names>P.A.</given-names></name><name><surname>Rege</surname><given-names>N.N.</given-names></name><name><surname>Raut</surname><given-names>S.B.</given-names></name><name><surname>Parekar</surname><given-names>R.R.</given-names></name></person-group><article-title>Effect of Jyoti&#x01e63;mat&#x0012b; seed oil on spatial and fear memory using scopolamine induced amnesia in mice</article-title><source>Anc. Sci. Life</source><year>2015</year><volume>34</volume><fpage>130</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.4103/0257-7941.157149</pub-id><pub-id pub-id-type="pmid">26120226</pub-id></element-citation></ref><ref id="B183-brainsci-10-00964"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervenka</surname><given-names>F.</given-names></name><name><surname>Koleckar</surname><given-names>V.</given-names></name><name><surname>Rehakova</surname><given-names>Z.</given-names></name><name><surname>Jahodar</surname><given-names>L.</given-names></name><name><surname>Kunes</surname><given-names>J.</given-names></name><name><surname>Opletal</surname><given-names>L.</given-names></name><name><surname>Hyspler</surname><given-names>R.</given-names></name><name><surname>Jun</surname><given-names>D.</given-names></name><name><surname>Kuca</surname><given-names>K.</given-names></name></person-group><article-title>Evaluation of natural substances from Evolvulus alsinoides L. with the purpose of determining their antioxidant potency</article-title><source>J. Enzym. Inhib. Med. Chem.</source><year>2008</year><volume>23</volume><fpage>574</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1080/14756360701674421</pub-id></element-citation></ref><ref id="B184-brainsci-10-00964"><label>184.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>A.</given-names></name></person-group><source>Treatise of Indian Medicinal Plants</source><comment>Council for Scientific and Industrial Research</comment><publisher-name>Publications &#x00026; Information Directorate</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>1990</year><fpage>327</fpage></element-citation></ref><ref id="B185-brainsci-10-00964"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomathi</surname><given-names>D.</given-names></name><name><surname>Kalaiselvi</surname><given-names>M.</given-names></name><name><surname>Ravikumar</surname><given-names>G.</given-names></name><name><surname>Devaki</surname><given-names>K.</given-names></name><name><surname>Uma</surname><given-names>C.</given-names></name></person-group><article-title>GC-MS analysis of bioactive compounds from the whole plant ethanolic extract of <italic>Evolvulus alsinoides</italic> (L.) L</article-title><source>J. Food Sci. Technol.</source><year>2015</year><volume>52</volume><fpage>1212</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1007/s13197-013-1105-9</pub-id><pub-id pub-id-type="pmid">25694742</pub-id></element-citation></ref><ref id="B186-brainsci-10-00964"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auddy</surname><given-names>B.</given-names></name><name><surname>Ferreira</surname><given-names>M.</given-names></name><name><surname>Blasina</surname><given-names>F.</given-names></name><name><surname>Lafon</surname><given-names>L.</given-names></name><name><surname>Arredondo</surname><given-names>F.</given-names></name><name><surname>Dajas</surname><given-names>F.</given-names></name><name><surname>Tripathi</surname><given-names>P.</given-names></name><name><surname>Seal</surname><given-names>T.</given-names></name><name><surname>Mukherjee</surname><given-names>B.</given-names></name></person-group><article-title>Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases</article-title><source>J. Ethnopharmacol.</source><year>2003</year><volume>84</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(02)00322-7</pub-id><pub-id pub-id-type="pmid">12648805</pub-id></element-citation></ref><ref id="B187-brainsci-10-00964"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganju</surname><given-names>L.</given-names></name><name><surname>Karan</surname><given-names>D.</given-names></name><name><surname>Chanda</surname><given-names>S.</given-names></name><name><surname>Srivastava</surname><given-names>K.</given-names></name><name><surname>Sawhney</surname><given-names>R.</given-names></name><name><surname>Selvamurthy</surname><given-names>W.</given-names></name></person-group><article-title>Immunomodulatory effects of agents of plant origin</article-title><source>Biomed. Pharm.</source><year>2003</year><volume>57</volume><fpage>296</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/S0753-3322(03)00095-7</pub-id></element-citation></ref><ref id="B188-brainsci-10-00964"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siripurapu</surname><given-names>K.B.</given-names></name><name><surname>Gupta</surname><given-names>P.</given-names></name><name><surname>Bhatia</surname><given-names>G.</given-names></name><name><surname>Maurya</surname><given-names>R.</given-names></name><name><surname>Nath</surname><given-names>C.</given-names></name><name><surname>Palit</surname><given-names>G.</given-names></name></person-group><article-title>Adaptogenic and anti-amnesic properties of Evolvulus alsinoides in rodents</article-title><source>Pharmacol. Biochem. Behav.</source><year>2005</year><volume>81</volume><fpage>424</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2005.03.003</pub-id><pub-id pub-id-type="pmid">15899513</pub-id></element-citation></ref><ref id="B189-brainsci-10-00964"><label>189.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Asolkar</surname><given-names>L.V.</given-names></name><name><surname>Kakkar</surname><given-names>K.K.</given-names></name><name><surname>Chakre</surname><given-names>O.J.</given-names></name></person-group><source>Second Supplement to Glossary of India Medicinal Plants with Active Constituents</source><comment>Council for Scientific and Industrial Research</comment><publisher-name>Publications &#x00026; Information Directorate</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>1992</year><fpage>1965</fpage></element-citation></ref><ref id="B190-brainsci-10-00964"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahata</surname><given-names>A.</given-names></name><name><surname>Patil</surname><given-names>U.K.</given-names></name><name><surname>Dixit</surname><given-names>V.K.</given-names></name></person-group><article-title>Anxiolytic activity of Evolvulus alsinoides and Convulvulus pluricaulis in rodents</article-title><source>Pharm Biol.</source><year>2009</year><volume>5</volume><fpage>444</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1080/13880200902822596</pub-id></element-citation></ref><ref id="B191-brainsci-10-00964"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethiya</surname><given-names>N.K.</given-names></name><name><surname>Nahata</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>P.K.</given-names></name><name><surname>Mishra</surname><given-names>S.</given-names></name></person-group><article-title>Neuropharmacological evaluation on four traditional herbs used as nervine tonic and commonly available as Shankhpushpi in India</article-title><source>J. Ayurveda Integr. Med.</source><year>2019</year><volume>10</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jaim.2017.08.012</pub-id><?supplied-pmid 29530454?><pub-id pub-id-type="pmid">29530454</pub-id></element-citation></ref><ref id="B192-brainsci-10-00964"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>M.K.</given-names></name><name><surname>Singh</surname><given-names>S.K.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Mishra</surname><given-names>S.S.</given-names></name><name><surname>Singh</surname><given-names>A.K.</given-names></name><name><surname>Tripathi</surname><given-names>J.S.</given-names></name><name><surname>Tripathi</surname><given-names>Y.B.</given-names></name></person-group><article-title>Neuroprotective Activity of Evolvulus alsinoides &#x00026; Centella asiatica Ethanolic Extracts in Scopolamine-Induced Amnesia in Swiss Albino Mice</article-title><source>Open Access Maced. J. Med Sci.</source><year>2019</year><volume>7</volume><fpage>1059</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.3889/oamjms.2019.247</pub-id><?supplied-pmid 31049081?><pub-id pub-id-type="pmid">31049081</pub-id></element-citation></ref><ref id="B193-brainsci-10-00964"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S.S.</given-names></name><name><surname>Raghuwanshi</surname><given-names>R.</given-names></name><name><surname>Masood</surname><given-names>M.</given-names></name><name><surname>Acharya</surname><given-names>A.</given-names></name><name><surname>Jain</surname><given-names>S.K.</given-names></name></person-group><article-title>Medicinal plants with acetylcholinesterase inhibitory activity</article-title><source>Rev. Neurosci.</source><year>2018</year><volume>29</volume><fpage>491</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1515/revneuro-2017-0054</pub-id><?supplied-pmid 29303784?><pub-id pub-id-type="pmid">29303784</pub-id></element-citation></ref><ref id="B194-brainsci-10-00964"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastogi</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>M.M.</given-names></name><name><surname>Rawat</surname><given-names>A.K.S.</given-names></name></person-group><article-title>An ethnomedicinal, phytochemical and pharmacological profile of <italic>Desmodium gangeticum</italic> (L.) DC. and <italic>Desmodium adscendens</italic> (Sw.) DC</article-title><source>J. Ethnopharmacol.</source><year>2011</year><volume>136</volume><fpage>283</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.04.031</pub-id><pub-id pub-id-type="pmid">21530632</pub-id></element-citation></ref><ref id="B195-brainsci-10-00964"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purushothaman</surname><given-names>K.K.</given-names></name><name><surname>Chandrasekharan</surname><given-names>S.</given-names></name><name><surname>Balakrishna</surname><given-names>K.</given-names></name><name><surname>Connolly</surname><given-names>J.D.</given-names></name></person-group><article-title>Gangetinin and desmodin, two minor pterocarpanoids of Desmodium gangeticum</article-title><source>Phytochemistry.</source><year>1975</year><volume>14</volume><fpage>1129</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(75)85206-X</pub-id></element-citation></ref><ref id="B196-brainsci-10-00964"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name></person-group><article-title>An ethnobotanical study of medicinal plants in Chandauli District of Uttar Pradesh, India</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>121</volume><fpage>324</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.10.018</pub-id><pub-id pub-id-type="pmid">19022368</pub-id></element-citation></ref><ref id="B197-brainsci-10-00964"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>P.K.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Ahmad</surname><given-names>G.</given-names></name><name><surname>Dube</surname><given-names>A.</given-names></name><name><surname>Maurya</surname><given-names>R.</given-names></name></person-group><article-title>Glycolipids and other constituents from Desmodium gangeticum with antileishmanial and immunomodulatory activities</article-title><source>Bioorganic Med. Chem. Lett.</source><year>2005</year><volume>15</volume><fpage>4543</fpage><lpage>4546</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2005.07.020</pub-id></element-citation></ref><ref id="B198-brainsci-10-00964"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>H.</given-names></name><name><surname>Parle</surname><given-names>M.</given-names></name></person-group><article-title>Anti-amnesic effect of Desmodium gangeticum in mice</article-title><source>Yakugaku Zasshi</source><year>2006</year><volume>126</volume><fpage>795</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1248/yakushi.126.795</pub-id><pub-id pub-id-type="pmid">16946593</pub-id></element-citation></ref><ref id="B199-brainsci-10-00964"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>H.</given-names></name><name><surname>Parle</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacological evidences for the antiamnesic effects of Desmodium gangeticum in mice</article-title><source>Iran. J. Pharm. Res.</source><year>2007</year><volume>6</volume><fpage>199</fpage><lpage>207</lpage></element-citation></ref><ref id="B200-brainsci-10-00964"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name></person-group><article-title>Antiamnesic Activity of Extracts and Fraction of Desmodium Gangeticum</article-title><source>J. Pharm. Technol. Res. Manag.</source><year>2015</year><volume>3</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.15415/jptrm.2015.31006</pub-id></element-citation></ref><ref id="B201-brainsci-10-00964"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govindarajan</surname><given-names>R.</given-names></name><name><surname>Rastogi</surname><given-names>S.</given-names></name><name><surname>Vijayakumar</surname><given-names>M.</given-names></name><name><surname>Shirwaikar</surname><given-names>A.</given-names></name><name><surname>Rawat</surname><given-names>A.K.S.</given-names></name><name><surname>Mehrotra</surname><given-names>S.</given-names></name><name><surname>Pushpangadan</surname><given-names>P.</given-names></name></person-group><article-title>Studies on the antioxidant activities of Desmodium gangeticum</article-title><source>Biol. Pharm. Bull.</source><year>2003</year><volume>26</volume><fpage>1424</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.1248/bpb.26.1424</pub-id><?supplied-pmid 14519948?><pub-id pub-id-type="pmid">14519948</pub-id></element-citation></ref><ref id="B202-brainsci-10-00964"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathi</surname><given-names>A.</given-names></name><name><surname>Rao</surname><given-names>C.</given-names></name><name><surname>Ravishankar</surname><given-names>B.</given-names></name><name><surname>De</surname><given-names>S.</given-names></name><name><surname>Mehrotra</surname><given-names>S.</given-names></name></person-group><article-title>Anti-inflammatory and anti-nociceptive activity of the water decoction Desmodium gangeticum</article-title><source>J. Ethnopharmacol.</source><year>2004</year><volume>95</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2004.07.009</pub-id><?supplied-pmid 15507346?><pub-id pub-id-type="pmid">15507346</pub-id></element-citation></ref><ref id="B203-brainsci-10-00964"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puri</surname><given-names>H.S.</given-names></name></person-group><article-title>Rasayana: Ayurvedic Herbs for Longevity and Rejuvenation: Volume 2 of Traditional Herbal Medicines for Modern Times</article-title><source>J. Altern. Complement. Med.</source><year>2003</year><volume>9</volume><fpage>331</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1089/10755530360623446</pub-id></element-citation></ref><ref id="B204-brainsci-10-00964"><label>204.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>L.D.</given-names></name></person-group><source>Handbook of Ayurvedic Medicinal Plants: Herbal Reference Library</source><publisher-name>CRC Press</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>2000</year><fpage>169</fpage></element-citation></ref><ref id="B205-brainsci-10-00964"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashok</surname><given-names>D.B.</given-names></name></person-group><article-title>The status and scope of Indian Medicinal Plants acting on Central nervous system</article-title><source>Indian J. Pharmacol.</source><year>1997</year><volume>29</volume><fpage>340</fpage><lpage>343</lpage></element-citation></ref><ref id="B206-brainsci-10-00964"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>V.</given-names></name><name><surname>Mengi</surname><given-names>S.</given-names></name></person-group><article-title>Neuropharmacological profile of <italic>Eclipta alba</italic> (Linn.) Hassk</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>102</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.05.037</pub-id><pub-id pub-id-type="pmid">16054316</pub-id></element-citation></ref><ref id="B207-brainsci-10-00964"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajani</surname><given-names>G.P.</given-names></name></person-group><article-title>Prasad KVSRG. Effect of <italic>Eclipta alba</italic> Linn on learning and memory in rats</article-title><source>Indian J. Pharm. Educ. Res.</source><year>2007</year><volume>41</volume><fpage>369</fpage><lpage>372</lpage></element-citation></ref><ref id="B208-brainsci-10-00964"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y.H.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Yeo</surname><given-names>S.J.</given-names></name><name><surname>Roh</surname><given-names>S.H.</given-names></name><name><surname>Jeong</surname><given-names>Y.C.</given-names></name><name><surname>Kang</surname><given-names>J.S.</given-names></name><name><surname>Ryu</surname><given-names>S.Y.</given-names></name></person-group><article-title>Ameliorating effect of balloon flower saponin on the ethanol-induced memory impairment in ice</article-title><source>Phytother. Res.</source><year>2008</year><volume>22</volume><fpage>973</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1002/ptr.2394</pub-id><pub-id pub-id-type="pmid">18521966</pub-id></element-citation></ref><ref id="B209-brainsci-10-00964"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.-I.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name><name><surname>Hong</surname><given-names>J.-H.</given-names></name><name><surname>Lillehoj</surname><given-names>H.S.</given-names></name><name><surname>Park</surname><given-names>H.-J.</given-names></name><name><surname>Rhie</surname><given-names>S.-G.</given-names></name><name><surname>Lee</surname><given-names>G.-S.</given-names></name></person-group><article-title>The butanol fraction of <italic>Eclipta prostrata</italic> (Linn) increases the formation of brain acetylcholine and decreases oxidative stress in the brain and serum of cesarean-derived rats</article-title><source>Nutr. Res.</source><year>2010</year><volume>30</volume><fpage>579</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2010.08.001</pub-id><pub-id pub-id-type="pmid">20851313</pub-id></element-citation></ref><ref id="B210-brainsci-10-00964"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.-I.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name><name><surname>Choi</surname><given-names>J.-H.</given-names></name><name><surname>Lillehoj</surname><given-names>H.S.</given-names></name><name><surname>Yu</surname><given-names>M.-H.</given-names></name><name><surname>Lee</surname><given-names>G.-S.</given-names></name></person-group><article-title>The butanol fraction of <italic>Eclipta prostrata</italic> (Linn) effectively reduces serum lipid levels and improves antioxidant activities in CD rats</article-title><source>Nutr. Res.</source><year>2008</year><volume>28</volume><fpage>550</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2008.05.003</pub-id><pub-id pub-id-type="pmid">19083459</pub-id></element-citation></ref><ref id="B211-brainsci-10-00964"><label>211.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kirtikar</surname><given-names>K.R.</given-names></name><name><surname>Basu</surname><given-names>B.D.</given-names></name></person-group><source>Indian Medicinal Plants</source><edition>2nd ed.</edition><publisher-name>Jayyed Press</publisher-name><publisher-loc>Delhi, India</publisher-loc><year>1975</year></element-citation></ref><ref id="B212-brainsci-10-00964"><label>212.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rajagopal</surname><given-names>V.</given-names></name></person-group><source>Standardization of Botanicals</source><publisher-name>Eastern Publishers</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>2002</year><volume>Volume 1</volume></element-citation></ref><ref id="B213-brainsci-10-00964"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banji</surname><given-names>O.</given-names></name><name><surname>Banji</surname><given-names>D.</given-names></name><name><surname>Annamalai</surname><given-names>A.R.</given-names></name><name><surname>Manavalan</surname><given-names>R.</given-names></name></person-group><article-title>Investigation on the effect of <italic>Eclipta alba</italic> on animal models of learning and memory</article-title><source>Indian J. Physiol. Pharmacol.</source><year>2007</year><volume>51</volume><fpage>274</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">18341224</pub-id></element-citation></ref><ref id="B214-brainsci-10-00964"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>B.</given-names></name><name><surname>Saxena</surname><given-names>A.K.</given-names></name><name><surname>Chandan</surname><given-names>B.K.</given-names></name><name><surname>Agarwal</surname><given-names>S.G.</given-names></name><name><surname>Bhatia</surname><given-names>M.S.</given-names></name><name><surname>Anand</surname><given-names>K.K.</given-names></name></person-group><article-title>Hepatoprotective effect of ethanolic extract ofEclipta alba on experimental liver damage in rats and mice</article-title><source>Phytother. Res.</source><year>1993</year><volume>7</volume><fpage>154</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1002/ptr.2650070212</pub-id></element-citation></ref><ref id="B215-brainsci-10-00964"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhongade</surname><given-names>H.K.J.</given-names></name><name><surname>Paikra</surname><given-names>B.K.</given-names></name><name><surname>Gidwani</surname><given-names>B.</given-names></name></person-group><article-title>Phytochemistry and Pharmacology of <italic>Moringa oleifera</italic> Lam</article-title><source>J. Pharm.</source><year>2017</year><volume>20</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.3831/KPI.2017.20.022</pub-id><?supplied-pmid 30087795?><pub-id pub-id-type="pmid">30087795</pub-id></element-citation></ref><ref id="B216-brainsci-10-00964"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rani</surname><given-names>N.Z.A.</given-names></name><name><surname>Husain</surname><given-names>K.</given-names></name><name><surname>Kumolosasi</surname><given-names>E.</given-names></name></person-group><article-title>Moringa Genus: A Review of Phytochemistry and Pharmacology</article-title><source>Front. Pharm.</source><year>2018</year><volume>9</volume><fpage>108</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00108</pub-id><?supplied-pmid 29503616?><pub-id pub-id-type="pmid">29503616</pub-id></element-citation></ref><ref id="B217-brainsci-10-00964"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vergara-Jimenez</surname><given-names>M.</given-names></name><name><surname>AlMatrafi</surname><given-names>M.M.</given-names></name><name><surname>Fernandez</surname><given-names>M.L.</given-names></name></person-group><article-title>Bioactive Components in Moringa Oleifera Leaves Protect against Chronic Disease</article-title><source>Antioxidants</source><year>2017</year><volume>6</volume><elocation-id>91</elocation-id><pub-id pub-id-type="doi">10.3390/antiox6040091</pub-id></element-citation></ref><ref id="B218-brainsci-10-00964"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caceres</surname><given-names>A.</given-names></name><name><surname>Saravia</surname><given-names>A.</given-names></name><name><surname>Rizzo</surname><given-names>S.</given-names></name><name><surname>Zabala</surname><given-names>L.</given-names></name><name><surname>De Leon</surname><given-names>E.</given-names></name><name><surname>Nave</surname><given-names>F.</given-names></name></person-group><article-title>Pharmacologic properties of <italic>Moringa oleifera</italic>. 2: Screening for antispasmodic, antiinflammatory and diuretic activity</article-title><source>J. Ethnopharmacol.</source><year>1992</year><volume>36</volume><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(92)90049-W</pub-id><pub-id pub-id-type="pmid">1434682</pub-id></element-citation></ref><ref id="B219-brainsci-10-00964"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faizi</surname><given-names>S.</given-names></name><name><surname>Siddiqui</surname><given-names>B.S.</given-names></name><name><surname>Saleem</surname><given-names>R.</given-names></name><name><surname>Siddiqui</surname><given-names>S.</given-names></name><name><surname>Aftab</surname><given-names>K.</given-names></name><name><surname>Gilani</surname><given-names>A.-U.-H.</given-names></name></person-group><article-title>Fully acetylated carbamate and hypotensive thiocarbamate glycosides from Moringa oleifera</article-title><source>Phytochemistry</source><year>1995</year><volume>38</volume><fpage>957</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(94)00729-D</pub-id><pub-id pub-id-type="pmid">7766390</pub-id></element-citation></ref><ref id="B220-brainsci-10-00964"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghasi</surname><given-names>S.</given-names></name><name><surname>Nwobodo</surname><given-names>E.</given-names></name><name><surname>Ofili</surname><given-names>J.</given-names></name></person-group><article-title>Hypocholesterolemic effects of crude extract of leaf of Moringa oleifera Lam in high-fat diet fed wistar rats</article-title><source>J. Ethnopharmacol.</source><year>2000</year><volume>69</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(99)00106-3</pub-id><pub-id pub-id-type="pmid">10661880</pub-id></element-citation></ref><ref id="B221-brainsci-10-00964"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>M.</given-names></name><name><surname>Kaul</surname><given-names>N.</given-names></name><name><surname>Punekar</surname><given-names>A.</given-names></name><name><surname>Girnar</surname><given-names>R.</given-names></name><name><surname>Junnare</surname><given-names>P.</given-names></name><name><surname>Patil</surname><given-names>L.</given-names></name></person-group><article-title>Nootropic activity of Moringa oleifera leaves</article-title><source>J. Nat. Remed.</source><year>2005</year><volume>5</volume><fpage>59</fpage><lpage>62</lpage></element-citation></ref><ref id="B222-brainsci-10-00964"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>A.R.</given-names></name><name><surname>Vijayakumar</surname><given-names>M.</given-names></name><name><surname>Mathela</surname><given-names>C.S.</given-names></name><name><surname>Rao</surname><given-names>C.V.</given-names></name></person-group><article-title>In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves</article-title><source>Food Chem. Toxicol.</source><year>2009</year><volume>47</volume><fpage>2196</fpage><lpage>2201</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.06.005</pub-id><pub-id pub-id-type="pmid">19520138</pub-id></element-citation></ref><ref id="B223-brainsci-10-00964"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>R.</given-names></name><name><surname>Guha</surname><given-names>D.</given-names></name></person-group><article-title>Protective role of an Indian herb, Moringa oleifera in memory impairment by high altitude hypoxic exposure, Possible role of monoamines</article-title><source>Biog. Amines.</source><year>2006</year><volume>20</volume><fpage>121</fpage><lpage>133</lpage></element-citation></ref><ref id="B224-brainsci-10-00964"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>R.</given-names></name><name><surname>Guha</surname><given-names>D.</given-names></name></person-group><article-title>Alteration of brain monoamines &#x00026; EEG wave pattern in rat model of Alzheimer&#x02019;s disease &#x00026; protection by Moringa oleifera</article-title><source>Indian J. Med Res.</source><year>2008</year><volume>128</volume><fpage>744</fpage><lpage>751</lpage><?supplied-pmid 19246799?><pub-id pub-id-type="pmid">19246799</pub-id></element-citation></ref><ref id="B225-brainsci-10-00964"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutalangka</surname><given-names>C.</given-names></name><name><surname>Wattanathorn</surname><given-names>J.</given-names></name><name><surname>Muchimapura</surname><given-names>S.</given-names></name><name><surname>Thukham-Mee</surname><given-names>W.</given-names></name></person-group><article-title>Moringa oleiferaMitigates Memory Impairment and Neurodegeneration in Animal Model of Age-Related Dementia</article-title><source>Oxidative Med. Cell. Longev.</source><year>2013</year><volume>2013</volume><fpage>695936</fpage><pub-id pub-id-type="doi">10.1155/2013/695936</pub-id><?supplied-pmid 24454988?><pub-id pub-id-type="pmid">24454988</pub-id></element-citation></ref><ref id="B226-brainsci-10-00964"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>W.-S.</given-names></name><name><surname>Suo</surname><given-names>D.-Q.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>L.-X.</given-names></name><name><surname>Zeng</surname><given-names>K.-Y.</given-names></name><name><surname>Ren</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Moringa oleifera Seed Extract Alleviates Scopolamine-Induced Learning and Memory Impairment in Mice</article-title><source>Front. Pharm.</source><year>2018</year><volume>9</volume><fpage>389</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00389</pub-id><?supplied-pmid 29740317?><pub-id pub-id-type="pmid">29740317</pub-id></element-citation></ref><ref id="B227-brainsci-10-00964"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahaman</surname><given-names>Y.A.R.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wei</surname><given-names>Z.</given-names></name><name><surname>Bao</surname><given-names>J.</given-names></name><name><surname>Salissou</surname><given-names>M.T.M.</given-names></name><name><surname>Ke</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer&#x02019;s Disease-Like Pathology and Cognitive Impairments</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2018</year><volume>63</volume><fpage>1141</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.3233/JAD-180091</pub-id><pub-id pub-id-type="pmid">29710724</pub-id></element-citation></ref><ref id="B228-brainsci-10-00964"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adedapo</surname><given-names>A.A.</given-names></name><name><surname>Mogbojuri</surname><given-names>O.M.</given-names></name><name><surname>Emikpe</surname><given-names>B.O.</given-names></name></person-group><article-title>Safety evaluations of the aqueous extract of the leaves of Moringa oleifera in rats</article-title><source>J. Med. Plants Res.</source><year>2009</year><volume>3</volume><fpage>586</fpage><lpage>591</lpage></element-citation></ref><ref id="B229-brainsci-10-00964"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasolo</surname><given-names>J.N.</given-names></name><name><surname>Bimenya</surname><given-names>G.S.</given-names></name><name><surname>Ojok</surname><given-names>L.</given-names></name><name><surname>Ogwal-okeng</surname><given-names>J.W.</given-names></name></person-group><article-title>Phytochemicals and acute toxicity of Moringa oleifera roots in mice</article-title><source>J. Pharmacog. Phytother.</source><year>2011</year><volume>3</volume><fpage>38</fpage><lpage>42</lpage></element-citation></ref><ref id="B230-brainsci-10-00964"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M.</given-names></name><name><surname>Gm&#x000fc;nder</surname><given-names>F.</given-names></name><name><surname>Hamburger</surname><given-names>M.</given-names></name></person-group><article-title>Plants traditionally used in age related brain disorders&#x02014;A survey of ethnobotanical literature</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>113</volume><fpage>363</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.07.016</pub-id><pub-id pub-id-type="pmid">17720341</pub-id></element-citation></ref><ref id="B231-brainsci-10-00964"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V.K.</given-names></name><name><surname>Ali</surname><given-names>Z.A.</given-names></name><name><surname>Zaidi</surname><given-names>S.T.H.</given-names></name><name><surname>Siddiqui</surname><given-names>M.K.</given-names></name></person-group><article-title>Ethnomedicinal uses of plants of Gonda district forests of Uttar Pradesh, India</article-title><source>Fitoterapia.</source><year>1996</year><volume>2</volume><fpage>129</fpage><lpage>139</lpage></element-citation></ref><ref id="B232-brainsci-10-00964"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethiya</surname><given-names>N.K.</given-names></name></person-group><article-title>An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine</article-title><source>J. Chin. Integr. Med.</source><year>2009</year><volume>7</volume><fpage>1001</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.3736/jcim20091101</pub-id></element-citation></ref><ref id="B233-brainsci-10-00964"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Zafar</surname><given-names>R.-U.</given-names></name><name><surname>Shahid</surname><given-names>M.</given-names></name></person-group><article-title>Anticonvulsant potential of callus cultures of Convolvulus microphyllus Sieb</article-title><source>Orient. Pharm. Exp. Med.</source><year>2007</year><volume>7</volume><fpage>46</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.3742/OPEM.2007.7.1.046</pub-id></element-citation></ref><ref id="B234-brainsci-10-00964"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhingra</surname><given-names>D.</given-names></name><name><surname>Valecha</surname><given-names>R.</given-names></name></person-group><article-title>Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests</article-title><source>Med. Sci. Monit.</source><year>2007</year><volume>13</volume><fpage>BR155</fpage><lpage>BR161</lpage><?supplied-pmid 17599020?><pub-id pub-id-type="pmid">17599020</pub-id></element-citation></ref><ref id="B235-brainsci-10-00964"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>G.P.</given-names></name><name><surname>Pathak</surname><given-names>S.R.</given-names></name><name><surname>Gupta</surname><given-names>B.S.</given-names></name></person-group><article-title>Combined effect of Brahmi (<italic>Bacopa monniera</italic>) and Shankhpushpi (<italic>Convolvulus pluricaulis</italic>) on cognitive functions</article-title><source>Pharmacopsychoecol</source><year>1994</year><volume>3</volume><fpage>249</fpage><lpage>251</lpage></element-citation></ref><ref id="B236-brainsci-10-00964"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Arora</surname><given-names>V.</given-names></name><name><surname>Rana</surname><given-names>A.C.</given-names></name><name><surname>Bhatnagar</surname><given-names>M.</given-names></name></person-group><article-title>Anxiolytic effect of Convolvulus pluricaulis petals on elevated plus maze model of anxiety in mice</article-title><source>J. Herb. Med. Toxicol.</source><year>2009</year><volume>1</volume><fpage>41</fpage><lpage>46</lpage></element-citation></ref><ref id="B237-brainsci-10-00964"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahata</surname><given-names>A.</given-names></name><name><surname>Patil</surname><given-names>U.K.</given-names></name><name><surname>Dixit</surname><given-names>V.K.</given-names></name></person-group><article-title>Effect of Convulvulus pluricaulis Choisy on learning behavior and memory enhancement activity in rodents</article-title><source>Nat. Prod. Res.</source><year>2008</year><volume>22</volume><fpage>1472</fpage><lpage>1482</lpage><pub-id pub-id-type="doi">10.1080/14786410802214199</pub-id><?supplied-pmid 19023811?><pub-id pub-id-type="pmid">19023811</pub-id></element-citation></ref><ref id="B238-brainsci-10-00964"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asthana</surname><given-names>S.</given-names></name><name><surname>Greig</surname><given-names>N.H.</given-names></name><name><surname>Holloway</surname><given-names>H.W.</given-names></name><name><surname>Raffaele</surname><given-names>K.C.</given-names></name><name><surname>Berardi</surname><given-names>A.</given-names></name><name><surname>Schapiro</surname><given-names>M.B.</given-names></name><name><surname>Rapoport</surname><given-names>S.I.</given-names></name><name><surname>Soncrant</surname><given-names>T.T.</given-names></name></person-group><article-title>Clinical pharmacokinetics of arecoline in subjects with Alzheimer&#x02019;s disease</article-title><source>Clin. Pharm.</source><year>1996</year><volume>60</volume><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/S0009-9236(96)90054-5</pub-id></element-citation></ref><ref id="B239-brainsci-10-00964"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzaev</surname><given-names>Y.R.</given-names></name><name><surname>Aripova</surname><given-names>S.F.</given-names></name></person-group><article-title>Neuro- and psychopharmacological investigation of the alkaloids convolvine and atropine</article-title><source>Chem. Nat. Compd.</source><year>1998</year><volume>34</volume><fpage>56</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/BF02249687</pub-id></element-citation></ref><ref id="B240-brainsci-10-00964"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Bhatnagar</surname><given-names>M.</given-names></name><name><surname>Kulkarni</surname><given-names>S.K.</given-names></name></person-group><article-title>Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: A comparative evaluation</article-title><source>Indian J. Exp. Boil.</source><year>2010</year><volume>48</volume><fpage>479</fpage><lpage>485</lpage></element-citation></ref><ref id="B241-brainsci-10-00964"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>M.</given-names></name><name><surname>Mali</surname><given-names>P.C.</given-names></name><name><surname>Dixit</surname><given-names>V.P.</given-names></name></person-group><article-title>Hypolipidaemic effect of Convolvulus microphyllus on cholesterol fed gerbils</article-title><source>J. Phytol. Res.</source><year>1997</year><volume>2</volume><fpage>153</fpage><lpage>155</lpage></element-citation></ref><ref id="B242-brainsci-10-00964"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bihaqi</surname><given-names>S.W.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>A.P.</given-names></name><name><surname>Tiwari</surname><given-names>M.</given-names></name></person-group><article-title>Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>124</volume><fpage>409</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.05.038</pub-id><pub-id pub-id-type="pmid">19505562</pub-id></element-citation></ref><ref id="B243-brainsci-10-00964"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.-F.</given-names></name><name><surname>Durairajan</surname><given-names>S.S.K.</given-names></name><name><surname>Lu</surname><given-names>J.-H.</given-names></name><name><surname>Koo</surname><given-names>I.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name></person-group><article-title>In vitro screening on amyloid precursor protein modulation of plants used in Ayurvedic and Traditional Chinese medicine for memory improvement</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>141</volume><fpage>754</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.08.065</pub-id><pub-id pub-id-type="pmid">21920424</pub-id></element-citation></ref><ref id="B244-brainsci-10-00964"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>J.</given-names></name><name><surname>Karan</surname><given-names>M.</given-names></name><name><surname>Vasisht</surname><given-names>K.</given-names></name></person-group><article-title>Attenuating effect of bioactive coumarins from Convolvulus pluricaulis on scopolamine-induced amnesia in mice</article-title><source>Nat. Prod. Res.</source><year>2016</year><volume>30</volume><fpage>578</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1080/14786419.2015.1025398</pub-id><?supplied-pmid 25828605?><pub-id pub-id-type="pmid">25828605</pub-id></element-citation></ref><ref id="B245-brainsci-10-00964"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawar</surname><given-names>S.A.</given-names></name><name><surname>Dhuley</surname><given-names>J.</given-names></name><name><surname>Naik</surname><given-names>S.</given-names></name></person-group><article-title>Neuropharmacology of an Extract derived from Convolvulus microphyllus</article-title><source>Pharm. Biol.</source><year>2001</year><volume>39</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1076/phbi.39.4.253.5920</pub-id></element-citation></ref><ref id="B246-brainsci-10-00964"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name></person-group><article-title>Nootropic effect of BR-16A (Mentat), a psychotropic herbal formulation, on cognitive deficits induced by prenatal undernutrition, postnatal environmental impoverishment and hypoxia in rats</article-title><source>Indian J. Exp. Boil.</source><year>1994</year><volume>32</volume><fpage>31</fpage><lpage>36</lpage></element-citation></ref><ref id="B247-brainsci-10-00964"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faruqi</surname><given-names>S.</given-names></name><name><surname>Andrade</surname><given-names>C.</given-names></name><name><surname>Ramteke</surname><given-names>S.</given-names></name><name><surname>Joseph</surname><given-names>J.</given-names></name><name><surname>Venkataraman</surname><given-names>B.V.</given-names></name><name><surname>Rani</surname><given-names>M.A.N.</given-names></name></person-group><article-title>Herbal pharmacotherapy for the attenuation of electroconvulsive shock-induced anterograde and retrograde amnestic deficits</article-title><source>Convuls. Ther.</source><year>1995</year><volume>11</volume><fpage>241</fpage><lpage>247</lpage><?supplied-pmid 8919574?><pub-id pub-id-type="pmid">8919574</pub-id></element-citation></ref><ref id="B248-brainsci-10-00964"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>S.S.</given-names></name><name><surname>Bhargava</surname><given-names>V.K.</given-names></name></person-group><article-title>Effect of BR-16A (MentatR) on cognitive deficits in aluminium-treated and aged rats</article-title><source>Indian J. Pharmacol.</source><year>1997</year><volume>29</volume><fpage>258</fpage><lpage>261</lpage></element-citation></ref><ref id="B249-brainsci-10-00964"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramteke</surname><given-names>S.</given-names></name><name><surname>Andrade</surname><given-names>C.</given-names></name><name><surname>Faruqi</surname><given-names>S.</given-names></name><name><surname>Joseph</surname><given-names>J.</given-names></name><name><surname>Venkataraman</surname><given-names>B.V.</given-names></name><name><surname>Naga Rani</surname><given-names>M.A.</given-names></name></person-group><article-title>BR-16A attenuates anterograde amnesia induced by electro-convulsive shocks in slow-learning rats</article-title><source>Indian J. Pharmacol.</source><year>1995</year><volume>27</volume><fpage>186</fpage><lpage>188</lpage></element-citation></ref><ref id="B250-brainsci-10-00964"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>A.</given-names></name><name><surname>Kulkarni</surname><given-names>S.K.</given-names></name></person-group><article-title>Effect of a herbal psychotropic preparation, BR-16A (Mentat), on performance of mice on elevated plus-maze</article-title><source>Indian J. Exp. Boil.</source><year>1991</year><volume>29</volume><fpage>1120</fpage><lpage>1123</lpage></element-citation></ref><ref id="B251-brainsci-10-00964"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Jaiswal</surname><given-names>A.K.</given-names></name></person-group><article-title>Effect of Mentat, a Herbal Formulation, on Experimental Models of Alzheimer&#x02019;s Disease and Central Cholinergic Markers in Rats</article-title><source>Fitoterapia</source><year>1995</year><volume>3</volume><fpage>216</fpage></element-citation></ref><ref id="B252-brainsci-10-00964"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A.</given-names></name><name><surname>Dubey</surname><given-names>M.</given-names></name><name><surname>Dubey</surname><given-names>G.P.</given-names></name></person-group><article-title>Effect of Mentat on memory, anxiety scores and neuroticism index in normal subjectsin three age groups</article-title><source>Probe</source><year>1991</year><volume>3</volume><fpage>257</fpage><lpage>261</lpage></element-citation></ref><ref id="B253-brainsci-10-00964"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koti</surname><given-names>S.T.</given-names></name></person-group><article-title>Effect of Mentat on school students performance</article-title><source>Probe</source><year>1991</year><volume>3</volume><fpage>250</fpage><lpage>252</lpage></element-citation></ref><ref id="B254-brainsci-10-00964"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagetia</surname><given-names>G.C.</given-names></name><name><surname>Baliga</surname><given-names>M.S.</given-names></name></person-group><article-title>Treatment of mice with a herbal preparation (Mentat) protects against radiation-induced mortality</article-title><source>Phytother. Res.</source><year>2003</year><volume>17</volume><fpage>876</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1002/ptr.1142</pub-id><?supplied-pmid 13680816?><pub-id pub-id-type="pmid">13680816</pub-id></element-citation></ref><ref id="B255-brainsci-10-00964"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group><article-title>Effect of Trasina<sup>&#x000ae;</sup>, an Ayurvedic Herbal Formulation, on Experimental Models of Alzheimer&#x02019;s Disease and Central Cholinergic Markers in Rats</article-title><source>J. Altern. Complement. Med.</source><year>1997</year><volume>3</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1089/acm.1997.3.327</pub-id><?supplied-pmid 9449054?><pub-id pub-id-type="pmid">9449054</pub-id></element-citation></ref><ref id="B256-brainsci-10-00964"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>C.</given-names></name><name><surname>Gowda</surname><given-names>S.</given-names></name><name><surname>Chaturvedi</surname><given-names>S.</given-names></name></person-group><article-title>Treatment of Age-Related Cognitive Decline with a Herbal Formulation: A Double-Blind Study</article-title><source>Indian J. Psychiatry</source><year>1998</year><volume>40</volume><fpage>240</fpage><lpage>246</lpage><?supplied-pmid 21494479?><pub-id pub-id-type="pmid">21494479</pub-id></element-citation></ref><ref id="B257-brainsci-10-00964"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinekar</surname><given-names>A.S.</given-names></name><name><surname>Andrade</surname><given-names>C.</given-names></name><name><surname>Sriprada</surname><given-names>V.T.</given-names></name><name><surname>George</surname><given-names>J.</given-names></name><name><surname>Joseph</surname><given-names>T.</given-names></name><name><surname>Chandra</surname><given-names>J.S.</given-names></name></person-group><article-title>Attenuation of ECS-Induced Retrograde Amnesia by Using an Herbal Formulation</article-title><source>J. ECT</source><year>1998</year><volume>14</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1097/00124509-199806000-00004</pub-id><pub-id pub-id-type="pmid">9641803</pub-id></element-citation></ref><ref id="B258-brainsci-10-00964"><label>258.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>B.</given-names></name></person-group><source>Caraka Samhita</source><edition>3rd ed.</edition><publisher-name>Chaukhamba Surbharati Prakashan</publisher-name><publisher-loc>Vanarasi, India</publisher-loc><year>1994</year><volume>Volume 2</volume></element-citation></ref><ref id="B259-brainsci-10-00964"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achliya</surname><given-names>G.</given-names></name><name><surname>Barabde</surname><given-names>U.</given-names></name><name><surname>Wadodkar</surname><given-names>S.</given-names></name><name><surname>Dorle</surname><given-names>A.</given-names></name></person-group><article-title>Effect of Bramhi Ghrita, an polyherbal formulation on learning and memory paradigms in experimental animals</article-title><source>Indian J. Pharmacol.</source><year>2004</year><volume>36</volume><fpage>159</fpage><lpage>162</lpage></element-citation></ref><ref id="B260-brainsci-10-00964"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>K.R.C.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name><name><surname>Yadav</surname><given-names>K.D.</given-names></name></person-group><article-title>Beneficial effect of Brahmi Ghrita on learning and memory in normal rat</article-title><source>Ayu (Int. Q. J. Res. Ayurveda)</source><year>2014</year><volume>35</volume><fpage>325</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.4103/0974-8520.153755</pub-id></element-citation></ref><ref id="B261-brainsci-10-00964"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parle</surname><given-names>M.</given-names></name><name><surname>Vasudevan</surname><given-names>M.</given-names></name></person-group><article-title>Memory Enhancing Activity of Abana<sup>&#x000ae;</sup>: An Indian Ayurvedic Poly-Herbal Formulation</article-title><source>J. Health Sci.</source><year>2007</year><volume>53</volume><fpage>43</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1248/jhs.53.43</pub-id></element-citation></ref><ref id="B262-brainsci-10-00964"><label>262.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>USFDA</collab></person-group><article-title>Botanical Drug Development: Guidance for Industry</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/botanical-drug-development-guidance-industry">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/botanical-drug-development-guidance-industry</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-19">(accessed on 19 October 2020)</date-in-citation></element-citation></ref><ref id="B263-brainsci-10-00964"><label>263.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>EMA</collab></person-group><article-title>Human Regulatory-Herbal Medicinal Products</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/human-regulatory/herbal-medicinal-products">https://www.ema.europa.eu/en/human-regulatory/herbal-medicinal-products</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-19">(accessed on 19 October 2020)</date-in-citation></element-citation></ref><ref id="B264-brainsci-10-00964"><label>264.</label><element-citation publication-type="gov"><article-title>New Drugs and Clinical Trials Rules</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDrugs_CTRules_2019.pdf">https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDrugs_CTRules_2019.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-29">(accessed on 29 October 2020)</date-in-citation></element-citation></ref><ref id="B265-brainsci-10-00964"><label>265.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>ASU Drug Industry</collab></person-group><source>Good Manufacturing Practices for Ayurvedic, Siddha and Unani Medicines</source><publisher-name>Department of AYUSH, Ministry of Health &#x00026; Family Welfare, Government of India</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>2014</year></element-citation></ref><ref id="B266-brainsci-10-00964"><label>266.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Department of AYUSH</collab></person-group><source>Good Clinical Trial Practices for Clinical Trials in Ayurveda, Siddha and Unani Medicine (GCP-ASU)</source><publisher-name>Department of AYUSH, Ministry of Health &#x00026; Family Welfare, Government of India</publisher-name><publisher-loc>New Delhi, India</publisher-loc><year>2013</year></element-citation></ref><ref id="B267-brainsci-10-00964"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S.-F.</given-names></name><name><surname>Zhou</surname><given-names>Z.-W.</given-names></name><name><surname>Li</surname><given-names>C.G.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Xue</surname><given-names>C.C.</given-names></name><name><surname>Herington</surname><given-names>A.C.</given-names></name></person-group><article-title>Identification of drugs that interact with herbs in drug development</article-title><source>Drug Discov. Today</source><year>2007</year><volume>12</volume><fpage>664</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2007.06.004</pub-id><pub-id pub-id-type="pmid">17706549</pub-id></element-citation></ref><ref id="B268-brainsci-10-00964"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>D.A.</given-names></name><name><surname>Seely</surname><given-names>D.M.R.</given-names></name></person-group><article-title>Clinically based evidence of drug-herb interactions: A systematic review</article-title><source>Expert Opin. Drug Saf.</source><year>2009</year><volume>9</volume><pub-id pub-id-type="doi">10.1517/14740330903405593</pub-id></element-citation></ref><ref id="B269-brainsci-10-00964"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izzo</surname><given-names>A.A.</given-names></name><name><surname>Ernst</surname><given-names>E.</given-names></name></person-group><article-title>Interactions between herbal medicines and prescribed drugs: An updated systematic review</article-title><source>Drugs</source><year>2009</year><volume>69</volume><fpage>1777</fpage><lpage>1798</lpage><pub-id pub-id-type="doi">10.2165/11317010-000000000-00000</pub-id><pub-id pub-id-type="pmid">19719333</pub-id></element-citation></ref><ref id="B270-brainsci-10-00964"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farlow</surname><given-names>M.R.</given-names></name></person-group><article-title>Clinical Pharmacokinetics of Galantamine</article-title><source>Clin. Pharm.</source><year>2003</year><volume>42</volume><fpage>1383</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.2165/00003088-200342150-00005</pub-id><?supplied-pmid 14674789?><pub-id pub-id-type="pmid">14674789</pub-id></element-citation></ref><ref id="B271-brainsci-10-00964"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shintani</surname><given-names>E.Y.</given-names></name><name><surname>Uchida</surname><given-names>K.M.</given-names></name></person-group><article-title>Donepezil: An anticholinesterase inhibitor for Alzheimer&#x02019;s disease</article-title><source>Am. J. Health Pharm.</source><year>1997</year><volume>54</volume><fpage>2805</fpage><lpage>2810</lpage><pub-id pub-id-type="doi">10.1093/ajhp/54.24.2805</pub-id><?supplied-pmid 9428950?><pub-id pub-id-type="pmid">9428950</pub-id></element-citation></ref><ref id="B272-brainsci-10-00964"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>V.</given-names></name></person-group><article-title>Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal</article-title><source>Curr. Drug Metab.</source><year>2018</year><volume>19</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.2174/1389200218666171031123738</pub-id><?supplied-pmid 29086684?><pub-id pub-id-type="pmid">29086684</pub-id></element-citation></ref><ref id="B273-brainsci-10-00964"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinyemi</surname><given-names>A.J.</given-names></name><name><surname>Oboh</surname><given-names>G.</given-names></name><name><surname>Oyeleye</surname><given-names>S.I.</given-names></name><name><surname>Ogunsuyi</surname><given-names>O.</given-names></name></person-group><article-title>Anti-amnestic Effect of Curcumin in Combination with Donepezil, an Anticholinesterase Drug: Involvement of Cholinergic System</article-title><source>Neurotox. Res.</source><year>2017</year><volume>31</volume><fpage>560</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1007/s12640-017-9701-5</pub-id><pub-id pub-id-type="pmid">28102474</pub-id></element-citation></ref><ref id="B274-brainsci-10-00964"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wei</surname><given-names>H.</given-names></name></person-group><article-title>Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer&#x02019;s disease based on the fusion of donepezil and curcumin</article-title><source>Bioorganic Med. Chem.</source><year>2017</year><volume>25</volume><fpage>2946</fpage><lpage>2955</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2017.02.048</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="brainsci-10-00964-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>General pathogenesis of Alzheimer&#x02019;s disease (APP, amyloid precursor protein).</p></caption><graphic xlink:href="brainsci-10-00964-g001"/></fig><fig id="brainsci-10-00964-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Multipronged approach of herbal medicines in Alzheimer&#x02019;s disease.</p></caption><graphic xlink:href="brainsci-10-00964-g002"/></fig></floats-group></article>